<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article article-type="research-article" dtd-version="1.2" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">69288</article-id><article-id pub-id-type="doi">10.7554/eLife.69288</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group></article-categories><title-group><article-title>Tbx5 drives <italic>Aldh1a2</italic> expression to regulate a RA-Hedgehog-Wnt gene regulatory network coordinating cardiopulmonary development</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-184350"><name><surname>Rankin</surname><given-names>Scott A</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3953-6016</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-234910"><name><surname>Steimle</surname><given-names>Jeffrey D</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="pa1">†</xref><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-97124"><name><surname>Yang</surname><given-names>Xinan H</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-234911"><name><surname>Rydeen</surname><given-names>Ariel B</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-234912"><name><surname>Agarwal</surname><given-names>Kunal</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-129892"><name><surname>Chaturvedi</surname><given-names>Praneet</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-234913"><name><surname>Ikegami</surname><given-names>Kohta</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="pa2">‡</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-234914"><name><surname>Herriges</surname><given-names>Michael J</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7842-9515</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-107483"><name><surname>Moskowitz</surname><given-names>Ivan P</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0014-4963</contrib-id><email>imoskowitz@peds.bsd.uchicago.edu</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-69925"><name><surname>Zorn</surname><given-names>Aaron M</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3217-3590</contrib-id><email>aaron.zorn@cchmc.org</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Center for Stem Cell and Organoid Medicine (CuSTOM), Division of Developmental Biology, Perinatal Institute, Cincinnati Children’s Hospital Medical Center</institution><addr-line><named-content content-type="city">Cincinnati</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution>Department of Pediatrics, University of Chicago</institution><addr-line><named-content content-type="city">Chicago</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution>Department of Pathology, University of Chicago</institution><addr-line><named-content content-type="city">Chicago</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution>Department of Human Genetics, University of Chicago</institution><addr-line><named-content content-type="city">Chicago</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution>University of Cincinnati, College of Medicine, Department of Pediatrics</institution><addr-line><named-content content-type="city">Chicago</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Morrisey</surname><given-names>Edward E</given-names></name><role>Reviewing Editor</role><aff><institution>University of Pennsylvania</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Morrisey</surname><given-names>Edward E</given-names></name><role>Senior Editor</role><aff><institution>University of Pennsylvania</institution><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="present-address" id="pa1"><label>†</label><p>Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, United States</p></fn><fn fn-type="present-address" id="pa2"><label>‡</label><p>Division of Molecular and Cardiovascular Biology, Heart Institute, Cincinnati Children’s Hospital Medical Center, Cincinnati, United States</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>13</day><month>10</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e69288</elocation-id><history><date date-type="received" iso-8601-date="2021-04-10"><day>10</day><month>04</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2021-09-23"><day>23</day><month>09</month><year>2021</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2021-04-11"><day>11</day><month>04</month><year>2021</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2021.04.09.439219"/></event></pub-history><permissions><copyright-statement>© 2021, Rankin et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Rankin et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-69288-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-69288-figures-v2.pdf"/><abstract><p>The gene regulatory networks that coordinate the development of the cardiac and pulmonary systems are essential for terrestrial life but poorly understood. The T-box transcription factor Tbx5 is critical for both pulmonary specification and heart development, but how these activities are mechanistically integrated remains unclear. Here using <italic>Xenopus</italic> and mouse embryos, we establish molecular links between Tbx5 and retinoic acid (RA) signaling in the mesoderm and between RA signaling and sonic hedgehog expression in the endoderm to unveil a conserved RA-Hedgehog-Wnt signaling cascade coordinating cardiopulmonary (CP) development. We demonstrate that Tbx5 directly maintains expression of <italic>aldh1a2,</italic> the RA-synthesizing enzyme, in the foregut lateral plate mesoderm via an evolutionarily conserved intronic enhancer. Tbx5 promotes posterior second heart field identity in a positive feedback loop with RA, antagonizing a Fgf8-Cyp regulatory module to restrict FGF activity to the anterior. We find that Tbx5/Aldh1a2-dependent RA signaling directly activates <italic>shh</italic> transcription in the adjacent foregut endoderm through a conserved MACS1 enhancer. Hedgehog signaling coordinates with Tbx5 in the mesoderm to activate expression of <italic>wnt2/2b,</italic> which induces pulmonary fate in the foregut endoderm. These results provide mechanistic insight into the interrelationship between heart and lung development informing CP evolution and birth defects.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd><italic>Xenopus</italic></kwd><kwd>retinoic acid</kwd><kwd>cardiopulmonary</kwd><kwd>lung development</kwd><kwd>Tbx5 transcription factor</kwd><kwd>mouse</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>Xenopus</italic></kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009633</institution-id><institution>Eunice Kennedy Shriver National Institute of Child Health and Human Development</institution></institution-wrap></funding-source><award-id>P01HD093363</award-id><principal-award-recipient><name><surname>Zorn</surname><given-names>Aaron M</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000050</institution-id><institution>National Heart, Lung, and Blood Institute</institution></institution-wrap></funding-source><award-id>R01HL092153</award-id><principal-award-recipient><name><surname>Moskowitz</surname><given-names>Ivan P</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000050</institution-id><institution>National Heart, Lung, and Blood Institute</institution></institution-wrap></funding-source><award-id>R01HL124836</award-id><principal-award-recipient><name><surname>Moskowitz</surname><given-names>Ivan P</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>T32GM007183</award-id><principal-award-recipient><name><surname>Steimle</surname><given-names>Jeffrey D</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000050</institution-id><institution>National Heart, Lung, and Blood Institute</institution></institution-wrap></funding-source><award-id>T32HL007381</award-id><principal-award-recipient><name><surname>Steimle</surname><given-names>Jeffrey D</given-names></name><name><surname>Rydeen</surname><given-names>Ariel B</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Epistatic analysis in <italic>Xenopus</italic> and mouse embryos reveals an evolutionarily conserved gene regulatory network downstream of the transcription factor Tbx5 and retinoic acid that coordinates cardiac and pulmonary development.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Proper integration of the cardiac and pulmonary systems begins during early embryogenesis and is essential for terrestrial life. A key feature of cardiopulmonary (CP) development is evolutionarily conserved bi-directional paracrine signaling between the foregut endoderm, which gives rise to pulmonary epithelium, and the cardiogenic mesoderm (<xref ref-type="bibr" rid="bib93">Xie et al., 2012</xref>; <xref ref-type="bibr" rid="bib60">Rankin et al., 2016</xref>; <xref ref-type="bibr" rid="bib78">Steimle et al., 2018</xref>). The interplay between these signals and lineage-specific transcription factors (TFs) to control lineage-specific gene regulatory networks (GRNs) for heart and lung morphogenesis is poorly understood. A better understanding of these CP GRNs will provide insight into the orchestration of heart and lung development and inform the molecular basis of life-threatening CP birth defects.</p><p>The vertebrate heart forms from two distinct populations of cardiac progenitor cells in the anterior lateral plate mesoderm (lpm), termed the first and second heart fields, respectively (FHF and SHF; <xref ref-type="bibr" rid="bib36">Kelly et al., 2014</xref>). The FHF differentiates first and forms the early heart tube, including portions of the two atria and left ventricle. The SHF contributes to the anterior and posterior poles of the developing heart and differentiates later. The anterior SHF (aSHF) is characterized by the expression of <italic>Fgf8, Fgf10</italic>, and <italic>Tbx1</italic> and generates the right ventricle, portions of the outflow tract, and pharyngeal mesoderm (<xref ref-type="bibr" rid="bib62">Rochais et al., 2009</xref>; <xref ref-type="bibr" rid="bib36">Kelly et al., 2014</xref>). The posterior SHF (pSHF) is characterized by the expression of <italic>Tbx5, Osr1</italic>, and <italic>Foxf1</italic>, (<xref ref-type="bibr" rid="bib93">Xie et al., 2012</xref>; <xref ref-type="bibr" rid="bib28">Hoffmann et al., 2014</xref>; <xref ref-type="bibr" rid="bib78">Steimle et al., 2018</xref>) and generates the atrial septum and sinus venosus. A subset of the pSHF marked by <italic>Isl1, Gli1,</italic> and <italic>Wnt2</italic> expression contains multipotent cardiopulmonary progenitors (CPPs) that give rise to lung mesenchyme, pulmonary vasculature, and myocardium of the inflow tract (<xref ref-type="bibr" rid="bib55">Peng et al., 2013</xref>). CPPs are both the recipient and source of reciprocal signaling with the adjacent pulmonary endoderm essential for heart and lung development.</p><p>The T-box TF Tbx5 is a key player coordinating CP organogenesis. Numerous studies in vertebrate animal models over the past 20 years have documented conserved <italic>Tbx5</italic> expression initially in the FHF and then later in the pSHF. Heterozygous mutations in human<italic>TBX5</italic> cause Holt–Oram syndrome with congenital heart anomalies including atrial septal defects and hypoplastic left heart (<xref ref-type="bibr" rid="bib40">Li et al., 1997</xref>; <xref ref-type="bibr" rid="bib63">Ryan and Chin, 2003</xref>). <italic>Tbx5<sup>−/</sup></italic><sup>−</sup> null mutant mice die between E9.5 and E10.5 with severe cardiac deficiencies and a failure of pulmonary development (<xref ref-type="bibr" rid="bib5">Bruneau et al., 2001</xref>; <xref ref-type="bibr" rid="bib93">Xie et al., 2012</xref>; <xref ref-type="bibr" rid="bib28">Hoffmann et al., 2014</xref>; <xref ref-type="bibr" rid="bib78">Steimle et al., 2018</xref>; <xref ref-type="bibr" rid="bib12">De Bono et al., 2018</xref>). While significant advances have been made in understanding the TBX5-regulated GRNs controlling cardiomyocyte development (<xref ref-type="bibr" rid="bib34">Kathiriya et al., 2021</xref>), how TBX5 coordinates heart and lung organogenesis is less clear. We recently showed that Tbx5 is non-cell-autonomously required to activate expression of Hedgehog (Hh) ligands in the adjacent foregut endoderm, which are essential for both heart and lung development (<xref ref-type="bibr" rid="bib78">Steimle et al., 2018</xref>). Endodermal Hh signals back to the lpm stimulating Gli TFs, which cooperate with Tbx5 to directly activate expression of mesodermal <italic>Wnt2/2b</italic> signals that are essential to induce pulmonary fate in the adjacent foregut endoderm (<xref ref-type="bibr" rid="bib78">Steimle et al., 2018</xref>; <xref ref-type="bibr" rid="bib22">Goss et al., 2009</xref>; <xref ref-type="bibr" rid="bib25">Harris-Johnson et al., 2009</xref>). Tbx5 is thereby required for establishing the reciprocal mesoderm—endoderm—mesoderm signaling loop that coordinates CP development. A major unanswered question is how Tbx5 non-cell-autonomously activates sonic hedgehog (Shh) ligand expression in the foregut endoderm.</p><p>Retinoic acid (RA) signaling is a strong candidate for the Tbx5-dependent signal that activates endodermal <italic>Shh</italic> expression. Like <italic>Tbx5</italic> mutants, RA deficient embryos have reduced <italic>Shh</italic> expression in the foregut (<xref ref-type="bibr" rid="bib89">Wang et al., 2006</xref>; <xref ref-type="bibr" rid="bib60">Rankin et al., 2016</xref>) and manifest multiple cardiac and pulmonary defects, like Tbx5 mutants (<xref ref-type="bibr" rid="bib95">Zaffran et al., 2014</xref>; <xref ref-type="bibr" rid="bib92">Xavier-Neto et al., 2015</xref>; <xref ref-type="bibr" rid="bib57">Perl and Waxman, 2019</xref>; <xref ref-type="bibr" rid="bib73">Sirbu et al., 2020</xref>). RA, a derivative of vitamin A, is produced in the lpm by the aldehyde dehydrogenase enzyme Aldh1a2, which converts cellular retinaldehyde into RA (<xref ref-type="bibr" rid="bib50">Niederreither et al., 1999</xref>; <xref ref-type="bibr" rid="bib47">Metzler and Sandell, 2016</xref>). <italic>Aldh1a2</italic> and <italic>Tbx5</italic> are co-expressed in a subset of the pSHF and previous studies have shown that RA patterns the SHF by promoting <italic>Tbx5+</italic> pSHF identity whilst repressing <italic>Tbx1<sup>+</sup></italic> aSHF fate (<xref ref-type="bibr" rid="bib51">Niederreither et al., 2001</xref>; <xref ref-type="bibr" rid="bib72">Sirbu et al., 2008</xref>; <xref ref-type="bibr" rid="bib64">Ryckebusch et al., 2008</xref>; <xref ref-type="bibr" rid="bib14">Deimling and Drysdale, 2009</xref>; <xref ref-type="bibr" rid="bib65">Ryckebüsch et al., 2010</xref>; <xref ref-type="bibr" rid="bib66">Rydeen and Waxman, 2016</xref>; <xref ref-type="bibr" rid="bib60">Rankin et al., 2016</xref>; <xref ref-type="bibr" rid="bib12">De Bono et al., 2018</xref>). How the regional production of RA is controlled to pattern the SHF and regulate <italic>shh</italic> expression remains unknown.</p><p>In this study, we demonstrate that RA signaling is the link between mesodermal Tbx5 activity and endodermal <italic>Shh</italic> expression. We further define the molecular basis by which Tbx5 drives RA signaling and by which RA signaling drives <italic>Shh</italic> expression. Specifically, Tbx5 directly maintains expression of <italic>Aldh1a2</italic> in pSHF via an evolutionarily conserved intronic enhancer, and Tbx5/Aldh1a2-dependent RA signaling directly activates <italic>Shh</italic> transcription in the foregut endoderm via an evolutionarily conserved MACS1 endoderm enhancer. We conclude that Tbx5 coordinates CP development by controlling expression of the RA-producing enzyme <italic>Aldh1a2</italic>, and that this RA signal initiates a mesenchyme-epithelial signaling cascade that controls both Hh/Wnt-dependent lung induction and SHF patterning. Hh/Gli and Tbx5 then cooperate to promote Wnt2/2b expression and lung induction. This work unifies previously unconnected observations to resolve the molecular basis of a mesoderm-endoderm-mesoderm signaling network that coordinates pulmonary induction and SHF cardiac patterning.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Tbx5 regulates cardiopulmonary development and <italic>Aldh1a2</italic> expression in mouse</title><p>To investigate the Tbx5-regulated GRN that coordinates heart and lung development, we re-examined our published RNA-seq data of CP tissue (containing both foregut mesoderm and endoderm) micro-dissected from wild-type (WT) and <italic>Tbx5<sup>−/</sup></italic><sup>−</sup> mouse embryos at E9.5 (<xref ref-type="bibr" rid="bib78">Steimle et al., 2018</xref>). Differential expression analysis revealed 1588 upregulated genes and 1480 downregulated genes and in the absence of <italic>Tbx5</italic> (≥1.5 fold change and 5% FDR) (<xref ref-type="fig" rid="fig1">Figure 1A</xref>; <xref ref-type="supplementary-material" rid="fig1sdata1">Figure 1—source data 1</xref>; <xref ref-type="bibr" rid="bib78">Steimle et al., 2018</xref>). Reduced expression of Hh signaling components (<italic>Shh</italic>, <italic>Ihh</italic>, and <italic>Patch2</italic>), Hh-targets (<italic>Hhip</italic> and <italic>Gli1</italic>), the lung-inducing <italic>Wnt2/2b</italic> ligands, and pulmonary progenitor marker <italic>Nkx2-1</italic>, indicated a loss of pulmonary fate in <italic>Tbx5<sup>−/</sup></italic><sup>−</sup> mutant CPP tissue (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). We examined the relationship between pSHF/lung and aSHF/pharyngeal transcripts in <italic>Tbx5<sup>−/</sup></italic><sup>−</sup> embryos by intersecting the Tbx5-regulated transcriptome with gene sets from recent single-cell RNA-seq studies of the developing E7.75–E9.5 mouse heart and foregut that define aSHF, pSHF, pharynx, and lung progenitor cells (<xref ref-type="bibr" rid="bib13">de Soysa et al., 2019</xref>; <xref ref-type="bibr" rid="bib24">Han et al., 2020</xref>, <xref ref-type="supplementary-material" rid="supp2 supp3">Supplementary files 2 and 3</xref>). We found that 25% of genes (91/366) specifically enriched in aSHF or pharyngeal cells, but only 5% of genes (10/213) specifically enriched in pSHF or lung progenitors, overlapped with transcripts upregulated in the <italic>Tbx5<sup>−/</sup></italic><sup>−</sup> mutants (*p&lt;0.0001, hypergeometric probability test, HGT) (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). On the other hand, 34% of the pSHF or lung marker genes (72/213) but only 6% of the pSHF+ pharynx enriched genes (21/366) were downregulated in <italic>Tbx5<sup>−/</sup></italic><sup>−</sup> mutants (*p&lt;0.001, HGT) (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). The aSHF-enriched genes upregulated in <italic>Tbx5<sup>−/</sup></italic><sup>−</sup> CP tissue included well-known patterning genes <italic>Hand1, Irx3, Irx5, Mef2c, Meg3, and Tlx1</italic> as well as FGF signaling components and targets including <italic>Fgf8, Fgf10, Spry1, Spry2</italic>, and <italic>Dusp6</italic> (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). Gene set enrichment analysis (GSEA) confirmed a statistically significant overrepresentation of aSHF/pharynx genes among upregulated genes (normalized enrichment score [NES]=1.58; p&lt;0.0001) and overrepresentation of pSHF/lung transcripts among the downregulated genes (NES=–1.99; p&lt;0.0001) in the <italic>Tbx5<sup>−/</sup></italic><sup>−</sup> CP tissue (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A,B</xref>). Thus, <italic>Tbx5</italic> mutant mouse embryos exhibit a reduction of the pSHF transcriptional program and gain of aSHF gene expression in the pSHF domain, consistent with recent reports (<xref ref-type="bibr" rid="bib12">De Bono et al., 2018</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Tbx5 is required for posterior cardiopulmonary (CP) development.</title><p>(<bold>A</bold>) Schematic of an E9.5 mouse embryo highlighting the dissected CP tissue (containing foregut mesoderm and endoderm) profiled by bulk RNA-seq. Venn diagrams show genes differentially expressed in wild-type (WT) versus <italic>Tbx5<sup>−/</sup></italic>− CP tissue (&gt;1.5 fold change, 5% FDR; <xref ref-type="bibr" rid="bib78">Steimle et al., 2018</xref>, GSE75077) intersected with gene sets from single-cell RNA-seq studies defining aSHF+ pharynx cells versus pSHF/CPP+ lung progenitor cells (<xref ref-type="bibr" rid="bib13">de Soysa et al., 2019</xref>, GSE126128; <xref ref-type="bibr" rid="bib24">Han et al., 2020</xref>, GSE136689) (<xref ref-type="supplementary-material" rid="supp2 supp3">Supplementary files 2 and 3</xref>). Statistically significant intersection based on hypergeometric tests. *p&lt;0.0001. (<bold>B</bold>) Transcriptome analysis of <italic>Tbx5</italic><sup>−/−</sup> CP tissue suggests disrupted SHF pattering and failed pulmonary development with reduced RA and increased FGF signaling. Heat map of selected differentially expressed genes in WT <italic>Tbx5<sup>+/+</sup></italic> (n=5) and <italic>Tbx5<sup>−/</sup></italic><sup>−</sup> mutant (n=2) CP tissue grouped by domain of expression or pathway. (<bold>C</bold>) RT-qPCR validation of decreased <italic>Aldh1a2</italic> and increased <italic>Fgf8, Fgf10</italic> expression in E9.5 WT and <italic>Tbx5<sup>−/</sup></italic><sup>−</sup> CP tissue. Relative mean expression+S.D. *p&lt;0.05 Student’s t-test relative to WT littermates. (<bold>D–F</bold>) Whole-mount immunostaining of E9.5 <italic>Shh:GFP</italic> mouse embryos show that Tbx5 (green) and Ald1a2 (red) expression overlaps in a subset of the pSHF (yellow in (<bold>F’</bold>) and (<bold>F”’</bold>)) adjacent to the Nkx2-1+/Shh:GFP+ pulmonary domain (<bold>F”, F”’</bold>). Scale bar in (<bold>D</bold>) = 200 μM, (<bold>E–E”</bold>) = 100 μM, and (<bold>F–F”’</bold>) = 50 μM. (<bold>G</bold>) Model of the proposed Tbx5-RA signaling networks in the cardiopulmonary tissue. Also see <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1–</xref> tables 1-3. aSHF, anterior second heart field; fg endo, foregut endoderm; ns, not significant; oft, outflow tract; pSHF, posterior SHF; RA, retinoic acid; ventr, ventricle.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Differentially expressed genes in mouse E9.5 micro-dissected cardiopulmonary progenitor (CPP) tissue based on bulk RNA-seq (<xref ref-type="bibr" rid="bib78">Steimle et al., 2018</xref>, GSE GSE75077).</title><p>1588 upregulated genes and 1480 downregulated genes were observed in <italic>Tbx5</italic> knockout CPP tissue (≥1.5 fold change and 5% FDR).</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69288-fig1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69288-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Analysis of the Tbx5 regulated transcriptome in mouse cardiopulmonary tissue and co-expression of Tbx5 with Aldh1a2 in the pSHF.</title><p>(<bold>A, B</bold>) Gene set enrichment analysis (GSEA) comparing Tbx5-regulated transcriptome in CP tissue (|&gt;1.5| fold change, 5% FDR; <xref ref-type="bibr" rid="bib78">Steimle et al., 2018</xref>, GSE75077) with gene sets from single-cell RNA-seq studies defining aSHF versus pSHF (<xref ref-type="bibr" rid="bib13">de Soysa et al., 2019</xref>, GSE126128) and pharynx versus CPP+ lung progenitor cells (<xref ref-type="bibr" rid="bib24">Han et al., 2020</xref>, GSE136689) (<xref ref-type="supplementary-material" rid="supp2 supp3">Supplementary files 2 and 3</xref>). Genes upregulated in <italic>Tbx5<sup>−/</sup></italic><sup>−</sup> CP tissue are enriched in aSHF and pharynx and depleted in pSHF/CPP/lung enriched markers (<bold>A</bold>). In contrast transcripts downregulated in <italic>Tbx5<sup>−/</sup></italic><sup>−</sup> CP tissue were significantly enrichened pSHF/CPP/lung marks and depleted for aSHF/pharynx markers (<bold>B</bold>). (<bold>C</bold>) Heat map of RNA-seq gene expression showing TGFβ pathway genes is upregulated in <italic>Tbx5<sup>−/</sup></italic><sup>−</sup> CP tissue. (<bold>D, E</bold>) Immunostaining of E8.5 (<bold>D</bold>) or E9 (<bold>E</bold>) mouse embryo foregut region shows co-expression of Tbx5 (green) and Aldh1a2 (red) protein in the foregut lateral plate mesoderm (fg lpm)/posterior second heart field (pSHF). (<bold>F</bold>) Digital in-situ hybridization using as online Spatial Mouse Atlas of single cell gene expression (<xref ref-type="bibr" rid="bib44">Lohoff et al., 2021</xref>). E9.5 digital in-situ hybridizations show the domains of <italic>Aldh1a2, Tbx5, Tbx1</italic>, and <italic>Shh</italic> expression; yellow boxed region indicates <italic>Tbx5/Aldh1a2</italic> co-expression in the pSHF lpm. (<bold>G, H</bold>) 3-D reconstructions from actual serial section in-situ hybridizations of E9.5 mouse CP foregut region showing expression domains of <italic>Fgf10, Fgf8, Aldh1a2</italic>, and <italic>Shh</italic> transcripts. Top row is a z-stack 3-D projection; bottom row is a rotated ventral view; (<bold>H</bold>) shows a ventral view, merged projection of the expression domains of <italic>Fg10, Fgf8</italic>, and <italic>Shh</italic>. aSHF, anterior second heart field; CPP, cardiopulmonary progenitor; NES, normalized enrichment score.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69288-fig1-figsupp1-v2.tif"/></fig></fig-group><p>These changes in pSHF gene expression suggested a possible loss of RA signaling. Indeed, genes that promote RA signaling were downregulated in <italic>Tbx5<sup>−/</sup></italic><sup>−</sup> CP tissue, including <italic>Aldh1a2, Crabp2</italic>, which promotes nuclear shuttling of RA, and <italic>Rbp1</italic>, a cytosolic chaperone of the RA precursor retinol (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). On the other hand, enzymes that attenuate RA signaling, including <italic>Cyp26a1, Cyp26b1, Cyp26c1</italic>, and <italic>Dhrs3</italic>, were increased in <italic>Tbx5<sup>−/</sup></italic><sup>−</sup> pSHF/CPP tissue. Reduced RA-signaling in <italic>Tbx5<sup>−/</sup></italic><sup>−</sup> CP tissue was also consistent with increased expression of multiple TGFβ pathway components and targets (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>), which are known to be suppressed by RA during foregut and heart development (<xref ref-type="bibr" rid="bib9">Chen et al., 2007</xref>; <xref ref-type="bibr" rid="bib42">Li et al., 2010</xref>; <xref ref-type="bibr" rid="bib45">Ma et al., 2016</xref>).</p><p>The observation that <italic>Aldh1a2</italic> expression was reduced in the <italic>Tbx5<sup>−/</sup></italic><sup>−</sup> pSHF whereas FGF signaling components and targets were increased is consistent with the known role of RA in negatively regulating <italic>Fgf8/Fgf10+</italic> aSHF fate (<xref ref-type="bibr" rid="bib64">Ryckebusch et al., 2008</xref>; <xref ref-type="bibr" rid="bib72">Sirbu et al., 2008</xref>; <xref ref-type="bibr" rid="bib66">Rydeen and Waxman, 2016</xref>). RT-qPCR of dissected E9.5 CP tissue validated the RNA-seq analysis with <italic>Aldh1a2</italic> being dramatically downregulated in <italic>Tbx5<sup>−/</sup></italic><sup>−</sup> mutants while <italic>Fgf8</italic> and <italic>Fgf10</italic> were upregulated (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Immunostaining of transgenic <italic>Shh:GFP</italic> embryos confirmed previous reports that Aldh1a2 is co-expressed with Tbx5 in a subset of pSHF cells adjacent to the foregut Shh/Nkx2-1-expressing pulmonary endoderm (<xref ref-type="fig" rid="fig1">Figure 1D–F”</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D-E''</xref> <xref ref-type="bibr" rid="bib26">Hochgreb et al., 2003</xref>; <xref ref-type="bibr" rid="bib64">Ryckebusch et al., 2008</xref>; <xref ref-type="bibr" rid="bib12">De Bono et al., 2018</xref>; <xref ref-type="bibr" rid="bib13">de Soysa et al., 2019</xref>). Co-expression of <italic>Tbx5</italic> and <italic>Aldh1a2</italic> transcripts in the pSHF adjacent to <italic>Tbx1<sup>+</sup></italic> aSHF and <italic>Shh +</italic> endoderm were also evident in an online spatial atlas of single-cell gene expression (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1F</xref>; <xref ref-type="bibr" rid="bib44">Lohoff et al., 2021</xref>). To further define the spatial distinct aSHF-FGF and pSHF-RA signaling domains, we generated 3D reconstructions using serial sections of <italic>Aldh1a2</italic>, <italic>Fgf8, Fgf10,</italic> and <italic>Shh</italic> in-situ hybridizations from the WT mouse E9.5 (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1G-H</xref>). Together these observations were consistent with the hypothesis that Tbx5 regulates CP development by controlling expression of <italic>Aldh1a2,</italic> which in turn establishes a local domain of RA activity in the pSHF that suppresses aSHF fate and promotes pulmonary development.</p></sec><sec id="s2-2"><title>Tbx5 regulates cardiopulmonary development and maintains <italic>Aldh1a2</italic> expression in <italic>Xenopus</italic></title><p>Since <italic>Tbx5<sup>−/</sup></italic><sup>−</sup> mutant mouse embryos die shortly after E9.5 from cardiac insufficiency (<xref ref-type="bibr" rid="bib5">Bruneau et al., 2001</xref>; <xref ref-type="bibr" rid="bib93">Xie et al., 2012</xref>), we turned to <italic>Xenopus</italic> to elucidate the molecular mechanisms by which Tbx5 coordinates CP development. <italic>Xenopus</italic> larva can live for many days without a functional heart, by absorbing oxygen from the water, and their experimental advantages facilitate epistatic analysis of signaling pathways.</p><p>Previous studies have shown that Tbx5-regulated CP development is conserved between <italic>Xenopus</italic> and mouse: Tbx5 loss-of-function (LOF) in <italic>Xenopus</italic>, either by CRISPR/CAS9-mediated mutation or morpholino (MO) knockdown, phenocopies the mouse <italic>Tbx5<sup>−/</sup></italic><sup>−</sup> phenotype with severe cardiac hypoplasia, a failure to induce Nkx2-1+ lung progenitors and the foregut tube fails to separate into distinct trachea and esophagus (<xref ref-type="bibr" rid="bib78">Steimle et al., 2018</xref>; <xref ref-type="bibr" rid="bib4">Brown et al., 2005</xref>; <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>).</p><p>Analysis of control and Tbx5 depleted <italic>Xenopus</italic> embryos showed that, like in mice, Tbx5 and Aldh1a2 were co-expressed in the foregut lpm/pSHF (<xref ref-type="fig" rid="fig2">Figure 2A and B</xref>) and that <italic>Xenopus</italic> Tbx5 is required for <italic>aldh1a2</italic> expression (<xref ref-type="fig" rid="fig2">Figure 2C–F</xref>). Both <italic>X. laevis</italic> Tbx5-MO morphant and <italic>X. trop tbx5</italic> CRISPR/CAS9 mutant embryos exhibited a loss or strong reduction of <italic>aldh1a2</italic> transcripts and Aldh1a2 protein in the foregut lpm at NF34 (a timepoint similar to mouse E9.5) (<xref ref-type="fig" rid="fig2">Figure 2C–F</xref>; <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>). Quantification of the Aldh1a2 immunostaining in 3D volume renderings of the fg lpm/pSHF domain of Tbx5 morphants and mutants revealed that Aldh1a2 protein was only expressed on average to approximately 28% (p=0.0009) and 33% (p≤0.0001) of WT levels, respectively (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref> and <xref ref-type="fig" rid="fig3">Figure 3K</xref>). Analysis of transgenic Wnt/β-catenin reporter embryos <italic>Tg(WntRE:dGFP</italic>) (<xref ref-type="bibr" rid="bib84">Tran et al., 2010</xref>), confirmed the failure of Wnt-dependent pulmonary induction in the ventral foregut of Tbx5-deficient embryos (<xref ref-type="fig" rid="fig2">Figure 2C and D</xref>). Importantly, co-injection of human <italic>TBX5</italic> RNA rescued <italic>aldh1a2</italic> expression and pulmonary development (<xref ref-type="fig" rid="fig2">Figure 2D–F</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>, and <xref ref-type="fig" rid="fig3">Figure 3</xref>). A time course analysis revealed that loss of Tbx5 resulted in a downregulation of <italic>aldh1a2</italic> expression in the foregut lpm starting at NF25, but not at early somitogenesis stages (NF15) (<xref ref-type="fig" rid="fig2">Figure 2E and F</xref>). These results demonstrate that Tbx5 is required to maintain <italic>aldh1a2</italic> expression in the foregut lpm, and that it regulates a conserved transcriptional program in <italic>Xenopus</italic> and mouse to coordinate SHF patterning and lung induction.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Tbx5 maintains <italic>aldh1a2</italic> expression in <italic>Xenopus</italic> foregut lpm.</title><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Summary of in-situ hybridization results from <italic>Xenopus</italic> CAS9/CRISPR injection experiments in F0 embryos.</title><p>The <italic>tbx5</italic> exon5 sgRNA (targeting the DNA binding domain; <xref ref-type="bibr" rid="bib78">Steimle et al., 2018</xref>) causes approximately 40% of injected embryos to have a molecular phenotype as revealed by in-situ hybridization. 2 nl of a mixture containing 50 pg/nl sgRNA with 0.5 ng/nl Cas9 protein (PNA Bio CP01-20) was injected on either side of the sperm entry point at the 1 cell stage (total of 200 pg sgRNA and 2 ng Cas9 protein per embryo), embryos were cultured to NF34 and assayed by in-situ hybridization for the indicated genes.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69288-fig2-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69288-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Tbx5 LOF phenotype at stage NF43/44 and quantification of reduced Aldh1a2 immunostaining.</title><p>(<bold>A</bold>) Immunostaining of stage NF43 transgenic <italic>Xenopus laevis Tg(nkx2-5:GFP</italic>) reporter embryos injected with either mismatch-MO (control) or Tbx5-MO. Confocal optical sections through the cardiopulmonary-foregut region showing Fibronectin+ tissue boundaries (purple), GFP in the ventral pharynx, trachea, and ventricle; and Sox2 (red) in the pharyngeal/esophageal endoderm. Tbx5-depleted embryos exhibit severe cardiac hypoplasia, a lack of ventricular trabeculae, and a single, undivided foregut tube lacking Nkx2-1 respiratory progenitors. (<bold>B</bold>) Immunostaining of NF44 <italic>X. tropicalis</italic> embryos for Fibronectin (purple), Sox2 (red), and FoxF1 (green) shows that <italic>tbx5</italic> mutants, have a single Sox2+ foregut tube and severe cardiac hypoplasia phenocopying <italic>X. laevis</italic> Tbx5 morphants. Injection of human <italic>TBX5</italic> RNA rescues trachea-esophageal morphogenesis and cardiac chamber development. (<bold>C</bold>) Representative images for quantitation of Aldh1a2 immunofluorescence signal in Tbx5 LOF embryos at NF34. Nikon Elements Analysis AR software was used to determine the average volume pixel intensity of the fg lpm region (dotted yellow lines). Each dot in the graphs represents a distinct fg lpm/pSHF region from N=3 total embryos, all imaged with identical confocal laser settings. *p&lt;0.05, parametric two-tailed paired t-test. at, atrium; eso, esophagus; lb, lung bud; LOF, loss-of- function; lpm, lateral plate mesoderm; MO, morpholino; pha, pharynx; tra, trachea; vent, ventricle.</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Quantitation of <italic>Xenopus</italic> NF34 fg lpm/pSHF Aldh1a2 immunostaining volume pixel intensity.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69288-fig2-figsupp1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69288-fig2-figsupp1-v2.tif"/></fig></fig-group><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Tbx5 regulates <italic>Xenopus</italic> cardiopulmonary development in part via RA.</title><p>(<bold>A</bold>) Schematic of the experimental design. (<bold>B–J</bold>) Exogenous RA rescues Tbx5 LOF, while inhibition of RA phenocopies Tbx5 LOF. Whole-mount in-situ hybridization of NF34 <italic>X. laevis embryos</italic> after the indicated experimental treatments: injection of negative control 3 bp mismatch-MO (10 ng), Tbx5-MO (10 ng), Human <italic>TBX5</italic> RNA (<italic>hTBX5;</italic> 100 pg), and/or 25 nM RA, 10 µM DEAB, DMSO vehicle control from NF20-34. The numbers of embryos with the observed expression pattern are indicated. Arrows indicate the relevant expression domain in the cardiopulmonar (CP) tissue. Brackets indicate the aSHF/pharyngeal domain. (<bold>K</bold>) Heat map showing relative expression from RT-PCR analysis of NF34 CP-foregut (fg) tissue dissected from control or Tbx5-MO injected embryos and treated with or without RA from NF20 to NF34. Each row is the average from the three biological replicates (n=4 explants per replicate). (<bold>L</bold>) Diagram of the proposed GRN model at NF25–35 showing the key role of Aldh1a2-dependent RA signaling downstream of Tbx5. White arrows indicate relationships tested in the above experiments and black arrows are demonstrated from the previous publications. Also see <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>, and related source data files. GRN, gene regulatory network; LOF, loss-of-function; MO, morpholino; RA, retinoic acid.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title><xref ref-type="fig" rid="fig3">Figure 3K</xref>.</title><p><italic>Xenopus</italic> explant RT-qPCR source data. Explants were dissected at NF20, cultured 48 hr±DMSO or 25 nM all-trans retinoic acid (RA); harvested at NF34; three biological replicates for each condition; n=4 pooled explants in each replicate; pooled explants came from 2 to 3 separate fertilization/injection experiments.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69288-fig3-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69288-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Aldh1a2 morpholino (MO) knockdown phenocopies DEAB treatment and WNT2B protein rescues <italic>Nkx2-1+</italic> pulmonary fate.</title><p>(<bold>A–E</bold>) Aldh1a2 MO knockdown phenocopies the pharmacological inhibition by DEAB treatment. Embryos were injected at the 8-cell stage into dorsal mesendoderm targeting the CP domain or treated from NF20 to NF34 with 10 µM DEAB or 25 nM RA. (<bold>A–C</bold>) Immunostaining of NF34 embryos for Aldh1a2 (red), Nkx2-1 (green), and Sox2 (blue) confirms that Aldh1a2-MO injection or DEAB treatment disrupts the RA&gt;Tbx5&gt;Aldh1a2&gt;RA positive feedback loop (diagrammed in (<bold>D</bold>)) and results in failed induction of Nkx2-1+ pulmonary progenitors. (<bold>E</bold>) Whole-mount in-situ hybridization of NF34 control, Aldh1a2-MO injection, or DEAB treatment (NF20–34) showing similar effects. Treatment with 25 nM RA (NF20–34) rescued the changes in gene expression. The numbers of embryos with the observed expression pattern are indicated. Arrows indicate the relevant expression domain in the foregut – cardiopulmonary region. (<bold>F</bold>) Experimental schematic. (<bold>G</bold>) WNT2B protein 100 ng/ml rescues <italic>nkx2-1</italic> but not <italic>Hh</italic> ligand expression in Tbx5-depleted fg explants. Graphs show mean relative expression ± standard deviation from N=3 biological replicates (four explants/replicate). Each black dot in the graphs represents a biological replicate (pool of n=4 explants). *p&lt;0.05, **p&lt;0.01, parametric two-tailed paired t-test relative to uninjected, untreated explants. CP, cardiopulmonary; ns, not significant; RA, retinoic acid.</p><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title><italic>Xenopus</italic> explant RT-qPCR source data.</title><p>Exogenous WNT2B protein treatment rescues <italic>nkx2-1</italic> expression in Tbx5-depleted <italic>Xenopus</italic> cardiopulmonary foregut explants. RT-qPCR analysis of <italic>Xenopus</italic> foregut cardiopulmonary explants treated ± recombinant Human WNT2B protein (100 ng/ml) 48 hr NF20–34.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69288-fig3-figsupp1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69288-fig3-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-3"><title>Tbx5 regulates cardiopulmonary development via RA signaling</title><p>A detailed analysis of Tbx5-MO embryos by in-situ hybridization and RT-PCR showed that many of the CP genes that were misregulated in mouse <italic>Tbx5<sup>−/</sup></italic><sup>−</sup> CP tissue were also misregulated in <italic>Xenopus</italic> (<xref ref-type="fig" rid="fig3">Figure 3A–K</xref>). In addition to a loss of <italic>aldh1a2</italic>, pSHF markers <italic>osr1</italic>, <italic>foxf1</italic>, <italic>gli1</italic>, and <italic>wnt2b</italic> and pulmonary endoderm markers <italic>shh, dhh,</italic> and <italic>nkx2-1</italic> were reduced, while pharyngeal/aSHF markers <italic>fgf8</italic>, <italic>fgf10, tbx1, cyp26a1, cyp26c1, spry2, hand1, hand2, dhrs3, tgfbR2,</italic> and <italic>tgfbi</italic> were all upregulated. In total, all 19 transcripts tested exhibited changes in gene expression similar to <italic>Tbx5<sup>−/</sup></italic><sup>−</sup> mice. Interestingly in the Tbx5-MO embryos, we observed changes in gene expression beyond just the CP region, including the kidney, pharynx, and head all of which are known to be regulated by RA, FGF, and/or Hh signaling. This suggests that non-cell-autonomous effects in Tbx5 depleted embryos are likely due to changes in secreted factors.</p><p>We hypothesized that the disrupted CP development in Tbx5-deficient <italic>Xenopus</italic> embryos was primarily caused by reduced Aldh1a2-dependent RA signaling. To address this, we tested whether blocking endogenous RA could phenocopy loss of Tbx5 or if addition of exogenous RA could rescue the Tbx5 LOF phenotype (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). We suppressed endogenous RA synthesis by addition of the Aldh enzyme inhibitor DEAB between NF20 and NF34, the time when <italic>aldh1a2</italic> expression was Tbx5-dependent. This phenocopied the Tbx5 LOF with loss of pSHF and pulmonary markers and an expansion of aSHF gene expression (<xref ref-type="fig" rid="fig3">Figure 3B–J</xref>). While DEAB allowed temporal-specific inhibition, in some instances pharmacological reagents can have off-target effects. Therefore, we also depleted Aldh1a2 protein by targeted microinjection of MOs into the foregut region, which phenocopied the DEAB treatment (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A-E</xref>).</p><p>Importantly, we could partially rescue the Tbx5-MO, Aldh1a2-MO, and DEAB phenotypes with exogenous RA between NF20 and NF34, using a physiological concentration of 25 nM (<xref ref-type="bibr" rid="bib30">Horton and Maden, 1995</xref>; <xref ref-type="bibr" rid="bib48">Mic et al., 2003</xref>; <xref ref-type="bibr" rid="bib70">Sheikh et al., 2014</xref>; <xref ref-type="fig" rid="fig3">Figure 3B–J</xref>; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1E</xref>). Addition of RA suppressed the expanded expression domains of aSHF markers <italic>fgf8, fgf10, spry2</italic>, <italic>cyp26a1, cyp26c1, and tbx1</italic> in Tbx5/RA-deficient embryos (<xref ref-type="fig" rid="fig3">Figure 3B–J</xref>; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1E</xref>). RA was also sufficient to rescue endodermal expression of <italic>shh</italic> and <italic>dhh</italic> as well as expression of known Hh-target genes <italic>gli1, foxf1, and osr1</italic> in the foregut lpm of Tbx5-MO embryos and explants (<xref ref-type="fig" rid="fig3">Figure 3B–K</xref>). However, exogenous RA did not rescue expression of the pulmonary-inducing <italic>wnt2/2b</italic> ligands nor the lung marker <italic>nkx2-1</italic>. In contrast, addition of recombinant WNT2B protein to Tbx5-MO foregut explants was sufficient to rescue <italic>nkx2-1+</italic> lung fate but not <italic>shh</italic> nor <italic>dhh</italic> expression (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1F,G</xref>), consistent with previous reports that Tbx5 directly promotes <italic>wnt2/2b</italic> transcription (<xref ref-type="bibr" rid="bib78">Steimle et al., 2018</xref>).</p><p>These results combined with our previous data suggest that Tbx5 promotes CP development by multiple mechanisms, which are experimentally separable (<xref ref-type="fig" rid="fig3">Figure 3L</xref>). First, by maintaining <italic>aldh1a2</italic> expression, Tbx5 ensures robust RA signaling required for SHF pattern and induction of endodermal <italic>shh/dhh</italic> expression, and second, by cooperating with Hh to activate mesodermal expression of <italic>Wnt2/2b</italic> which promotes pulmonary induction.</p></sec><sec id="s2-4"><title>Tbx5 directly activates <italic>Aldh1a2</italic> transcription and indirectly represses <italic>Fgf8</italic> via RA</title><p>In preliminary experiments, we found that expression of a doxycycline (Dox) inducible <italic>Tbx5</italic> transgene during the directed differentiation of mouse embryonic stem cells (mESCs) into cardiac fate (<xref ref-type="bibr" rid="bib35">Kattman et al., 2011</xref>; <xref ref-type="bibr" rid="bib78">Steimle et al., 2018</xref>) was sufficient to increase <italic>Aldh1a2</italic> expression and suppress <italic>Fgf8</italic> and <italic>Fgf10</italic> levels (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). However, in these experiments, it was unclear whether Tbx5 regulated <italic>Aldh1a2</italic> or <italic>Fgf</italic> expression directly or indirectly.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Tbx5 directly activates <italic>aldh1a2</italic> transcription via an evolutionarily conserved first intron enhancer.</title><p>(<bold>A</bold>) Dox-inducible Tbx5 activated <italic>Aldh1a2</italic> expression and repressed <italic>Fgf8</italic> and <italic>Fgf10</italic> during the directed differentiation <italic>of</italic> mouse embryonic stem cells (mESCs) into cardiac progenitors in a dose-dependent manner. (<bold>B</bold>) Tbx5 directly activated <italic>aldh1a2</italic> expression in <italic>Xenopus</italic> anterior or posterior mesendoderm (AME, PME) explants. RT-qPCR shows that <italic>aldh1a2</italic> transcription was induced by DEX activated GR-Tbx5 in the presence of translation inhibitor CHX. Graphs show mean relative expression ± standard deviation from N=3 biological replicates, four explants/replicate. *p&lt;0.05, pair-wise Student’s t-test relative to uninjected, untreated explants. (<bold>C</bold>) Whole-mount in-situ hybridization of <italic>aldh1a2</italic> expression of <italic>X. laevis</italic> NF34 embryos injected with GR-Tbx5 (100 pg) into the PME with or without DEX. (<bold>D</bold>) Genome browser of the mouse <italic>Aldh1a2</italic> locus showing Tbx5 ChIP-seq tracks from E14.5 mouse lung (GSE167207) and E14.5 mouse heart (<xref ref-type="bibr" rid="bib6">Burnicka-Turek et al., 2020</xref>, GSE139803) as well as ATAC-seq track from the ENCODE project (<xref ref-type="bibr" rid="bib7">Castillo et al., 2010</xref>; <xref ref-type="bibr" rid="bib11">Davis et al., 2018</xref>; ENCSR335VJW). Tbx5 ChIP-seq peaks in the E14.5 lung are indicated in blue. Phascon multiple species conservation track shows that the prominent Tbx5-bound first intron enhancer (enh1) is evolutionarily conserved from mammals to <italic>Xenopus</italic>. (<bold>E</bold>) Multiple species sequence alignment of enh1 reveals one Tbx5 DNA-binding site conserved from mammals to <italic>Xenopus</italic> and two additional mammalian-specific Tbx5 sites, which were mutated in reporter constructs. (<bold>F</bold>) Schematic of the Wild-type (WT) and mutant (ΔTbx) enh1:gfp and enh1:luciferase reporter constructs. (<bold>G</bold>) Both the <italic>Xenopus</italic> and mouse intronic enh1 enhancer are sufficient to drive GFP expression in the foregut lpm in <italic>Xenopus</italic> transgenic assays. (<bold>H</bold>) Time course of <italic>Xenopus</italic> and mouse enh1:luc reporter activity injected into <italic>X. laevis</italic> CP-foregut tissue, reflects endogenous Tbx5-dependent <italic>aldh1a2</italic> expression between NF25 and NF34. Graphs show mean relative luciferase activity ± standard deviation. N=5 biological replicates/time point with five embryos/replicate. *p&lt;0.05, parametric two-tailed paired t-test. (<bold>I</bold>) The <italic>Xenopus</italic> and mouse <italic>aldh1a2 enh1</italic> reporter constructs are regulated by Tbx5. Graphs show relative mean luciferase activity ± standard deviation of reporters injected into CP-foregut tissue with control mm-MO, Tbx5-MO, and/or human <italic>TBX5</italic> RNA. N=3 biological replicates/time point with five embryos/replicate. *p&lt;0.05, parametric two-tailed paired t-test. (<bold>J</bold>) The three putative Tbx5 motifs in the mouse <italic>aldh1a2-enh1</italic> enhancer are required for reporter activity in the CP-foregut tissue and Tbx5-dependent activation in the hindgut. Graphs show mean relative luciferase activity ± standard deviation. N=5 biological replicates/time point with five embryos/replicate. *p&lt;0.05, parametric two-tailed paired t-test. Also see <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>, <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref> and related source data files. CP, cardiopulmonary.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title><xref ref-type="fig" rid="fig4">Figure 4B</xref>.</title><p><italic>Xenopus</italic> explant RT-qPCR source data. GR-Tbx5 directly activated <italic>aldh1a2</italic> in <italic>Xenopus</italic> anterior or posterior mesendoderm explants. NF10.5 anterior or posterior mesendoderm explants were treated for 2 hr in CHX prior to 6 hr in CHX+DEX.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69288-fig4-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4sdata2"><label>Figure 4—source data 2.</label><caption><title><xref ref-type="fig" rid="fig4">Figure 4H</xref> Luciferase source data.</title><p>Temporal analyses of mouse and <italic>Xenopus tropicalis</italic> enh1-driven luciferase activity in the foregut.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69288-fig4-data2-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4sdata3"><label>Figure 4—source data 3.</label><caption><title><xref ref-type="fig" rid="fig4">Figure 4I</xref>.</title><p>Luciferase source data. NF34 analysis of mouse and <italic>Xenopus tropicalis</italic> enh1-driven luciferase activity in the foregut±mismatch MO, tbx5-MO,±Human TBX5 RNA.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69288-fig4-data3-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4sdata4"><label>Figure 4—source data 4.</label><caption><title><xref ref-type="fig" rid="fig4">Figure 4J</xref>.</title><p>Luciferase source data. NF34 analysis of mouse WT Enh1 or Tbx motif mutant Enh1-driven luciferase activity in fg or in hg±Tbx5 RNA.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69288-fig4-data4-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69288-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>GR-Tbx5 indirectly suppresses <italic>fg8</italic> in <italic>Xenopus</italic> via RA and additional analysis of the first intron Tbx5 enh1 enhancer.</title><p>(<bold>A–C</bold>) Experimental schematic of GR-Tbx5 direct/indirect target gene assay in <italic>Xenopus</italic> gastrula explants. (<bold>B</bold>) GR-Tbx5 suppresses <italic>fgf8</italic> in both anterior and posterior tissue in a CHX sensitive manner demonstrating indirect suppression. The ability of GR-Tbx5 to suppress <italic>fgf8</italic> is DEAB sensitive and thus is dependent on RA production. Graphs show mean relative expression ± standard deviation from N=3 biological replicates (four explants/replicate). Each black dot in the graphs represents a biological replicate (pool of n=4 explants). *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, parametric two-tailed paired t-test relative to uninjected, untreated explants. (<bold>C</bold>) Model of the indirect regulation of <italic>fgf8</italic> by Tbx5, which these experiments show is CHX and DEAB sensitive. (<bold>D, E</bold>) Immunostaining of stage NF34 transgenic <italic>X. laevis</italic> embryos shows that the enh1 enhancer drives GFP expression in the endogenous Aldh1a2 lpm domain but not in the somites. Scale bar=100 µM. (<bold>F, G</bold>) Both the mouse and <italic>X. tropicalis (X. trop) Aldh1a2</italic> enh1 enhancers drive reporter activity in NF25 and NF34 foregut but not hindgut tissue, demonstrating spatial specificity. Graphs show mean relative luciferase activity ± standard deviation. N=6 biological replicates/time point, each containing n=5 embryos/replicate. *p&lt;0.05, parametric two-tailed paired t-test. (<bold>H, I</bold>) Analysis of wild-type enh1 or enh1 with the single, perfectly conserved T-box/Tbx5 motif mutated. Mutation of the single T-box/Tbx5 motif in the mouse (<bold>H</bold>) or <italic>X. trop</italic> (<bold>I</bold>) <italic>Aldh1a2</italic> enh1 enhancers significantly reduces enhancer ability to drive expression in the foregut as well as to be activated by exogenous Tbx5 in hindgut gain-of-function injections. Graphs show mean relative luciferase activity ± standard deviation. N=6 biological replicates/time point, each containing n=5 embryos/replicate. *p&lt;0.05, parametric two-tailed paired t-test. ns, not significant; RA, retinoic acid.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>RT-qPCR source data of <italic>Xenopus</italic> anterior (AME) or posterior (PME) NF10.5 mesendoderm explants injected with GR-Tbx5 RNA and treated±DEX, CHX, or DEAB.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69288-fig4-figsupp1-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4s1sdata2"><label>Figure 4—figure supplement 1—source data 2.</label><caption><title>Luciferase source data of mouse and <italic>Xenopus tropicalis</italic> enh1 reporter activity in foregut and hindgut at NF25, NF34.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69288-fig4-figsupp1-data2-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69288-fig4-figsupp1-v2.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>Multiple species sequence alignment of the <italic>Aldh1a2</italic> enh1 enhancers.</title><p>(<bold>A</bold>) Clustal DNA sequence alignment; putative T-box/Tbx5 motifs predicted by the CisBP tool (<xref ref-type="bibr" rid="bib91">Weirauch et al., 2014</xref>) are shaded in aqua blue (CisBP score&gt;10) and in yellow (CisBP score&gt;8). Asterisks below the nucleotide alignment indicated conserved bases amongst all four species. Tbx motifs mutated and tested in this study are indicated in gray. Genomic co-ordinates of the <italic>Aldh1a2</italic> enh1 enhancers used were: <italic>Xenopus tropicalis</italic>,&gt; xenTrov9.1_dna range = chr3:89631924–89632943; Chicken,&gt; galGal6_dna range = chr10:7578306–7579190;Mouse,&gt; mm10_dna range = chr9:71241739–71242765 Human,&gt; hg38_dna range = chr15:58038775–58039647.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69288-fig4-figsupp2-v2.tif"/></fig></fig-group><p>We therefore examined whether Tbx5 was sufficient to directly activate <italic>aldh1a2</italic> transcription in <italic>Xenopus</italic>. We injected RNA encoding a dexamethasone (DEX) inducible Glucocorticoid receptor (GR)-Tbx5 fusion protein (<xref ref-type="bibr" rid="bib29">Horb and Thomsen, 1999</xref>) into either the anterior or posterior mesoderm. We then induced GR-Tbx5 nuclear translocation at gastrula stage before endogenous <italic>tbx5</italic> is normally expressed by addition of DEX, with or without the translation inhibitor cycloheximide (CHX) to block secondary protein synthesis (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>). GR-Tbx5 activated precocious <italic>aldh1a2</italic> transcription in both the anterior and posterior tissue even in the presence of CHX, demonstrating direct activation (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). In-situ hybridization of NF34 embryos confirmed robust, ectopic activation of <italic>aldh1a2</italic> by GR-Tbx5 (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). In contrast, suppression of <italic>fgf8</italic> transcription by GR-Tbx5 was sensitive to CHX, demonstrating indirect repression (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A,B</xref>). We hypothesized that Tbx5 indirectly represses <italic>fgf8</italic> via Aldh1a2-dependent RA production since RA is known to directly repress <italic>Fgf8</italic> transcription in the mouse SHF (<xref ref-type="bibr" rid="bib37">Kumar et al., 2016</xref>). We tested this by inhibiting Aldh activity with DEAB which prevented the suppression of <italic>fgf8</italic> by GR-Tbx5 (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A-C</xref>). These data demonstrate that Tbx5 directly activates <italic>aldh1a2</italic> transcription and indirectly suppresses <italic>fgf8</italic> expression via RA.</p></sec><sec id="s2-5"><title>Tbx5 maintains <italic>Aldh1a2</italic> transcription via an evolutionarily conserved intronic enhancer</title><p>We next sought to identify <italic>Aldh1a2</italic> enhancers that are directly regulated by Tbx5, predicting that these would be evolutionarily conserved across terrestrial vertebrates. Since a number of putative enhancers have been documented for the mouse <italic>Aldh1a2</italic> locus (<xref ref-type="bibr" rid="bib7">Castillo et al., 2010</xref>; <xref ref-type="bibr" rid="bib88">Vitobello et al., 2011</xref>; <xref ref-type="bibr" rid="bib31">Huang et al., 2012</xref>), we focused on the murine genome. To identify Tbx5-bound enhancers in the CP lineage, we performed Tbx5 chromatin immunoprecipitation followed by high-throughput sequencing (ChIP-seq) of E14.5 fetal mouse lungs as lung mesenchyme is derived from the E9.5 CPPs (<xref ref-type="bibr" rid="bib55">Peng et al., 2013</xref>). ChIP-seq uncovered five Tbx5-bound regions at the <italic>Aldh1a2</italic> locus. Comparing the lung ChIP-seq data to our previously published Tbx5 ChIP-seq from E14.5 heart (<xref ref-type="bibr" rid="bib78">Steimle et al., 2018</xref>), we found that four of the five Tbx5-bound sites were lung-specific and not bound by Tbx5 in the fetal heart (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). Among the four Tbx5-bound sites, only one peak in the <italic>Aldh1a2</italic> first intron<italic>,</italic> which we refer to as enh1 (for ‘enhancer 1;’ <xref ref-type="fig" rid="fig4">Figure 4D</xref>, <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>), showed strong evolutionarily conservation from mammals to <italic>Xenopus</italic>. The enh1 region also had a strong ATAC-seq peak in E14.5 lungs consistent with open enhancer chromatin (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). Sequence analysis of enh1 revealed multiple predicted Tbx5 DNA-binding motifs, one of which was perfectly conserved amongst human, mouse, chicken, and <italic>Xenopus</italic> (<xref ref-type="fig" rid="fig4">Figure 4E</xref>; <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>).</p><p>We tested the ability of both the mouse and <italic>X. trop</italic> enh1 intronic enhancers to drive reporter expression in <italic>Xenopus</italic> transgenics and luciferase reporter assays (<xref ref-type="fig" rid="fig4">Figure 4F–J</xref>). In transgenics, both the mouse and <italic>X. trop</italic> enh1 enhancers drove GFP expression in the foregut lpm/pSHF at NF34 overlapping endogenous <italic>aldh1a2</italic> (<xref ref-type="fig" rid="fig4">Figure 4G</xref>; <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1D-E''</xref>). We noted however that the transgene expression domain in the lpm was broader than endogenous <italic>aldh1a2</italic> (<xref ref-type="fig" rid="fig4">Figure 4G</xref>), moreover, enh1 did not drive expression in the somites (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1D-E</xref>), suggesting other enhancers must refine the lpm expression and promote somitic expression in vivo. To quantitatively assess temporal and spatial enhancer activity, we micro-injected enh1 reporters into blastomeres targeting the future CP-foregut or hindgut regions and assayed luciferase activity at a range of developmental stages, from gastrula to tailbud (<xref ref-type="fig" rid="fig4">Figure 4H</xref>; <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1F,G</xref>). Neither the mouse nor <italic>X. trop</italic> enh1 enhancers drove significant reporter activity during early development at NF10.5, NF15, or NF20; however, at NF25 and N34 both the mouse and <italic>X. trop</italic> enh1 enhancers were active in the foregut but not hindgut (<xref ref-type="fig" rid="fig4">Figure 4H</xref>; <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1F,G</xref>). This coincides with the timing at which endogenous <italic>aldh1a2</italic> expression is Tbx5-dependent (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Taken together, these data demonstrate that the evolutionarily conserved enh1 regulates the temporal and spatial transcription of <italic>aldh1a2</italic> in the foregut lpm/pSHF.</p><p>We next tested Tbx5 regulation of the enh1 enhancer by combining reporter assays with LOF or gain-of-function (GOF) experiments. Tbx5-MO knockdown resulted in a dramatic reduction of the mouse and <italic>X. trop</italic> enh1 reporter activity in CP-foregut tissue at NF34, which was rescued by injection of human <italic>TBX5</italic> RNA (<xref ref-type="fig" rid="fig4">Figure 4I</xref>). Moreover, injection of <italic>Xenopus</italic> or human <italic>TBX5</italic> RNAs were sufficient to ectopically induce robust enh1 reporter activity in hindgut tissue, which does not express endogenous <italic>tbx5</italic> (<xref ref-type="fig" rid="fig4">Figure 4J</xref>). Mutation of the single Tbx5-binding site that was perfectly conserved amongst human, mouse, chicken, and <italic>Xenopus</italic> enh1 resulted in a 48% (p=0.0046) and 60% reduction (p=0.0031) of the mouse and frog reporter activity in the foregut respectively, and also significantly blunted their response to ectopic Tbx5 in the hindgut (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1H,I</xref>). Mutation of all three putative Tbx5 motifs conserved amongst mammals (<xref ref-type="fig" rid="fig4">Figure 4J</xref>) largely abolished reporter activity in both the foregut and hindgut (<xref ref-type="fig" rid="fig4">Figure 4J</xref>). We conclude Tbx5 directly maintains <italic>Aldh1a2</italic> expression via multiple T-box motifs found in an evolutionarily conserved first intron enhancer.</p></sec><sec id="s2-6"><title>FGF gain-of-function phenocopies Tbx5-loss-of-function in <italic>Xenopus</italic></title><p>In light of the finding that Tbx5-dependent RA signaling suppresses <italic>fgf8</italic> and <italic>fgf10,</italic> we tested if a temporal FGF GOF would phenocopy Tbx5 LOF (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). We treated WT CP-foregut explants with recombinant FGF8 protein from NF20 to NF34, the period when exogenous RA was sufficient to rescue Tbx5 LOF. As predicted FGF8 treatment largely phenocopied Tbx5 depletion with increased expression of aSHF/pharyngeal markers <italic>tbx1, fgf10, spry2,</italic> and <italic>cyp26a1, as well as</italic> reduced expression of pSHF and pulmonary endoderm genes <italic>wnt2b</italic>, <italic>shh</italic>, <italic>gli1,</italic> and <italic>nkx2-1</italic> (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). We also observed reduced expression of <italic>tbx5</italic> and <italic>aldh1a2</italic> consistent with a feedback loop where FGF restricts Tbx5/Aldh1a2-mediate RA signaling (<xref ref-type="fig" rid="fig5">Figure 5C</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>FGF8 gain-of-function (GOF) phenocopies Tbx5 loss-of-function in <italic>Xenopus</italic>.</title><p>(<bold>A</bold>) Schematic of FGF8 GOF assay in <italic>Xenopus</italic> cardiopulmonary foregut (CP-FG) explants dissected at NF20, and treated with vehicle controls (DMSO+0.2% BSA) or the indicated combinations of 100 ng/ml FGF8b and/or 0.5 µM ketoconazole (Cyp-inhibitor), harvested at NF34, and analyzed via RT-qPCR. (<bold>B</bold>) RT-qPCR showing mean relative expression of genes for pSHF (red), aSHF (blue), and pulmonary endoderm (yellow), ± standard deviation from N=3 biological replicates (four explants/replicate). *p&lt;0.05, parametric two-tailed paired t-test. (<bold>C</bold>) Model depicting the observed FGF8 GOF results. White arrows indicate relationships tested in these experiments. (<bold>D</bold>) FGF8 direct target gene assay in <italic>Xenopus</italic> CP foregut explants, demonstrating that FGF8 directly activates <italic>cyp26a1, cyp26c1</italic> and indirectly suppresses <italic>shh</italic>. Explants dissected at NF20 were pre-treated with 1 µM cycloheximide (CHX) for 2 hr prior to culture in 100 ng/ml FGF8b+CHX for 6 hr followed by RT-qPCR analysis. Graphs display mean relative expression ± standard deviation from N=3 biological replicates that contained four explants/replicate. *p&lt;0.05, parametric two-tailed paired t-test. (<bold>E</bold>) RA signaling is required for the <italic>tbx5</italic> expression in the fg lpm/pSHF domain, but not the heart. Embryos were cultured in 10 µM DEAB from NF20 to NF34 and assayed by in-situ hybridization. Number of embryos assayed and with the observed expression pattern is indicated. Also see <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref> and related source data files. aSHF, anterior second heart field; pSHF, posterior second heart field.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title><xref ref-type="fig" rid="fig5">Figure 5B</xref>.</title><p>RT-qPCR analysis of <italic>Xenopus</italic> foregut CP explants treated with FGF8±ketoconazole (Cyp26 inhibitor). Explants were dissected at NF20, cultured 48 hr±DMSO or recombinant Human FGF8a (200 ng/ml)±20 µM ketoconazole and assayed at NF34. RT-qPCR source data.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69288-fig5-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig5sdata2"><label>Figure 5—source data 2.</label><caption><title><xref ref-type="fig" rid="fig5">Figure 5D</xref>.</title><p>RT-qPCR source data of <italic>Xenopus</italic> foregut cardiopulmonary explants treated with FGF8±CHX (cycloheximide).</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69288-fig5-data2-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69288-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Cyp26a1/c1 morpholino (MO) knockdown phenocopies Cyp inhibitor treatment.</title><p>(<bold>A</bold>) Schematic of experiment testing FGF8-Cyp26 epistasis in <italic>Xenopus</italic> cardiopulmonary foregut (CP-FG) explants. Embryos were injected at the -cell stage with Cyp26a1+ Cyp26 c1 MOs, explants were then dissected at NF20, treated with vehicle controls (DMSO+0.2% BSA) or the indicated combinations of 100 ng/ml FGF8b, harvested at NF34, and analyzed via RT-qPCR. (<bold>B</bold>) FGF8 treatment suppresses the <italic>shh</italic>, <italic>tbx5</italic>, <italic>wnt2b</italic>, and <italic>nkx2-1</italic> expression, and this inhibitory effect is blocked by Cyp26a1/c1 MO knockdown. RT-qPCR showing mean relative expression of the indicated genes, ± standard deviation. Each black dot in the graph represents a biological replicate (pool of n=4 foregut explants). *p&lt;0.05, parametric two-tailed paired t-test.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69288-fig5-figsupp1-v2.tif"/></fig></fig-group><p>FGF signaling is known to promote the expression of RA-degrading Cyp26 enzymes (<xref ref-type="bibr" rid="bib71">Shiotsugu et al., 2004</xref>; <xref ref-type="bibr" rid="bib15">Deimling and Drysdale, 2011</xref>; <xref ref-type="bibr" rid="bib66">Rydeen and Waxman, 2016</xref>), but it is unclear whether this is by direct transcriptional regulation. Therefore, we repeated the FGF8 experiments in the presence of CHX and found that indeed <italic>cyp26a1</italic> and <italic>cyp26c1</italic> were still upregulated by FGF8, demonstrating direct activation (<xref ref-type="fig" rid="fig5">Figure 5D</xref>). In contrast, the ability of FGF8 to suppress <italic>shh</italic> was CHX sensitive, demonstrating indirect repression (<xref ref-type="fig" rid="fig5">Figure 5D</xref>). We hypothesized that FGF8 indirectly suppresses expression of <italic>shh</italic> and other RA-dependent pSHF genes by promoting Cyp26-mediated RA degradation (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). To test this, we treated CP-foregut explants with both FGF8 and the CYP enzyme inhibitor ketoconazole (keto). Keto blocked the ability of FGF8 to suppress <italic>shh, dhh, tbx5, aldh1a2, wnt2b,</italic> and <italic>nkx2-1</italic> (<xref ref-type="fig" rid="fig5">Figure 5B</xref>), indicating that FGF indeed acts via Cyp-dependent RA degradation. Consistent with Cyp-mediated RA degradation being a major factor in endogenous CP patterning, keto treatment alone elevated expression of pSHF (<italic>tbx5, aldh1a2</italic>, and <italic>wnt2b</italic>) and pulmonary endoderm genes (<italic>shh</italic> and <italic>nkx2-1</italic>), whilst decreasing aSHF markers (<italic>fgf8, fgf10,</italic> and <italic>tbx1</italic>) (<xref ref-type="fig" rid="fig5">Figure 5B</xref>), similar to exogenous RA treatment (<xref ref-type="fig" rid="fig3">Figure 3</xref>). Moreover, knockdown of Cyp26a1 and Cyp26c1 by targeted MO injection phenocopied the ketoconazole treatment (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A,B</xref>). Interestingly, inhibition or knockdown of Cyp26 resulted in increased <italic>tbx5</italic> levels suggesting that RA promotes its expression. Indeed, in-situ hybridization showed <italic>tbx5</italic> expression in the pSHF/foregut lpm, but not in the FHF/heart tube, reduced by DEAB indicating that it requires RA (<xref ref-type="fig" rid="fig5">Figure 5E</xref>). Combined with our finding that Tbx5 directly maintains <italic>aldh1a2</italic> expression, these data identify a RA-Tbx5 positive feedback loop in the pSHF.</p></sec><sec id="s2-7"><title>RA directly promotes <italic>shh</italic> transcription through the evolutionarily conserved MACS1 endoderm enhancer</title><p>Our data suggest that RA from the Aldh1a2-expressing lpm is a likely candidate to activate Hh ligand expression in the endoderm. We tested whether exogenous RA could directly activate <italic>shh</italic> and <italic>dhh</italic> transcription in <italic>Xenopus</italic> foregut endoderm explants where the <italic>tbx5/aldh1a2</italic>+ lpm, the source of endogenous RA, had been removed (<xref ref-type="fig" rid="fig6">Figure 6A and B</xref>). Without the RA-producing lpm, the foregut endoderm did not express <italic>shh</italic> nor <italic>dhh</italic>; however, addition of exogenous RA rescued their expression, even in the presence of CHX, demonstrating direct activation (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). As controls, RA also rescued expression of the known direct RA-target <italic>hnf1b</italic>, whereas the known indirect target <italic>ptf1a</italic> was not rescued in the presence of CHX (<xref ref-type="fig" rid="fig6">Figure 6B</xref>).</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>RA-RAR directly activates <italic>shh</italic> transcription in the <italic>Xenopus</italic> foregut endoderm via an evolutionarily conserved MACS1 enhancer.</title><p>(<bold>A</bold>) Schematic of direct RA target gene assay. Foregut endoderm (fg endo; yellow) was dissected from foregut mesoderm (fg meso; red) at NF25, pre-treated with 1 µM cycloheximide (CHX) for 2 hr prior to culture in 25 nM RA + CHX (or DMSO vehicle control) for 6 hr followed by RT-qPCR analysis. (<bold>B</bold>) RA directly activates <italic>shh</italic> and <italic>dhh</italic> expression in the presence of CHX. Graphs show mean relative expression ± standard deviation from N=3 biological replicates (four explants/replicate). Endoderm genes are shown in yellow, mesoderm makers in red confirm dissections. *p&lt;0.05, parametric two-tailed paired t-test. (<bold>C</bold>) Genome browser of the human <italic>SHH</italic> locus showing the evolutionarily conserved MACS1 distal enhancer (green shading) embedded in an intron of the <italic>RNF32</italic>. Published ChIP-seq tracks of RXR, H3K4me1, and H3K27ac1 from hPSC-derived foregut endoderm (<xref ref-type="bibr" rid="bib87">Vinckier et al., 2020</xref>, GSE104840; <xref ref-type="bibr" rid="bib90">Wang et al., 2015</xref>, GSE54471). (<bold>D</bold>) MACS1 enhancer contains multiple RAR/RXR DNA-binding half sites, two of which are highly conserved. Schematics of the wild-type and mutant MACS1:luciferase reporter constructs. (<bold>E</bold>) Luciferase reporter assay in <italic>Xenopus</italic> show that the Human and <italic>X. tropicalis</italic> MACS1 enhancers are activated by RA via the RAR/RXR DNA-binding sites. 50 pg of MACS1:luciferase reporter +5 pg pRL-TK reporter were microinjected±250 pg of dominant-negative RARa RNA into either the C1 foregut (fg; red bars) or C4 hindgut (hg; gray bars) blastomeres and luciferase activity was assayed at NF34. 10 μM DEAB treatment was from NF20 to NF34. Mean relative luciferase activity ± standard deviation, from N=6 biological replicates/time point with five embryos/replicate. *p&lt;0.05, parametric two-tailed paired t-test relative to WT MACS1:luc in the foregut (fg). Also see <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>, <xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2</xref> and related source data files. ns, not significant.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title><xref ref-type="fig" rid="fig6">Figure 6B</xref>.</title><p>RT-qPCR source data of <italic>Xenopus</italic> foregut endoderm explants treated for 2 hr in cycloheximide (CHX) prior to 6 hr in CHX +25 nM RA.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69288-fig6-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig6sdata2"><label>Figure 6—source data 2.</label><caption><title><xref ref-type="fig" rid="fig6">Figure 6E</xref>.</title><p>Luciferase source data of <italic>Xenopus tropicalis</italic> and human Shh MACS1-enhancer-reporter activity at NF34.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69288-fig6-data2-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69288-fig6-v2.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Multiple species alignment of the <italic>Shh</italic> MACS1 enhancers.</title><p>(<bold>A</bold>) Clustal DNA sequence alignment; putative RAR/RXR nuclear receptor motifs predicted by the CisBP tool (<xref ref-type="bibr" rid="bib91">Weirauch et al., 2014</xref>) are shaded in aqua blue (CisBP score&gt;10) and in yellow (CisBP score&gt;8). Asterisks below the nucleotide alignment indicated conserved bases amongst all four species. RAR/RXR motifs mutated and tested in this study are indicated and boxed in red. Genomic co-ordinates of the <italic>Shh</italic> MACS1 (mammalian-amphibian-conserved sequence 1; <xref ref-type="bibr" rid="bib67">Sagai et al., 2009</xref>) enhancers used in the multiple alignment were. <italic>Xenopus tropicalis</italic>: v9.1/xenTro9 genome build, chr6:9535614–9536245; Chick: galGal3 genome build, chr2:8370257–8370909; Human: hg19 genome build, chr7:156459384–156460049; Mouse: mm9 genome build, chr5:29538631–29539277.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69288-fig6-figsupp1-v2.tif"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 2.</label><caption><title>Conserved RAR/RXR sites in the <italic>Shh</italic> MACS1 enhancer are required for RA-mediated activation.</title><p>(<bold>A</bold>) Experimental schematic testing the ability of the wild-type (WT) or RAR/RXR mutant site reporters to respond to exogenous RA in <italic>Xenopus</italic> foregut endoderm explants. 50 pg of WT or mutant MACS1:luciferase reporter+5 pg pRL-TK reporter were microinjected into C1 foregut (fg) blastomeres; then at NF20 foregut explants were cut and the Aldh1a2+ fg lpm was manually removed, explants were treated with DMSO vehicle or 25 nM RA, and luciferase activity was assayed at NF34. Graphs show mean relative luciferase activity ± standard deviation; black dots in the graphs represent N=6 biological replicates, containing five embryos/replicate. Biological replicates contained pooled embryos from two separate fertilization/injection/dissections. *p&lt;0.05, parametric two-tailed paired t-test. RA, retinoic acid.</p><p><supplementary-material id="fig6s2sdata1"><label>Figure 6—figure supplement 2—source data 1.</label><caption><title>Luciferase source data of wild-type and mutant Shh-MACS1 reporters in <italic>Xenopus</italic> foregut endoderm explants ±25 nM RA.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69288-fig6-figsupp2-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69288-fig6-figsupp2-v2.tif"/></fig></fig-group><p>Previous work has identified an evolutionarily conserved distal <italic>Shh</italic> enhancer called MACS1 (for <bold><underline>m</underline></bold>ammalian-<bold><underline>a</underline></bold>mphibian-<bold><underline>c</underline></bold>onserved <bold><underline>s</underline></bold>equence <bold><underline>1</underline>),</bold> which is located more than 800 kb from <italic>Shh</italic>, within an intron of the <italic>Rnf32</italic> gene (<xref ref-type="bibr" rid="bib67">Sagai et al., 2009</xref>; <xref ref-type="bibr" rid="bib85">Tsukiji et al., 2014</xref>; <xref ref-type="bibr" rid="bib68">Sagai et al., 2017</xref>). The MACS1 enhancer is able to dive transcription in mouse foregut endoderm but the signals and TFs that control <italic>Shh</italic> expression via the MACS1 enhancer are unknown. An analysis of publicly available ChIP-seq data from human foregut endoderm, differentiated from pluripotent stem cells (hPSCs) in part by RA treatment (<xref ref-type="bibr" rid="bib87">Vinckier et al., 2020</xref>; <xref ref-type="bibr" rid="bib90">Wang et al., 2015</xref>), revealed binding of the RA nuclear receptor RXR at the human <italic>SHH</italic> MACS1 enhancer as well as H3K4me1 and H3K27ac1, epigenetic marks indicative of enhancer activation (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). Sequence analysis of the MACS1 enhancer predicted multiple RXR/RAR nuclear RA receptor half sites (<xref ref-type="bibr" rid="bib56">Penvose et al., 2019</xref>), two of which were evolutionarily conserved between human, mouse, chicken, and <italic>Xenopus</italic> (<xref ref-type="fig" rid="fig6">Figure 6D</xref>; <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>), suggesting that RA directly activates <italic>SHH</italic> transcription.</p><p>We functionally interrogated human and <italic>X. tropicalis SHH</italic> MACS1 enhancer activity in <italic>Xenopus</italic> luciferase assays (<xref ref-type="fig" rid="fig6">Figure 6E</xref>) and found both could drive robust reporter activity in foregut but not hindgut endoderm, demonstrating spatial specificity (<xref ref-type="fig" rid="fig6">Figure 6E</xref>). Disruption of endogenous RA signaling via DEAB treatment (NF20–34) or injection of dominant-negative RAR alpha RNA (dN-RARa) abolished human and <italic>X. trop</italic> MACS1 enhancer activity (<xref ref-type="fig" rid="fig6">Figure 6E</xref>). Moreover, exogenous RA could activate the enhancer in foregut explants lacking the RA-producing lpm. Mutation of the two highly conserved RAR/RXR half sites in the MACS1 enhancers dramatically reduced reporter activity in the foregut (<xref ref-type="fig" rid="fig6">Figure 6E</xref>) as well as a significantly blunted activation by exogenous RA in isolated endoderm explants (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2</xref>). These data demonstrate that RA signaling directly stimulated <italic>shh</italic> transcription in foregut endoderm, via conserved RAR/RXR motifs in the <italic>shh</italic> MACS1 enhancer.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><sec id="s3-1"><title>Tbx5 regulates a RA-HH-Wnt GRN that coordinates SHF patterning and pulmonary specification</title><p>Our findings reveal complex and evolutionarily conserved interconnected signaling networks downstream of Tbx5 that coordinate early development of the cardiac and pulmonary systems (modeled in <xref ref-type="fig" rid="fig7">Figure 7</xref>). We identify the following aspects of this SHF mesoderm—pulmonary endoderm signaling network: (1) Direct Tbx5 activation of an <italic>aldh1a2</italic> enhancer, which maintains <italic>aldh1a2</italic> transcription in pSHF mesoderm; RA is in turn required to maintain <italic>tbx5</italic> expression in the pSHF, establishing a positive feedback loop between Tbx5 and RA; (2) Tbx5-RA and FGF-Cyp form mutually antagonistic modules, with the Tbx5-RA loop promoting pSHF/CPP identity and suppressing aSHF fate, and Cyp-mediated RA degradation refining the spatial domain of RA activity; and (3) Direct RXR/RAR activation of the MACS1 enhancer at the shh locus, which provides a mechanism underlying the cell-non-autonomous activation of endodermal <italic>Hh</italic> ligand expression by Tbx5/Aldh1a2-dependent RA signaling in the pSHF. Reception of Hh signaling in the pSHF mesoderm activates Gli TFs, which cooperate with Tbx5 to directly activate <italic>wnt2/2b</italic> transcription; Wnt2/2b then induce pulmonary fate in the foregut endoderm (<xref ref-type="bibr" rid="bib28">Hoffmann et al., 2014</xref>; <xref ref-type="bibr" rid="bib60">Rankin et al., 2016</xref>; <xref ref-type="bibr" rid="bib78">Steimle et al., 2018</xref>; <xref ref-type="bibr" rid="bib21">Goddeeris et al., 2008</xref>). Thus, during CP development, Tbx5 regulates the production of three key paracrine signals, RA and Wnt directly via Tbx5-dependent enhancers and Hh indirectly via a RA-dependent enhancer. These interdependent signaling loops ensure that the lung primordia and pSHF-derived atria and pulmonary vessels from adjacent to one another, in preparation for the coordinated morphogenesis and functional integration of these two organ systems during development.</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Model of the Tbx5 regulated GRN coordinating SHF pattering and pulmonary induction.</title><p>Our data indicate that between NF25and NF35 in <italic>Xenopus</italic> and around E9.5 in mice, Tbx5 directly maintains <italic>Aldh1a2</italic> expression and a RA-Tbx5 positive feedback loop in the pSHF, which is necessary for <italic>Hh</italic> ligand expression, Wnt2/2b-dependent pulmonary fate induction, and SHF patterning. Blue arrows in the model indicate relationships demonstrated in this study. Tbx5/Aldh1a2-dependent RA signaling restricts FGF/Cyp activity in the aSHF, promotes pSHF identity, and drives expression of <italic>shh</italic> in pulmonary foregut endoderm. The <italic>aldh1a2</italic> enh1 enhancer is directly regulated by Tbx5 and the <italic>shh</italic> MACS1 enhancer is regulated by RA/RXR/RAR. aSHF, anterior second heart field; GRN, gene regulatory network; pSHF, posterior second heart field.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69288-fig7-v2.tif"/></fig></sec><sec id="s3-2"><title>T-box TFs and RA: a conserved regulatory node disrupted in cardiopulmonary and limb birth defects</title><p>Integrated regulatory loops between Tbx5, RA, and FGF regulate limb development and lung branching morphogenesis in addition to SHF cardiac development (<xref ref-type="bibr" rid="bib52">Nishimoto et al., 2015</xref>; <xref ref-type="bibr" rid="bib3">Arora et al., 2012</xref>; <xref ref-type="bibr" rid="bib18">Feneck and Logan, 2020</xref>). We show that Tbx5 and RA form a positive feedforward loop in the pSHF; in this domain, Tbx5 directly maintains Aldh1a2-dependent RA production while RA maintains <italic>tbx5</italic> expression. This is consistent with reports that RA is required for the expression of Tbx5 in SHF but not the FHF during early in mouse heart development (<xref ref-type="bibr" rid="bib12">De Bono et al., 2018</xref>; <xref ref-type="bibr" rid="bib76">Stefanovic et al., 2020</xref> ). We predict that this is equivalent to the RA-dependent maintenance of <italic>tbx5</italic> that we observed in <italic>Xenopus</italic>. In the developing limb bud, RA response elements in a regulatory element at <italic>Tbx5</italic> are required for enhancer activity and other enhancers at the <italic>Tbx5</italic> locus have been identified that can activate transcription in the heart and limb (<xref ref-type="bibr" rid="bib49">Minguillon et al., 2012</xref>; <xref ref-type="bibr" rid="bib75">Smemo et al., 2012</xref>; <xref ref-type="bibr" rid="bib10">Cunningham et al., 2018</xref>), it remains to be determined whether these enhancers are also directly regulated by RA/RAR/RXR or control expression in the pSHF. Regardless, Tbx5 and RA are from a shared module in both SHF and limb development (<xref ref-type="bibr" rid="bib52">Nishimoto et al., 2015</xref>). Limb defects and atrioventricular septal defects, caused by altered pSHF development, are both a facet of the phenotypic spectrum observed in Holt–Oram syndrome in human patients with <italic>TBX5</italic> mutations (<xref ref-type="bibr" rid="bib77">Steimle and Moskowitz, 2017</xref>). This raises the intriguing possibility that Tbx5-RA interactions were an evolutionary innovation in both limb and CP mesoderm in the adaptation to terrestrial life and that disrupting the Tbx5-RA feedforward loop is a component of <italic>TBX5</italic>-associated birth defects. Overall, this work provides a framework for understanding the developmental basis of the human birth defects observed in Holt–Oram Syndrome.</p></sec><sec id="s3-3"><title>Enhancers controlling the reciprocal RA-HH mesoderm and endoderm signaling</title><p>We found that Tbx5-dependent RA signaling directly promotes <italic>Shh</italic> expression in foregut endoderm via RAR/RXR half-site motifs in the evolutionarily conserved <italic>Shh</italic> MACS1 enhancer (<xref ref-type="bibr" rid="bib67">Sagai et al., 2009</xref>; <xref ref-type="bibr" rid="bib85">Tsukiji et al., 2014</xref>; <xref ref-type="bibr" rid="bib68">Sagai et al., 2017</xref>; <xref ref-type="bibr" rid="bib56">Penvose et al., 2019</xref>). Other endodermal TFs that contribute to <italic>Shh</italic> expression in the foregut have been described, including FoxA2, Meis3, Islet1, Tbx2, and Tbx3 (<xref ref-type="bibr" rid="bib43">Lin et al., 2006</xref>; <xref ref-type="bibr" rid="bib16">diIorio et al., 2007</xref>; <xref ref-type="bibr" rid="bib81">Tamplin et al., 2008</xref>; <xref ref-type="bibr" rid="bib46">Mesbah et al., 2012</xref>; <xref ref-type="bibr" rid="bib39">Lee et al., 2019</xref>; <xref ref-type="bibr" rid="bib19">Genga et al., 2019</xref>), but whether they directly function on the <italic>Shh</italic> MACS1 enhancer, potentially in cooperation with RA/RAR/RXRs, remains unknown.</p><p>Previous studies have defined multiple enhancers that regulate different temporal and spatial expression domains of <italic>Aldh1a2</italic> during development, with input from T-box TFs as a reoccurring theme. For example, the T-box TFs VegT, Eomesodermin, and Brachyury, regulate <italic>aldh1a2</italic> in the <italic>Xenopus</italic> gastrula mesoderm via cis-regulatory elements near the promoter (<xref ref-type="bibr" rid="bib20">Gentsch et al., 2013</xref>; <xref ref-type="bibr" rid="bib17">Faial et al., 2015</xref>; <xref ref-type="bibr" rid="bib83">Tosic et al., 2019</xref>). Subsequent expression of <italic>Aldh1a2</italic> in the paraxial mesoderm and early lpm is promoted by Hox/Pbx/Meis TF complexes acting on a first intron enhancer (<xref ref-type="bibr" rid="bib88">Vitobello et al., 2011</xref>) that is distinct from the enh1 enhancer identified here. Indeed, the Tbx5-responsive enh1 transgene did not drive expression in the paraxial mesoderm-derived somites.</p><p>The fidelity of these T-box/RA modules is essential for avoiding common cardiovascular birth defects affecting both the aSHF and pSHF. While Tbx5 and RA act in a positive feedback loop during pSHF patterning, Tbx1 and RA have an antagonistic relationship in the aSHF. Interestingly Tbx1, which can act as a transcriptional repressor, is known to spatially restrict <italic>Aldh1a2</italic> expression (<xref ref-type="bibr" rid="bib23">Guris et al., 2006</xref>; <xref ref-type="bibr" rid="bib1">Aggarwal et al., 2006</xref>; <xref ref-type="bibr" rid="bib65">Ryckebüsch et al., 2010</xref>), although it is currently unknown whether this activity is direct. On the other hand, RA suppresses <italic>tbx1</italic> expression in both <italic>Xenopus</italic> pSHF (our study) and in mice (<xref ref-type="bibr" rid="bib65">Ryckebüsch et al., 2010</xref>). In mouse, both loss of <italic>Tbx1</italic> and aberrant RA synthesis can result in cardiovascular defects similar to human DiGeorge syndrome patients. Moreover, genetically removing one copy of <italic>Aldh1a2</italic>, thereby reducing the level of RA, ameliorates the cardiovascular malformations in Tbx1 heterozygous embryos (<xref ref-type="bibr" rid="bib65">Ryckebüsch et al., 2010</xref>; <xref ref-type="bibr" rid="bib86">Vermot et al., 2003</xref>). Taken together, these observations suggest that the opposing actions of Tbx5 and Tbx1 act as a mechanistic toggle, wherein RA is activated by Tbx5 to promote the CP program in the pSHF and restrict aSHF identity. In the aSHF Tbx1 suppresses RA production and the CP program. We speculate that Tbx1 and Tbx5 may engage T-box elements in the same enh1 enhancer, with Tbx5 promoting <italic>Aldh1a2</italic> in the pSHF and Tbx1 inhibiting <italic>Aldh1a2</italic> transcription in the aSHF as a transcriptional mechanism contributing to posterior/anterior patterning of the SHF.</p><p>Identification of the specific transcriptional enhancers that mediate the reinforcing signaling loops that pattern the SHF is essential for the genotype-phenotype interpretation of animal model and patient CP defects. The enhancers we identified by which Tbx5 directly activates <italic>aldh1a2</italic> transcription and RA directly activates <italic>shh</italic> are both highly conserved amongst air breathing terrestrial vertebrate species, suggesting a potential role in CP evolution. Previous work has identified a single nucleotide variant in a TBX5 enhancer that contributes to human CHD (<xref ref-type="bibr" rid="bib75">Smemo et al., 2012</xref>). Identification of the enhancers modulating the essential signaling pathways for heart development will contribute to the curation of whole-genome sequencing, refining the search space for functional non-coding variants and allowing the nomination of non-coding SNPs that may alter the function of known enhancers and thereby contribute to CHD risk.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Strain, strain background(<italic>Xenopus tropicalis,</italic> females)</td><td align="left" valign="bottom">Wild-typeadult females</td><td align="left" valign="bottom">Nasco</td><td align="left" valign="bottom">LM00823</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background(<italic>X. tropicalis,</italic> males)</td><td align="left" valign="bottom">Wild-typeadult males</td><td align="left" valign="bottom">Nasco</td><td align="left" valign="bottom">LM00822</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background(<italic>X. laevis,</italic> females)</td><td align="left" valign="bottom">Wild-typeadult females</td><td align="left" valign="bottom">Nasco</td><td align="left" valign="bottom">LM00531</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background(<italic>X. laevis,</italic> males)</td><td align="left" valign="bottom">Wilt-typeadult males</td><td align="left" valign="bottom">Nasco</td><td align="left" valign="bottom">LM00715</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent(<italic>X. tropicalis</italic>)</td><td align="left" valign="bottom"><italic>Xtr.Tg(WntREs: dEGFP)<sup>Vlemx</sup></italic></td><td align="left" valign="bottom"><bold><underline>N</underline></bold>ational <bold><underline><italic>X</italic></underline></bold><italic>enopus</italic> <bold><underline>R</underline></bold>esource (NXR) Center,Woods Hole, MA</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:NXR_1094">NXR_1094</ext-link></td><td align="left" valign="bottom"><italic>X. tropicalis</italic> Wnt/Bcat reporter line</td></tr><tr><td align="left" valign="bottom">Genetic reagent(<italic>X. laevis</italic>)</td><td align="left" valign="bottom"><italic>Xla</italic>.<italic>Tg(WntREs: dEGFP)<sup>Vlemx</sup></italic>,</td><td align="left" valign="bottom">NXR</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:NXR_0064">NXR_0064</ext-link></td><td align="left" valign="bottom"><italic>X. laevis</italic> Wnt/Bcat reporter line</td></tr><tr><td align="left" valign="bottom">Genetic reagent(<italic>X. laevis</italic>)</td><td align="left" valign="bottom"><italic>Xla.Tg.(nkx2-5:GFP)<sup>Mohun</sup></italic></td><td align="left" valign="bottom">NXR</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:NXR_0030">NXR_0030</ext-link></td><td align="left" valign="bottom"><italic>X. laevis</italic> Nkx2-5:GFP reporter line</td></tr><tr><td align="left" valign="bottom">Strain, strain background(<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">CD-1</td><td align="left" valign="bottom">Charles River Labs</td><td align="left" valign="bottom">Strain Code022<bold>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_CRL:022">IMSR_CRL:022</ext-link></bold></td><td align="left" valign="bottom">WT mice</td></tr><tr><td align="left" valign="bottom">Genetic reagent(<italic>M. musculus</italic>)</td><td align="left" valign="bottom">Shh<sup>tm1(EGFP/cre)Cjt</sup></td><td align="left" valign="bottom">Jax Labs</td><td align="left" valign="bottom">JAX: 005622<bold>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:005622">IMSR_JAX:005622</ext-link></bold></td><td align="left" valign="bottom"><italic>Shh:GFP</italic> mice</td></tr><tr><td align="left" valign="bottom">Cell line(<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Tbx5</italic>OE-mESC line</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib78">Steimle et al., 2018</xref></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib78">Steimle et al., 2018</xref></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Doxycycline</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">D9891</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">(Rabbit polyclonal) anti-Aldh1a2</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab96060, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10679336">AB_10679336</ext-link></td><td align="left" valign="bottom">IF (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">(MouseMonoclonal)Anti-Aldh1/2</td><td align="left" valign="bottom">Santa Cruz Biotechnology</td><td align="left" valign="bottom">sc-166362, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2009458">AB_2009458</ext-link></td><td align="left" valign="bottom">IF (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">(Mouse monoclonal) anti-Sox2</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab79351; RRID:<ext-link ext-link-type="uri" xlink:href="http://antibodyregistry.org/AB_10710406">AB_10710406</ext-link></td><td align="left" valign="bottom">IF (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">(Rabbit polyclonal) anti-Nkx2-1 (H-190)</td><td align="left" valign="bottom">Santa CruzBiotechnology</td><td align="left" valign="bottom">sc-13040X; RRID:<ext-link ext-link-type="uri" xlink:href="http://antibodyregistry.org/AB_793532">AB_793532</ext-link></td><td align="left" valign="bottom">IF (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">(Mouse monoclonal) anti-Fibronectin (4H2)</td><td align="left" valign="bottom">Developmental Studies Hybridoma Bank</td><td align="left" valign="bottom">DSHB #4H2; RRID:<ext-link ext-link-type="uri" xlink:href="http://antibodyregistry.org/AB_2721949">AB_2721949</ext-link></td><td align="left" valign="bottom">IF (1:2000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">(Chicken polyclonal) anti-GFP</td><td align="left" valign="bottom">Aves Labs</td><td align="left" valign="bottom">GFP-1020; RRID:<ext-link ext-link-type="uri" xlink:href="http://antibodyregistry.org/AB_10000240">AB_10000240</ext-link></td><td align="left" valign="bottom">IF (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">(Goat polyclonal)anti-Tbx5</td><td align="left" valign="bottom">Santa Cruz Biotechnology</td><td align="left" valign="bottom">sc-17866, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2200827">AB_2200827</ext-link></td><td align="left" valign="bottom">IF (1:300)ChIP: 5 µg</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pI-SceI-d2EGFP plasmid</td><td align="left" valign="bottom">Addgene</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:Addgene_32674">Addgene_32674</ext-link></td><td align="left" valign="bottom">For meganuclease transgenics</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pRL-TK(plasmid)</td><td align="left" valign="bottom">Promega</td><td align="left" valign="bottom">E2241</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pGL4.23 luc2/miniP(plasmid)</td><td align="left" valign="bottom">Promega</td><td align="left" valign="bottom">E8411</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pCS2+ GR-xTbx5</td><td align="left" valign="bottom">Addgene</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:Addgene_117248">Addgene 117248</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pCS2+ xTbx5</td><td align="left" valign="bottom">Addgene</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:Addgene_117247">Addgene 117247</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pCSf107mT-Gateway-3′myc</td><td align="left" valign="bottom">Addgene</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:Addgene_67617">Addgene 67617</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pENTR223Human TBX5</td><td align="left" valign="bottom">Horizon Discovery</td><td align="left" valign="bottom">OHS5894-202500411</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Gateway LR Clonase II enzyme mix</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="char" char="." valign="bottom">11791020</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">mMessage mMachine SP6 RNA synthesis kit</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">AM1340</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">FGF8b</td><td align="left" valign="bottom">R&amp;D Systems</td><td align="char" char="hyphen" valign="bottom">423-F8-025</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">WNT2B</td><td align="left" valign="bottom">R&amp;D Systems</td><td align="char" char="hyphen" valign="bottom">3900-WN-025</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">TRIzol</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="char" char="." valign="bottom">15596018</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Direct-zolMiniprep plus kit</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">R2070</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">SuperscriptVILO mastermix</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="char" char="." valign="bottom">11755050</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">PowerUP2× SYBR Green MasterMix</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">A25742</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Firefly Luciferase 2.0 kit</td><td align="left" valign="bottom">Biotium</td><td align="char" char="ndash" valign="bottom">30085-1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Renilla Luciferase2.0 kit</td><td align="left" valign="bottom">Biotium</td><td align="char" char="ndash" valign="bottom">30082-1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">DEAB</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">D86256</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">All-trans retinoic acid(RA)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">R2625</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Ketoconazole</td><td align="left" valign="bottom">Tocris</td><td align="left" valign="bottom">Tocris#1103</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Cycloheximide</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">C4859</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Dexamethasone</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Sigma D4902</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">CAS9</td><td align="left" valign="bottom">PNA Bio</td><td align="left" valign="bottom">CP01-20</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>X. tropicalis tbx5</italic> exon5 sgRNA</td><td align="left" valign="bottom">IDT DNA</td><td align="left" valign="bottom">GGGGTTCTGATATGAAGTGA</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib78">Steimle et al., 2018</xref></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>X. laevis</italic> Tbx5 MO1</td><td align="left" valign="bottom">GeneTools</td><td align="left" valign="bottom">5′-TTA GGA AAG TGT CTC TGG TGT TGC C -3′;</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib4">Brown et al., 2005</xref></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>X. laevis</italic> Tbx5 3 bp mismistach MO1</td><td align="left" valign="bottom">GeneTools</td><td align="left" valign="bottom">5′-TCA GTA AAG TAT CTC TGG TGT TGC C-3′</td><td align="left" valign="bottom">This paper</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>X. laevis</italic> Tbx5 MO2</td><td align="left" valign="bottom">GeneTools</td><td align="left" valign="bottom">5′-CAT AAG CCT CCT CTG TGT CCG CCA T-3</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib4">Brown et al., 2005</xref></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>X. laevis</italic> Tbx5 3 bp mismatch MO2</td><td align="left" valign="bottom">GeneTools</td><td align="left" valign="bottom">5′-TAT CAG ACT CCT CTG TGT CCG CCA T-3′</td><td align="left" valign="bottom">This paper</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>X. laevis</italic> Aldh1a2-MO</td><td align="left" valign="bottom">GeneTools</td><td align="left" valign="bottom">5′-GCA TCT CTA TTT TAC TGG AAG TCAT-3′</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib79">Strate et al., 2009</xref></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>X. laevis</italic> Cyp26a1-MO</td><td align="left" valign="bottom">GeneTools</td><td align="left" valign="bottom">5′-TAG TGA GCA GAG TAT ACA GAT CCA T-3′</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib32">Janesick et al., 2013</xref></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>X. laevis</italic> Cyp26c1-MO</td><td align="left" valign="bottom">GeneTools</td><td align="left" valign="bottom">5′-TAC AAG ATG TTC CTC CTT GAG ATC A-3′</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib94">Yu et al., 2016</xref></td></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">Protein G-conjugated magnetic beads</td><td align="left" valign="bottom">Life Technologies</td><td align="char" char="." valign="bottom">1,003D</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">NEBNext Ultra DNA Library Prep Kit</td><td align="left" valign="bottom">New England Biolabs</td><td align="left" valign="bottom">E7370S</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">Sera-Mag magnetic beads</td><td align="left" valign="bottom">GE</td><td align="char" char="hyphen" valign="bottom">6515-2105-050-250</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Morpheus</td><td align="left" valign="bottom">Broad Institute</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://software.broadinstitute.org/morpheus">https://software.broadinstitute.org/morpheus</ext-link>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_017386">SCR_017386</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">SceI mega-nuclease enzyme</td><td align="left" valign="bottom">New England Biolabs</td><td align="left" valign="bottom">R0694S</td><td align="left" valign="bottom">Use within 1 month of purchase, store at –80°C</td></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">Dispase</td><td align="left" valign="bottom">Corning Life Sciences</td><td align="char" char="." valign="bottom">354235</td><td align="left" valign="bottom">Use at 10 U/ml on <italic>Xenopus</italic> explants</td></tr></tbody></table></table-wrap><sec id="s4-1"><title><italic>Xenopus</italic> methods</title><sec id="s4-1-1"><title><italic>Xenopus</italic> embryo injections</title><p>WT adult <italic>X. laevis</italic> and <italic>X. tropicalis</italic> frogs were purchased from Nasco (Fort Atkinson, WI). Adult transgenic <italic>X. laevis</italic> and <italic>X. tropicalis</italic> Wnt/B-catenin reporter (<italic>Xla.Tg(WntREs:dEGFP)<sup>Vlemx</sup></italic>, NXR_0064; and <italic>Xtr.Tg(WntREs:dEGFP)<sup>Vlemx</sup></italic>, NXR_1094), and adult transgenic <italic>X. laevis</italic> nkx2-5:GFP (<italic>Xla.Tg.(nkx2-5:GFP)<sup>Mohu</sup></italic>, NXR_0030) frogs were purchased from the National <italic>Xenopus</italic> Resource (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_013713">SCR_013713</ext-link>). Ovulation, in-vitro fertilization and natural mating, embryo de-jellying, and microinjection were performed as described (<xref ref-type="bibr" rid="bib74">Sive et al., 2000</xref>). Plasmids for <italic>Xenopus</italic> GR-Tbx5 (Addgene 117248), <italic>Xenopus</italic> Tbx5 (Addgene 117247) (<xref ref-type="bibr" rid="bib29">Horb and Thomsen, 1999</xref>), and <italic>Xenopus</italic> dominant-negative RARa (<xref ref-type="bibr" rid="bib69">Sharpe and Goldstone, 1997</xref>) were previously described. Human <italic>TBX5</italic> (Horizon Discovery OHS5894-202500411) was gateway sub-cloned from its entry vector pENTR223 into the expression vector pCSf107mT-Gateway-3′myc (Addgene 67617) using clonase (ThermoFisher 11791020) according to manufacturer’s instructions. Linearized plasmid templates were used to make mRNA for injection using the Ambion mMessage mMachine SP6 RNA Synthesis Kit (ThermoFisher AM1340). Total amounts of injected mRNA were as follows: GR-Tbx5 RNA, 125 pg; dN-RARa, 200 pg; and human TBX5-myc, 100 pg. Previously validated translation-blocking MOs against Tbx5 (<xref ref-type="bibr" rid="bib4">Brown et al., 2005</xref>; <xref ref-type="bibr" rid="bib78">Steimle et al., 2018</xref>), Aldh1a2 (<xref ref-type="bibr" rid="bib79">Strate et al., 2009</xref>), Cyp26a1 (<xref ref-type="bibr" rid="bib32">Janesick et al., 2013</xref>), and Cyp26c1 (<xref ref-type="bibr" rid="bib94">Yu et al., 2016</xref>) were injected at the 8-cell stage (for Tbx5-MO: a mixture of 2.5 ng each MO1 +2 per dorsal marginal zone (dmz) in <italic>X. laevis</italic>; mixture of 0.5 ng each MO1 +2 per dmz in <italic>X. tropicalis</italic>). MOs were purchased from GeneTools (Philmath, OR) and were as follows: Tbx5-MO1: 5′-TTA GGA AAG TGT CTC TGG TGT TGC C-3′; a negative control Tbx5 mismatch MO1 with three nucleotides mutated: 5′-T<bold><underline>C</underline></bold>A G<bold><underline>T</underline></bold>A AAG T<bold><underline>A</underline></bold>T CTC TGG TGT TGC C-3′; Tbx5-MO2: 5′-CAT AAG CCT CCT CTG TGT CCG CCA T-3′; Tbx5 3 bp mismatch MO2: 5′-<bold><underline>T</underline></bold>AT <bold><underline>C</underline></bold>AG <bold><underline>A</underline></bold>CT CCT CTG TGT CCG CCA T-3′ (mismatch bases are indicated in bold, underlined); Aldh1a2-MO: 5′-GCA TCT CTA TTT TAC TGG AAG TCAT-3′; Cyp26a1 MO: 5′-TAG TGA GCA GAG TAT ACA GAT CCA T-3′; and Cyp26c1 MO: 5′-TAC AAG ATG TTC CTC CTT GAG ATC A-3′.</p><p>For F0 CISPR-mediated indel mutations, a sgRNA targeting <italic>X. trop tbx5</italic> exon 5 (DNA-binding domain) that causes frameshift mutations was synthesized in-vitro as previously described (<xref ref-type="bibr" rid="bib78">Steimle et al., 2018</xref>). This exon5 sgRNA causes approximately 40% of injected embryos to have a phenotype (<xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>). Briefly, 2 nl of a mixture containing 50 pg/nl sgRNA with 0.5 ng/nl Cas9 protein (PNA Bio CP01-20) was injected on either side of the sperm entry point at the 1-cell stage (total of 200 pg sgRNA and 2 ng Cas9 protein per embryo).</p><p>For <italic>Xenopus</italic> whole embryo small-molecule treatments, embryos were cultured in 0.1× MBS +50 µg/ml gent with concentrations of 1 µM dexamethasone, 25 nM RA, or 10 µM DEAB (Sigma D86256). In all experiments, corresponding amounts of vehicle controls (DMSO or 0.2% fatty-acid free BSA) were used.</p><p>Gastrula or CP-foregut explants (containing both endoderm and lpm) were micro-dissected in 1× MBS +50 μg/ml gentamycin sulfate (gent; MP Biochemicals 1676045)±10 U/ml dispase (Corning Life Sciences 354235; to help remove the lpm) and were cultured in 0.5× MBS +0.2% fatty acid free BSA (Fisher BP9704)+50 μg/ml gent with the following concentrations of factors: 1 μM dexamethasone (DEX; Sigma D4902); 1 μM cycloheximide (CHX; Sigma C4859); 25 nM all-trans RA (Sigma R2625); 100 ng/ml WNT2B (R&amp;D Systems 3900-WN-025); 1 μM DEAB (Sigma D86256); 100 ng/ml FGF8b (R&amp;D Systems 423-F8-025); and 0.5 μM ketoconazole (Tocris 1103). In CHX experiments, explants were treated for 2 hr in CHX prior to DEX+CHX treatment for 6 hr.</p></sec><sec id="s4-1-2"><title><italic>Xenopus</italic> RT-qPCR</title><p>Xenopus explants were dissected from embryos of 2–3 separate fertilization/injection experiments, frozen on dry ice in 200 μl of TRIzol (ThermoFisher 15596018), and stored at –80°C. RNA was extracted using TRIzol and purified using the Direct-zol RNA miniprep plus kit (ZymoResearch R2070); 500 ng RNA was used in cDNA synthesis reactions using Superscript Vilo Mastermix (ThermoFisher 11755050), all according to the manufacturer’s instructions. qPCR reactions were carried out using PowerUp Mastermix (ThermoFisher A25742) on ABI StepOnePlus or QuantStudio3 machines. <italic>Xenopus</italic> RT-qPCR primer sequences are listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>. Relative expression, normalized to ubiquitously expressed <italic>odc</italic>, was determined using the 2<sup>−ΔΔCt</sup> method. Graphs display the average 2<sup>−ΔΔCt</sup> value ± standard deviation. Statistical significance (p&lt;0.05) was determined using parametric two-tailed paired t-test, relative to uninjected, untreated explants. Each black dot in the RT-qPCR graphs represents an independent biological replicate containing four explants. Heat map of <italic>Xenopus</italic> RT-qPCR gene expression was generated using Morpheus software (<ext-link ext-link-type="uri" xlink:href="https://software.broadinstitute.org/morpheus/">https://software.broadinstitute.org/morpheus/</ext-link>) and shows the average 2<sup>−ΔΔCt</sup> value from three biological replicates for each condition.</p></sec></sec><sec id="s4-2"><title><italic>Xenopus</italic> in-situ hybridization</title><p>In-situ hybridization of <italic>Xenopus</italic> embryos was performed as described (<xref ref-type="bibr" rid="bib74">Sive et al., 2000</xref>) with minor modifications. Briefly, embryos were fixed overnight at 4°C in MEMFA (0.1 M MOPS, 2 mM EGTA, 1 mM MgSO4, and 3.7% formaldehyde), washed 3× 5 min in MEMFA without formaldehyde, dehydrated directly into 100% ethanol, washed 5–6 times in 100% ethanol, and stored at −20°C for at least 24 hr. Proteinase K (ThermoFisher AM2548) on day 1 was used at 2 µg/ml for 10 min on stage NF15, NF25 embryos and 5 µg/ml on NF34 embryos; hybridization buffer included 0.1% SDS; RNAse A (ThermoFisher 12091021) used at 0.5 µg/ml; and anti-DIG-alkaline phosphatase antibody (Sigma 11093274910) used at 1:5000 in MAB buffer (100 mM Maleic acid, 150 mM NaCl, and pH 7.5) + 10% heat-inactivated lamb serum (Gibco 16070096) + 2% blocking reagent (Sigma 11096176001). Anti-sense DIG-labeled in-situ probes were generated using linearized plasmid cDNA templates with 10× DIG RNA labeling mix (Sigma 11277073910) according to the manufacturer’s instructions.</p></sec><sec id="s4-3"><title><italic>Xenopus</italic> immunofluorescence</title><p>Embryos were fixed in 100 mM HEPES (pH 7.5), 100 mM NaCl, 2.7% methanol-free formaldehyde for 2 hr at room temperature, dehydrated directly into Dent’s post-fixative (80% Methanol/20% DMSO), washed five times in Dent’s, and stored in Dent’s at −20°C for at least 48 hr. Embryos were serially rehydrated (75%, 40%, 25% methanol) into PBS +0.1% TritonX-100 (PBSTr). Embryos were then cut in a transverse plane through the pharynx and posterior to the liver to create a foregut sample using a fine razor blade on a 2% agarose-coated dish in PBSTr. Foreguts were subjected to antigen retrieval in 1× R-universal epitope recovery buffer (Electron Microscopy Sciences 62719-10) for 1 hr at 60–65°C, washed 2× 10 min in PBSTr, blocked for 1–2 hr in PBSTr +10% normal donkey serum (Jackson ImmunoResearch 017-000-001) + 11% DMSO at room temperature, and incubated overnight at 4°C in this blocking solution+primary antibodies: chicken anti-GFP (Aves GPF-1020; diluted 1:1000), mouse anti-Sox2 (Abcam ab79351; 1:1000), rabbit anti-Aldh1a2 (Abcam ab96060; 1:500), and goat anti-Tbx5 (Santa Cruz Biotechnology sc-17866, 1:350). Secondary antibodies were donkey anti-chicken 488, donkey anti-rabbit Cy3, and donkey anti-mouse Cy5, donkey anti-goat 405 (Jackson ImmunoResearch 703-546-155, 711-166-152, 715-175-151, and 705-476-147, respectively; all used at 1:1000 dilution). After extensive washing in PBSTr, samples were incubated overnight at 4°C in PBSTr +0.2% DMSO+secondary antibodies. Samples were again extensively washed in PBSTr, dehydrated into 100% methanol, washed five times in 100% methanol, cleared, and imaged in Murray’s Clear (two parts benzyl benzoate, one part benzyl alcohol) on a metal slide with glass coverslip bottom using a Nikon A1R confocal microscope to obtain optical sections.</p><sec id="s4-3-1"><title><italic>Xenopus</italic> luciferase assays</title><p>The <italic>Xenopus tropicalis</italic> v9.1 genome on <ext-link ext-link-type="uri" xlink:href="http://www.xenbase.org/entry/">Xenbase.org</ext-link>; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_003280">SCR_003280</ext-link> (<xref ref-type="bibr" rid="bib33">Karimi et al., 2018</xref>) was used to define <italic>Xenopus</italic> enhancers. For <italic>Xenopus</italic> luciferase assays, the sequences of the mouse <italic>Aldh1a2</italic> Enh1 (chr9:71241739–71242765; mm10 genome), <italic>X. trop aldh1a2</italic> enh1 (chr3:89631924–89632943; v9.1/xenTro9 genome), <italic>X.trop shh</italic> MACS1(chr6:9535614–9536245; v9.1/xenTro9 genome), and human <italic>SHH</italic> MACS1 (chr7:156459384–156460049; hg19 genome) enhancers, as well as their respective mutant forms, were commercially synthesized (GenScript USA, Piscataway NJ; or IDT DNA, Coralville, IA) and cloned into the pGL4.23 firefly luc2/miniP vector (Promega E8411). For enh1 enhancer assays, embryos were co-injected with 5 pg of pRL-TK:renilla luciferase plasmid (Promega E2241) + 50 pg of the pGL4.23 luc2/miniP enhancer:luciferase plasmid and the following amounts of MOs or mRNAs into each dorsal marginal zone (dmz) region of 4–8 cell embryos: 3.5 ng of tbx5-MO or 3 bp mismatch-MO; 62.5 pg GR-Tbx5 RNA; 50 pg <italic>Xenopus</italic> Tbx5 RNA; 50 pg human TBX5-myc RNA. For hindgut mesendoderm injections, the luciferase reporters were injected into the ventral-posterior marginal zone at the 4–8 cell stage±Tbx5 RNA. For analysis of Shh MACS1 enhancer activity in endoderm, C1 (foregut) or C4 (hindgut) blastomeres were injected at the 16- or 32-cell stage with 5 pg pRL-TK+50 pg MACS1:luc±100 pg dnRARa RNA.</p><p>Each biological replicate contained a pool of five embryos, obtained from 2 to 3 separate fertilization/injection experiments which were frozen on dry ice in a minimal volume of 0.1× MBS and stored at –80°C. To assay luciferase activity samples were lysed in 100 µl of 100 mM TRIS-Cl pH 7.5, centrifuged for 10 min at ~13,000×<italic>g</italic> and then 25 µl of the clear supernatant lysate was used separately in firefly (Biotium #30085-1) and renilla (Biotium 300821) luciferase assays according to the manufacturer’s instructions. Relative luciferase activity was determined by normalizing firefly to renilla levels for each sample. Graph show the average relative luciferase activity ± standard deviation with dots showing values of biological replicates. Statistical significance was determined by parametric two-tailed paired t-test, *p&lt;0.05.</p></sec><sec id="s4-3-2"><title><italic>Xenopus</italic> transgenesis</title><p>Transgenesis was carried out using the I-SceI meganuclease procedure (<xref ref-type="bibr" rid="bib53">Ogino et al., 2006</xref>; <xref ref-type="bibr" rid="bib54">Pan et al., 2006</xref>; <xref ref-type="bibr" rid="bib58">Rankin et al., 2009</xref> ). <italic>Xenopus</italic> transgenic plasmids were constructed using the pI-SceI-d2EGFP plasmid backbone (Addgene 32674). First, a fragment containing the mouse or <italic>X. trop</italic> enh1 enhancers upstream of a minimal TATA box promoter (<xref ref-type="bibr" rid="bib84">Tran et al., 2010</xref>) flanked by duplicated copies of the 250 bp chick B-globin HS4 insulator (<xref ref-type="bibr" rid="bib2">Allen and Weeks, 2009</xref>; <xref ref-type="bibr" rid="bib59">Rankin et al., 2011</xref>) was commercially synthesized (GenScript USA) and cloned into the ApaI/XhoI sites of pBluescript II KS+ (Agilent 212207). ApaI/XhoI digestion released this fragment, and it was ligated into ApaI/XhoI digested pI-SceI-d2EGFP plasmid. The meganuclease reaction contained 200 ng DNA, 2.5 μl I-SceI enzyme (New England Biolabs R0694S; kept at –80°C and used within 1 month of purchase) in 20 μl total volume and was incubated at 37°C for 30 min. 5 nl was then injected two times into 1 cell embryo on either side of the sperm entry point (10 nl total of meganuclease reaction injected per embryo). We observed 14/102 (~13%) and 21/183 (11%) GFP+full transgenic embryos using the mouse and <italic>X. trop</italic> enh1 constructs, respectively, from two independent injection experiments. As a negative control, 0/87 embryos were GFP positive when injected using reactions that omitted the I-SceI enzyme.</p></sec></sec><sec id="s4-4"><title>Mouse methods</title><sec id="s4-4-1"><title>RNA-seq</title><p>RNA-seq of the micro-dissected E9.5 WT and <italic>Tbx5<sup>−/</sup></italic><sup>−</sup> pSHF/CPP was previously published and is available on GEO (<xref ref-type="bibr" rid="bib78">Steimle et al., 2018</xref>, GSE75077). Heat maps were generated using Morpheus software (<ext-link ext-link-type="uri" xlink:href="https://software.broadinstitute.org/morpheus/">https://software.broadinstitute.org/morpheus/</ext-link>). Columns in the <xref ref-type="fig" rid="fig1">Figure 1</xref> heat map represent biological replicates (<italic>Tbx5<sup>+/+</sup></italic> WT N=5, <italic>Tbx5<sup>−/</sup></italic><sup>−</sup> N=2), and each column replicate contained n=4 pooled CP dissected regions.</p></sec><sec id="s4-4-2"><title>RT-qPCR, in-situ hybridization, and immunofluorescence</title><p>RT-qPCR of dissected, pooled (n=4) mouse E9.5 pSHF/CPP regions was performed as described (<xref ref-type="bibr" rid="bib78">Steimle et al., 2018</xref>), cDNA generated using SuperScript III First-Strand Synthesis SuperMix (ThermoFisher 18080051), and qPCR was performed using PowerUp Mastermix (ThermoFisher A25742). Gene-expression levels were normalized by <italic>Gapdh</italic> and RT-qPCR primers are listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>. In-situ hybridization on mouse embryos was performed as described (<xref ref-type="bibr" rid="bib27">Hoffmann et al., 2009</xref>). <italic>Shh</italic> probe was provided by Elizabeth Grove (University of Chicago). Immunofluorescence of WT CD-1 (Charles River) or <italic>Shh:GFP</italic> (<ext-link ext-link-type="uri" xlink:href="https://www.jax.org/strain/008466">B6.129</ext-link> <ext-link ext-link-type="uri" xlink:href="https://www.jax.org/strain/008466">×</ext-link> <ext-link ext-link-type="uri" xlink:href="https://www.jax.org/strain/008466">1</ext-link><ext-link ext-link-type="uri" xlink:href="https://www.jax.org/strain/008466">(Cg)-Shhtm6Amc/J</ext-link>; Jax Labs Stock Number #008466) mouse embryos was performed as described (<xref ref-type="bibr" rid="bib60">Rankin et al., 2016</xref>; <xref ref-type="bibr" rid="bib61">Rankin et al., 2018</xref>) using mouse anti-Aldh1a2 (Santa Cruz Biotechnology sc-166362; 1:1000), goat anti-Tbx5 (Santa Cruz Biotechnology sc-17866, 1:300), rabbit anti-Nkx2-1 (Santa Cruz Biotechnology sc-13040 H-190, 1:500), and chicken anti-GFP (Aves Labs GFP-1020, 1:1000).</p><p>Reconstructions of whole-mount in-situ hybridizations were generated using previously published methods (<xref ref-type="bibr" rid="bib78">Steimle et al., 2018</xref>). In brief, images were obtained and pre-processed using Adobe Photoshop CS3 Extended (version 10.0.1, <ext-link ext-link-type="uri" xlink:href="http://www.adobe.com">http://www.adobe.com</ext-link>) and reconstructed with AMIRA (version 5.3.2, <ext-link ext-link-type="uri" xlink:href="http://www.amira.com">http://www.amira.com</ext-link>). Manual review of each image in the stack was performed and corrections were made when necessary. LabelFields for gene expression and tissue were generated from the same series of sections using separate CastField and LabelVoxel modules. The SurfaceGen module was used to generate surfaces from these LabelFields. Gene expression models for two different genes were initially aligned using the Landmark (two sets) module, and a minimum of three landmarks were used to align the separate models. These landmarks were located using the pharyngeal endoderm and ventral edge of the SHF. Final alignments were fine-tuned manually using the Transform editor.</p></sec><sec id="s4-4-3"><title>Digital in-situ hybridization</title><p>Digital in-situ hybridization for <italic>Aldh1a2</italic>, <italic>Tbx1</italic>, <italic>Tbx5</italic>, and <italic>Shh</italic> was generated using the single cells Spatial Mouse Atlas (<xref ref-type="bibr" rid="bib44">Lohoff et al., 2021</xref>; <ext-link ext-link-type="uri" xlink:href="https://crukci.shinyapps.io/SpatialMouseAtlas/">https://crukci.shinyapps.io/SpatialMouseAtlas/</ext-link>). Images are centered around the cardiothoracic region with cardiomyocytes highlighted.</p></sec><sec id="s4-4-4"><title>Mouse ESCs</title><p>The inducible <italic>Tbx5</italic>OE-mESC line was previously generated (<xref ref-type="bibr" rid="bib78">Steimle et al., 2018</xref>) and differentiated to the cardiac lineage as described (<xref ref-type="bibr" rid="bib35">Kattman et al., 2011</xref>). Doxycycline (Sigma D9891; concentrations of 0, 5, 10, 25, 50, 100, 250, and 500 ng/ml) was applied at the cardiac progenitor-like stage (day 6) and cells were harvested for RNA 24 hr later.</p></sec><sec id="s4-4-5"><title>ChIP-seq</title><p>ChIP-seq was performed using dissected whole lungs from E14.5 CD-1 mouse embryos obtained from Charles River. Chromatin was prepared as previously described (<xref ref-type="bibr" rid="bib78">Steimle et al., 2018</xref>). For immunoprecipitation, the chromatin extract was incubated with 5 µg of the anti-TBX5 antibody (Santa Cruz Biotechnology sc-17866; Lot #G1516) at 4°C for &gt;12 hr in a total volume of 200 μl. The immune complexes were captured by Protein G-conjugated magnetic beads (Life Technologies, 1003D) and washed as previously described (<xref ref-type="bibr" rid="bib78">Steimle et al., 2018</xref>). The captured chromatin was eluted in ChIP Elution Buffer (10 mM Tris-HCl, pH 8.0, 1 mM EDTA, 1% SDS, and 250 mM NaCl) at 65°C. After RNase and proteinase K treatment and reverse cross-linking, DNA was purified. High-throughput sequencing libraries from ChIP and input DNA were prepared using NEBNext Ultra DNA Library Prep Kit (New England Biolabs, E7370S). During library preparation, adaptor-ligated DNA fragments of 200–650 bp in size were selected before PCR amplification using Sera-Mag magnetic beads (GE, 6515-2105-050-250). DNA libraries were sequenced using Illumina Hi-seq instruments (single-end 50 base) by the Genomics Core Facility at the University of Chicago.</p></sec></sec><sec id="s4-5"><title>Bioinformatics</title><sec id="s4-5-1"><title>ChIP-seq analysis</title><p>Raw sequencing reads were aligned to the mm10 genome using Bowtie2 (<xref ref-type="bibr" rid="bib38">Langmead and Salzberg, 2012</xref>) and SAMtools (<xref ref-type="bibr" rid="bib41">Li et al., 2009</xref>) requiring a minimum mapping quality of 10 (−q 10). Pooled peak calling was performed using default settings of MACS2 callpeak (<xref ref-type="bibr" rid="bib96">Zhang et al., 2008</xref>) with a q-value set to 0.05 and tag size set to 6 (−q 0.05 s 6). A fold-enrichment track was generated using MACS2 with the bdgcmp function (−m FE) for visualization on the IVG genome browser (<xref ref-type="bibr" rid="bib82">Thorvaldsdottir et al., 2012</xref>). Public data reanalyzed in this study was downloaded from GEO either as Bigwig files or raw reads which were processed as described above.</p></sec><sec id="s4-5-2"><title>RNA-seq analysis</title><p>RNA-seq of the micro-dissected E9.5 WT and <italic>Tbx5<sup>−/</sup></italic><sup>−</sup> pSHF/CPP was previously published and is available on GEO (<xref ref-type="bibr" rid="bib78">Steimle et al., 2018</xref>, GSE75077). This RNA-seq data was re-analyzed using Computational Suite for Bioinformaticians and Biologists (CSBB – v3.0.0) using <italic>ProcessPublicData</italic> module (<ext-link ext-link-type="uri" xlink:href="https://github.com/praneet1988/Computational-Suite-For-Bioinformaticians-and-Biologists">https://github.com/praneet1988/Computational-Suite-For-Bioinformaticians-and-Biologists</ext-link>), (<xref ref-type="bibr" rid="bib8">Chaturvedi, 2019</xref>). Differentially expressed genes (DEGs) between <italic>Tbx5<sup>−/</sup></italic><sup>−</sup> and WT were identified using RUVSeq, with a threshold of 1.5 fold change and 5% FDR. Expression heat maps were generated using Morpheus (<ext-link ext-link-type="uri" xlink:href="https://software.broadinstitute.org/morpheus/">https://software.broadinstitute.org/morpheus/</ext-link>).</p><p>DEGs were compared with gene sets from single-cell RNA-seq defining aSHF versus pSHF (<xref ref-type="bibr" rid="bib13">de Soysa et al., 2019</xref>, GSE126128) and pharynx versus CPP+ lung progenitor cells (<xref ref-type="bibr" rid="bib24">Han et al., 2020</xref>, GSE136689) from the early mouse embryo. We created a cardio-pharyngeal enriched gene set by combining marker genes of aSHF and pharynx mesendoderm, and a CP gene set by combining markers pSHF, pulmonary mesoderm, and lung endoderm. Overlaps in gene sets were visualized by Venn diagrams and significant overlaps were defined by HGTs. In addition, we assessed the enrichment of upregulated and downregulated DEGs from the <italic>Tbx5<sup>−/</sup></italic><sup>−</sup> embryos compared to the single-cell data sets by GSEA (<xref ref-type="bibr" rid="bib80">Subramanian et al., 2005</xref>).</p></sec></sec></sec></body><back><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing - original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Formal analysis, Investigation, Visualization, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con5"><p>Formal analysis, Software</p></fn><fn fn-type="con" id="con6"><p>Formal analysis, Software, Visualization, Writing – review and editing</p></fn><fn fn-type="con" id="con7"><p>Formal analysis, Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con8"><p>Formal analysis, Investigation, Visualization</p></fn><fn fn-type="con" id="con9"><p>Funding acquisition, Project administration, Supervision, Writing – review and editing</p></fn><fn fn-type="con" id="con10"><p>Conceptualization, Funding acquisition, Project administration, Supervision, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Mouse and <italic>Xenopus</italic> experiments were performed according to Institutional Animal Care and Use Committee (IACUC) protocols (University of Chicago protocol 71737; Cincinnati Children's Hospital protocol 2019-0053).</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>RT-qPCR primers used in this study for <italic>Xenopus</italic> and mouse.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69288-supp1-v2.xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Gene sets, utilized in <xref ref-type="fig" rid="fig1">Figure 1</xref>, from <xref ref-type="bibr" rid="bib13">de Soysa et al., 2019</xref> (GSE126128) single-cell RNA-seq studies of developing E7.75-E9.5 mouse embryos that transcriptionally define the anterior and posterior second heart field territories.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69288-supp2-v2.xlsx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>Gene sets, utilized in <xref ref-type="fig" rid="fig1">Figure 1</xref>, from <xref ref-type="bibr" rid="bib24">Han et al., 2020</xref> (GSE136689) single-cell RNA-seq studies of developing e8.75-e9.5 mouse embryos that transcriptionally define the cardiopulmonary progenitor (CPP)+ lung and ventral pharynx territories.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-69288-supp3-v2.xlsx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-69288-transrepform1-v2.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>ChIP-seq data generated in this study is available from the Gene Expression Omnibus (GEO) accession number GSE167207.</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Steimle</surname><given-names>JD</given-names></name><name><surname>Ikegami</surname><given-names>K</given-names></name><name><surname>Burnicka-Turek</surname><given-names>O</given-names></name><name><surname>Moskowitz</surname><given-names>IP</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>TBX5 ChIP from the Fetal Lung</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE167207">GSE167207</pub-id></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation id="dataset2" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>XH</given-names></name><name><surname>Steimle</surname><given-names>JD</given-names></name><name><surname>Kweon</surname><given-names>J</given-names></name><name><surname>Moskowitz</surname><given-names>IP</given-names></name></person-group><year iso-8601-date="2015">2015</year><data-title>Whole genome transcriptomic experiments in mice heart development system</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE75077">GSE75077</pub-id></element-citation></p><p><element-citation id="dataset3" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>de Soysa</surname><given-names>TY</given-names></name><name><surname>Gifford</surname><given-names>CA</given-names></name><name><surname>Srivastava</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>Single-cell analysis of cardiogenesis reveals basis for organ level developmental defects</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE126128">GSE126128</pub-id></element-citation></p><p><element-citation id="dataset4" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Han</surname><given-names>L</given-names></name><name><surname>Chaturvedi</surname><given-names>P</given-names></name><name><surname>Zorn</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>Single cell sequencing of dissected mouse foreguts at embryonic day 8.5 to 9.5</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE136689">GSE136689</pub-id></element-citation></p><p><element-citation id="dataset5" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Steimle</surname><given-names>JD</given-names></name><name><surname>Ikegami</surname><given-names>K</given-names></name><name><surname>Burnicka-Turek</surname><given-names>O</given-names></name><name><surname>Moskowitz</surname><given-names>IP</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>TBX5 ChIP from the Fetal Heart</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE139803">GSE139803</pub-id></element-citation></p><p><element-citation id="dataset6" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Nicholas</surname><given-names>V</given-names></name><name><surname>Sander</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>LSD1-mediated enhancer silencing enables endocrine cell development through attenuation of retinoic acid signaling</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE104840">GSE104840</pub-id></element-citation></p><p><element-citation id="dataset7" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>A</given-names></name><name><surname>Yue F</surname><given-names>Li Y</given-names></name></person-group><year iso-8601-date="2015">2015</year><data-title>Developmental Competence Encoded at the Level of Enhancers</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE54471">GSE54471</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>The authors thank members of the Zorn and Wells labs for suggestions and Lisa Sandell (University of Louisville) for discussions. The authors thank Nicole Edwards and Leslie Brown for help generating and genotyping <italic>Shh:GFP</italic> mouse embryos.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aggarwal</surname><given-names>VS</given-names></name><name><surname>Liao</surname><given-names>J</given-names></name><name><surname>Bondarev</surname><given-names>A</given-names></name><name><surname>Schimmang</surname><given-names>T</given-names></name><name><surname>Lewandoski</surname><given-names>M</given-names></name><name><surname>Locker</surname><given-names>J</given-names></name><name><surname>Shanske</surname><given-names>A</given-names></name><name><surname>Campione</surname><given-names>M</given-names></name><name><surname>Morrow</surname><given-names>BE</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Dissection of Tbx1 and Fgf interactions in mouse models of 22q11DS suggests functional redundancy</article-title><source>Human Molecular Genetics</source><volume>15</volume><fpage>3219</fpage><lpage>3228</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddl399</pub-id><pub-id pub-id-type="pmid">17000704</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>BG</given-names></name><name><surname>Weeks</surname><given-names>DL</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Bacteriophage phiC31 integrase mediated transgenesis in Xenopus laevis for protein expression at endogenous levels</article-title><source>Methods in Molecular Biology</source><volume>518</volume><fpage>113</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1007/978-1-59745-202-1_9</pub-id><pub-id pub-id-type="pmid">19085128</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arora</surname><given-names>R</given-names></name><name><surname>Metzger</surname><given-names>RJ</given-names></name><name><surname>Papaioannou</surname><given-names>VE</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Multiple roles and interactions of Tbx4 and Tbx5 in development of the respiratory system</article-title><source>PLOS Genetics</source><volume>8</volume><elocation-id>e1002866</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1002866</pub-id><pub-id pub-id-type="pmid">22876201</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>DD</given-names></name><name><surname>Martz</surname><given-names>SN</given-names></name><name><surname>Binder</surname><given-names>O</given-names></name><name><surname>Goetz</surname><given-names>SC</given-names></name><name><surname>Price</surname><given-names>BMJ</given-names></name><name><surname>Smith</surname><given-names>JC</given-names></name><name><surname>Conlon</surname><given-names>FL</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Tbx5 and Tbx20 act synergistically to control vertebrate heart morphogenesis</article-title><source>Development</source><volume>132</volume><fpage>553</fpage><lpage>563</lpage><pub-id pub-id-type="doi">10.1242/dev.01596</pub-id><pub-id pub-id-type="pmid">15634698</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruneau</surname><given-names>BG</given-names></name><name><surname>Nemer</surname><given-names>G</given-names></name><name><surname>Schmitt</surname><given-names>JP</given-names></name><name><surname>Charron</surname><given-names>F</given-names></name><name><surname>Robitaille</surname><given-names>L</given-names></name><name><surname>Caron</surname><given-names>S</given-names></name><name><surname>Conner</surname><given-names>DA</given-names></name><name><surname>Gessler</surname><given-names>M</given-names></name><name><surname>Nemer</surname><given-names>M</given-names></name><name><surname>Seidman</surname><given-names>CE</given-names></name><name><surname>Seidman</surname><given-names>JG</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease</article-title><source>Cell</source><volume>106</volume><fpage>709</fpage><lpage>721</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(01)00493-7</pub-id><pub-id pub-id-type="pmid">11572777</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burnicka-Turek</surname><given-names>O</given-names></name><name><surname>Broman</surname><given-names>MT</given-names></name><name><surname>Steimle</surname><given-names>JD</given-names></name><name><surname>Boukens</surname><given-names>BJ</given-names></name><name><surname>Petrenko</surname><given-names>NB</given-names></name><name><surname>Ikegami</surname><given-names>K</given-names></name><name><surname>Nadadur</surname><given-names>RD</given-names></name><name><surname>Qiao</surname><given-names>Y</given-names></name><name><surname>Arnolds</surname><given-names>DE</given-names></name><name><surname>Yang</surname><given-names>XH</given-names></name><name><surname>Patel</surname><given-names>VV</given-names></name><name><surname>Nobrega</surname><given-names>MA</given-names></name><name><surname>Efimov</surname><given-names>IR</given-names></name><name><surname>Moskowitz</surname><given-names>IP</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Transcriptional Patterning of the Ventricular Cardiac Conduction System</article-title><source>Circulation Research</source><volume>127</volume><fpage>e94</fpage><lpage>e106</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.118.314460</pub-id><pub-id pub-id-type="pmid">32290757</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castillo</surname><given-names>HA</given-names></name><name><surname>Cravo</surname><given-names>RM</given-names></name><name><surname>Azambuja</surname><given-names>AP</given-names></name><name><surname>Simões-Costa</surname><given-names>MS</given-names></name><name><surname>Sura-Trueba</surname><given-names>S</given-names></name><name><surname>Gonzalez</surname><given-names>J</given-names></name><name><surname>Slonimsky</surname><given-names>E</given-names></name><name><surname>Almeida</surname><given-names>K</given-names></name><name><surname>Abreu</surname><given-names>JG</given-names></name><name><surname>de Almeida</surname><given-names>MAA</given-names></name><name><surname>Sobreira</surname><given-names>TP</given-names></name><name><surname>de Oliveira</surname><given-names>SHP</given-names></name><name><surname>de Oliveira</surname><given-names>PSL</given-names></name><name><surname>Signore</surname><given-names>IA</given-names></name><name><surname>Colombo</surname><given-names>A</given-names></name><name><surname>Concha</surname><given-names>ML</given-names></name><name><surname>Spengler</surname><given-names>TS</given-names></name><name><surname>Bronner-Fraser</surname><given-names>M</given-names></name><name><surname>Nobrega</surname><given-names>M</given-names></name><name><surname>Rosenthal</surname><given-names>N</given-names></name><name><surname>Xavier-Neto</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>sights into the organization of dorsal spinal cord pathways from an evolutionarily conserved raldh2 intronic enhancer</article-title><source>Development</source><volume>137</volume><fpage>507</fpage><lpage>518</lpage><pub-id pub-id-type="doi">10.1242/dev.043257</pub-id><pub-id pub-id-type="pmid">20081195</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Chaturvedi</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>Computational-Suite-For-Bioinformaticians-and-Biologists</data-title><version designator="00ca12d">00ca12d</version><source>GitHub</source><ext-link ext-link-type="uri" xlink:href="https://github.com/praneet1988/Computational-Suite-For-Bioinformaticians-and-Biologists">https://github.com/praneet1988/Computational-Suite-For-Bioinformaticians-and-Biologists</ext-link></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>F</given-names></name><name><surname>Desai</surname><given-names>TJ</given-names></name><name><surname>Qian</surname><given-names>J</given-names></name><name><surname>Niederreither</surname><given-names>K</given-names></name><name><surname>Lü</surname><given-names>J</given-names></name><name><surname>Cardoso</surname><given-names>WV</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Inhibition of Tgf beta signaling by endogenous retinoic acid is essential for primary lung bud induction</article-title><source>Development</source><volume>134</volume><fpage>2969</fpage><lpage>2979</lpage><pub-id pub-id-type="doi">10.1242/dev.006221</pub-id><pub-id pub-id-type="pmid">17634193</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cunningham</surname><given-names>TJ</given-names></name><name><surname>Lancman</surname><given-names>JJ</given-names></name><name><surname>Berenguer</surname><given-names>M</given-names></name><name><surname>Dong</surname><given-names>PDS</given-names></name><name><surname>Duester</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Genomic Knockout of Two Presumed Forelimb Tbx5 Enhancers Reveals They Are Nonessential for Limb Development</article-title><source>Cell Reports</source><volume>23</volume><fpage>3146</fpage><lpage>3151</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2018.05.052</pub-id><pub-id pub-id-type="pmid">29898387</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>CA</given-names></name><name><surname>Hitz</surname><given-names>BC</given-names></name><name><surname>Sloan</surname><given-names>CA</given-names></name><name><surname>Chan</surname><given-names>ET</given-names></name><name><surname>Davidson</surname><given-names>JM</given-names></name><name><surname>Gabdank</surname><given-names>I</given-names></name><name><surname>Hilton</surname><given-names>JA</given-names></name><name><surname>Jain</surname><given-names>K</given-names></name><name><surname>Baymuradov</surname><given-names>UK</given-names></name><name><surname>Narayanan</surname><given-names>AK</given-names></name><name><surname>Onate</surname><given-names>KC</given-names></name><name><surname>Graham</surname><given-names>K</given-names></name><name><surname>Miyasato</surname><given-names>SR</given-names></name><name><surname>Dreszer</surname><given-names>TR</given-names></name><name><surname>Strattan</surname><given-names>JS</given-names></name><name><surname>Jolanki</surname><given-names>O</given-names></name><name><surname>Tanaka</surname><given-names>FY</given-names></name><name><surname>Cherry</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The Encyclopedia of DNA elements (ENCODE): data portal update</article-title><source>Nucleic Acids Research</source><volume>46</volume><fpage>D794</fpage><lpage>D801</lpage><pub-id pub-id-type="doi">10.1093/nar/gkx1081</pub-id><pub-id pub-id-type="pmid">29126249</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Bono</surname><given-names>C</given-names></name><name><surname>Thellier</surname><given-names>C</given-names></name><name><surname>Bertrand</surname><given-names>N</given-names></name><name><surname>Sturny</surname><given-names>R</given-names></name><name><surname>Jullian</surname><given-names>E</given-names></name><name><surname>Cortes</surname><given-names>C</given-names></name><name><surname>Stefanovic</surname><given-names>S</given-names></name><name><surname>Zaffran</surname><given-names>S</given-names></name><name><surname>Théveniau-Ruissy</surname><given-names>M</given-names></name><name><surname>Kelly</surname><given-names>RG</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>T-box genes and retinoic acid signaling regulate the segregation of arterial and venous pole progenitor cells in the murine second heart field</article-title><source>Human Molecular Genetics</source><volume>27</volume><fpage>3747</fpage><lpage>3760</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddy266</pub-id><pub-id pub-id-type="pmid">30016433</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Soysa</surname><given-names>TY</given-names></name><name><surname>Ranade</surname><given-names>SS</given-names></name><name><surname>Okawa</surname><given-names>S</given-names></name><name><surname>Ravichandran</surname><given-names>S</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Salunga</surname><given-names>HT</given-names></name><name><surname>Schricker</surname><given-names>A</given-names></name><name><surname>Del Sol</surname><given-names>A</given-names></name><name><surname>Gifford</surname><given-names>CA</given-names></name><name><surname>Srivastava</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Single-cell analysis of cardiogenesis reveals basis for organ-level developmental defects</article-title><source>Nature</source><volume>572</volume><fpage>120</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1414-x</pub-id><pub-id pub-id-type="pmid">31341279</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deimling</surname><given-names>SJ</given-names></name><name><surname>Drysdale</surname><given-names>TA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Retinoic acid regulates anterior-posterior patterning within the lateral plate mesoderm of <italic>Xenopus</italic></article-title><source>Mechanisms of Development</source><volume>126</volume><fpage>913</fpage><lpage>923</lpage><pub-id pub-id-type="doi">10.1016/j.mod.2009.07.001</pub-id><pub-id pub-id-type="pmid">19595764</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deimling</surname><given-names>SJ</given-names></name><name><surname>Drysdale</surname><given-names>TA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Fgf is required to regulate anterior-posterior patterning in the <italic>Xenopus</italic> lateral plate mesoderm</article-title><source>Mechanisms of Development</source><volume>128</volume><fpage>327</fpage><lpage>341</lpage><pub-id pub-id-type="doi">10.1016/j.mod.2011.06.002</pub-id><pub-id pub-id-type="pmid">21763769</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>diIorio</surname><given-names>P</given-names></name><name><surname>Alexa</surname><given-names>K</given-names></name><name><surname>Choe</surname><given-names>S-K</given-names></name><name><surname>Etheridge</surname><given-names>L</given-names></name><name><surname>Sagerström</surname><given-names>CG</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>TALE-family homeodomain proteins regulate endodermal sonic hedgehog expression and pattern the anterior endoderm</article-title><source>Developmental Biology</source><volume>304</volume><fpage>221</fpage><lpage>231</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2006.12.024</pub-id><pub-id pub-id-type="pmid">17289013</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faial</surname><given-names>T</given-names></name><name><surname>Bernardo</surname><given-names>AS</given-names></name><name><surname>Mendjan</surname><given-names>S</given-names></name><name><surname>Diamanti</surname><given-names>E</given-names></name><name><surname>Ortmann</surname><given-names>D</given-names></name><name><surname>Gentsch</surname><given-names>GE</given-names></name><name><surname>Mascetti</surname><given-names>VL</given-names></name><name><surname>Trotter</surname><given-names>MWB</given-names></name><name><surname>Smith</surname><given-names>JC</given-names></name><name><surname>Pedersen</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Brachyury and SMAD signalling collaboratively orchestrate distinct mesoderm and endoderm gene regulatory networks in differentiating human embryonic stem cells</article-title><source>Development</source><volume>142</volume><fpage>2121</fpage><lpage>2135</lpage><pub-id pub-id-type="doi">10.1242/dev.117838</pub-id><pub-id pub-id-type="pmid">26015544</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feneck</surname><given-names>E</given-names></name><name><surname>Logan</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The Role of Retinoic Acid in Establishing the Early Limb Bud</article-title><source>Biomolecules</source><volume>10</volume><elocation-id>E312</elocation-id><pub-id pub-id-type="doi">10.3390/biom10020312</pub-id><pub-id pub-id-type="pmid">32079177</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Genga</surname><given-names>RMJ</given-names></name><name><surname>Kernfeld</surname><given-names>EM</given-names></name><name><surname>Parsi</surname><given-names>KM</given-names></name><name><surname>Parsons</surname><given-names>TJ</given-names></name><name><surname>Ziller</surname><given-names>MJ</given-names></name><name><surname>Maehr</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Single-Cell RNA-Sequencing-Based CRISPRi Screening Resolves Molecular Drivers of Early Human Endoderm Development</article-title><source>Cell Reports</source><volume>27</volume><fpage>708</fpage><lpage>718</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.03.076</pub-id><pub-id pub-id-type="pmid">30995470</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gentsch</surname><given-names>GE</given-names></name><name><surname>Owens</surname><given-names>NDL</given-names></name><name><surname>Martin</surname><given-names>SR</given-names></name><name><surname>Piccinelli</surname><given-names>P</given-names></name><name><surname>Faial</surname><given-names>T</given-names></name><name><surname>Trotter</surname><given-names>MWB</given-names></name><name><surname>Gilchrist</surname><given-names>MJ</given-names></name><name><surname>Smith</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>vivo T-box transcription factor profiling reveals joint regulation of embryonic neuromesodermal bipotency</article-title><source>Cell Reports</source><volume>4</volume><fpage>1185</fpage><lpage>1196</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2013.08.012</pub-id><pub-id pub-id-type="pmid">24055059</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goddeeris</surname><given-names>MM</given-names></name><name><surname>Rho</surname><given-names>S</given-names></name><name><surname>Petiet</surname><given-names>A</given-names></name><name><surname>Davenport</surname><given-names>CL</given-names></name><name><surname>Johnson</surname><given-names>GA</given-names></name><name><surname>Meyers</surname><given-names>EN</given-names></name><name><surname>Klingensmith</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>tracardiac septation requires hedgehog-dependent cellular contributions from outside the heart</article-title><source>Development</source><volume>135</volume><fpage>1887</fpage><lpage>1895</lpage><pub-id pub-id-type="doi">10.1242/dev.016147</pub-id><pub-id pub-id-type="pmid">18441277</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goss</surname><given-names>AM</given-names></name><name><surname>Tian</surname><given-names>Y</given-names></name><name><surname>Tsukiyama</surname><given-names>T</given-names></name><name><surname>Cohen</surname><given-names>ED</given-names></name><name><surname>Zhou</surname><given-names>D</given-names></name><name><surname>Lu</surname><given-names>MM</given-names></name><name><surname>Yamaguchi</surname><given-names>TP</given-names></name><name><surname>Morrisey</surname><given-names>EE</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Wnt2/2b and beta-catenin signaling are necessary and sufficient to specify lung progenitors in the foregut</article-title><source>Developmental Cell</source><volume>17</volume><fpage>290</fpage><lpage>298</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2009.06.005</pub-id><pub-id pub-id-type="pmid">19686689</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guris</surname><given-names>DL</given-names></name><name><surname>Duester</surname><given-names>G</given-names></name><name><surname>Papaioannou</surname><given-names>VE</given-names></name><name><surname>Imamoto</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Dose-dependent interaction of Tbx1 and Crkl and locally aberrant RA signaling in a model of del22q11 syndrome</article-title><source>Developmental Cell</source><volume>10</volume><fpage>81</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2005.12.002</pub-id><pub-id pub-id-type="pmid">16399080</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>L</given-names></name><name><surname>Chaturvedi</surname><given-names>P</given-names></name><name><surname>Kishimoto</surname><given-names>K</given-names></name><name><surname>Koike</surname><given-names>H</given-names></name><name><surname>Nasr</surname><given-names>T</given-names></name><name><surname>Iwasawa</surname><given-names>K</given-names></name><name><surname>Giesbrecht</surname><given-names>K</given-names></name><name><surname>Witcher</surname><given-names>PC</given-names></name><name><surname>Eicher</surname><given-names>A</given-names></name><name><surname>Haines</surname><given-names>L</given-names></name><name><surname>Lee</surname><given-names>Y</given-names></name><name><surname>Shannon</surname><given-names>JM</given-names></name><name><surname>Morimoto</surname><given-names>M</given-names></name><name><surname>Wells</surname><given-names>JM</given-names></name><name><surname>Takebe</surname><given-names>T</given-names></name><name><surname>Zorn</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single cell transcriptomics identifies a signaling network coordinating endoderm and mesoderm diversification during foregut organogenesis</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>4158</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-17968-x</pub-id><pub-id pub-id-type="pmid">32855417</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris-Johnson</surname><given-names>KS</given-names></name><name><surname>Domyan</surname><given-names>ET</given-names></name><name><surname>Vezina</surname><given-names>CM</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Beta-Catenin promotes respiratory progenitor identity in mouse foregut</article-title><source>PNAS</source><volume>106</volume><fpage>16287</fpage><lpage>16292</lpage><pub-id pub-id-type="doi">10.1073/pnas.0902274106</pub-id><pub-id pub-id-type="pmid">19805295</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hochgreb</surname><given-names>T</given-names></name><name><surname>Linhares</surname><given-names>VL</given-names></name><name><surname>Menezes</surname><given-names>DC</given-names></name><name><surname>Sampaio</surname><given-names>AC</given-names></name><name><surname>Yan</surname><given-names>CYI</given-names></name><name><surname>Cardoso</surname><given-names>WV</given-names></name><name><surname>Rosenthal</surname><given-names>N</given-names></name><name><surname>Xavier-Neto</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>A caudorostral wave of RALDH2 conveys anteroposterior information to the cardiac field</article-title><source>Development</source><volume>130</volume><fpage>5363</fpage><lpage>5374</lpage><pub-id pub-id-type="doi">10.1242/dev.00750</pub-id><pub-id pub-id-type="pmid">13129847</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffmann</surname><given-names>A. D</given-names></name><name><surname>Peterson</surname><given-names>MA</given-names></name><name><surname>Friedland-Little</surname><given-names>JM</given-names></name><name><surname>Anderson</surname><given-names>SA</given-names></name><name><surname>Moskowitz</surname><given-names>IP</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Sonic hedgehog is required in pulmonary endoderm for atrial septation</article-title><source>Development</source><volume>136</volume><fpage>1761</fpage><lpage>1770</lpage><pub-id pub-id-type="doi">10.1242/dev.034157</pub-id><pub-id pub-id-type="pmid">19369393</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffmann</surname><given-names>AD</given-names></name><name><surname>Yang</surname><given-names>XH</given-names></name><name><surname>Burnicka-Turek</surname><given-names>O</given-names></name><name><surname>Bosman</surname><given-names>JD</given-names></name><name><surname>Ren</surname><given-names>X</given-names></name><name><surname>Steimle</surname><given-names>JD</given-names></name><name><surname>Vokes</surname><given-names>SA</given-names></name><name><surname>McMahon</surname><given-names>AP</given-names></name><name><surname>Kalinichenko</surname><given-names>VV</given-names></name><name><surname>Moskowitz</surname><given-names>IP</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Foxf genes integrate tbx5 and hedgehog pathways in the second heart field for cardiac septation</article-title><source>PLOS Genetics</source><volume>10</volume><elocation-id>e1004604</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1004604</pub-id><pub-id pub-id-type="pmid">25356765</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horb</surname><given-names>ME</given-names></name><name><surname>Thomsen</surname><given-names>GH</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Tbx5 is essential for heart development</article-title><source>Development</source><volume>126</volume><fpage>1739</fpage><lpage>1751</lpage><pub-id pub-id-type="pmid">10079235</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horton</surname><given-names>C</given-names></name><name><surname>Maden</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Endogenous distribution of retinoids during normal development and teratogenesis in the mouse embryo</article-title><source>Developmental Dynamics</source><volume>202</volume><fpage>312</fpage><lpage>323</lpage><pub-id pub-id-type="doi">10.1002/aja.1002020310</pub-id><pub-id pub-id-type="pmid">7780180</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>GN</given-names></name><name><surname>Thatcher</surname><given-names>JE</given-names></name><name><surname>McAnally</surname><given-names>J</given-names></name><name><surname>Kong</surname><given-names>Y</given-names></name><name><surname>Qi</surname><given-names>X</given-names></name><name><surname>Tan</surname><given-names>W</given-names></name><name><surname>DiMaio</surname><given-names>JM</given-names></name><name><surname>Amatruda</surname><given-names>JF</given-names></name><name><surname>Gerard</surname><given-names>RD</given-names></name><name><surname>Hill</surname><given-names>JA</given-names></name><name><surname>Bassel-Duby</surname><given-names>R</given-names></name><name><surname>Olson</surname><given-names>EN</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>C/EBP transcription factors mediate epicardial activation during heart development and injury</article-title><source>Science</source><volume>338</volume><fpage>1599</fpage><lpage>1603</lpage><pub-id pub-id-type="doi">10.1126/science.1229765</pub-id><pub-id pub-id-type="pmid">23160954</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janesick</surname><given-names>A</given-names></name><name><surname>Abbey</surname><given-names>R</given-names></name><name><surname>Chung</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Taketani</surname><given-names>M</given-names></name><name><surname>Blumberg</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>ERF and ETV3L are retinoic acid-inducible repressors required for primary neurogenesis</article-title><source>Development</source><volume>140</volume><fpage>3095</fpage><lpage>3106</lpage><pub-id pub-id-type="doi">10.1242/dev.093716</pub-id><pub-id pub-id-type="pmid">23824578</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karimi</surname><given-names>K</given-names></name><name><surname>Fortriede</surname><given-names>JD</given-names></name><name><surname>Lotay</surname><given-names>VS</given-names></name><name><surname>Burns</surname><given-names>KA</given-names></name><name><surname>Wang</surname><given-names>DZ</given-names></name><name><surname>Fisher</surname><given-names>ME</given-names></name><name><surname>Pells</surname><given-names>TJ</given-names></name><name><surname>James-Zorn</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Ponferrada</surname><given-names>VG</given-names></name><name><surname>Chu</surname><given-names>S</given-names></name><name><surname>Chaturvedi</surname><given-names>P</given-names></name><name><surname>Zorn</surname><given-names>AM</given-names></name><name><surname>Vize</surname><given-names>PD</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Xenbase: a genomic, epigenomic and transcriptomic model organism database</article-title><source>Nucleic Acids Research</source><volume>46</volume><fpage>D861</fpage><lpage>D868</lpage><pub-id pub-id-type="doi">10.1093/nar/gkx936</pub-id><pub-id pub-id-type="pmid">29059324</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kathiriya</surname><given-names>IS</given-names></name><name><surname>Rao</surname><given-names>KS</given-names></name><name><surname>Iacono</surname><given-names>G</given-names></name><name><surname>Devine</surname><given-names>WP</given-names></name><name><surname>Blair</surname><given-names>AP</given-names></name><name><surname>Hota</surname><given-names>SK</given-names></name><name><surname>Lai</surname><given-names>MH</given-names></name><name><surname>Garay</surname><given-names>BI</given-names></name><name><surname>Thomas</surname><given-names>R</given-names></name><name><surname>Gong</surname><given-names>HZ</given-names></name><name><surname>Wasson</surname><given-names>LK</given-names></name><name><surname>Goyal</surname><given-names>P</given-names></name><name><surname>Sukonnik</surname><given-names>T</given-names></name><name><surname>Hu</surname><given-names>KM</given-names></name><name><surname>Akgun</surname><given-names>GA</given-names></name><name><surname>Bernard</surname><given-names>LD</given-names></name><name><surname>Akerberg</surname><given-names>BN</given-names></name><name><surname>Gu</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>K</given-names></name><name><surname>Speir</surname><given-names>ML</given-names></name><name><surname>Haeussler</surname><given-names>M</given-names></name><name><surname>Pu</surname><given-names>WT</given-names></name><name><surname>Stuart</surname><given-names>JM</given-names></name><name><surname>Seidman</surname><given-names>CE</given-names></name><name><surname>Seidman</surname><given-names>JG</given-names></name><name><surname>Heyn</surname><given-names>H</given-names></name><name><surname>Bruneau</surname><given-names>BG</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Modeling Human TBX5 Haploinsufficiency Predicts Regulatory Networks for Congenital Heart Disease</article-title><source>Developmental Cell</source><volume>56</volume><fpage>292</fpage><lpage>309</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2020.11.020</pub-id><pub-id pub-id-type="pmid">33321106</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kattman</surname><given-names>SJ</given-names></name><name><surname>Witty</surname><given-names>AD</given-names></name><name><surname>Gagliardi</surname><given-names>M</given-names></name><name><surname>Dubois</surname><given-names>NC</given-names></name><name><surname>Niapour</surname><given-names>M</given-names></name><name><surname>Hotta</surname><given-names>A</given-names></name><name><surname>Ellis</surname><given-names>J</given-names></name><name><surname>Keller</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Stage-Specific Optimization of Activin/Nodal and BMP Signaling Promotes Cardiac Differentiation of Mouse and Human Pluripotent Stem Cell Lines</article-title><source>Cell Stem Cell</source><volume>8</volume><fpage>228</fpage><lpage>240</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2010.12.008</pub-id><pub-id pub-id-type="pmid">21295278</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>RG</given-names></name><name><surname>Buckingham</surname><given-names>ME</given-names></name><name><surname>Moorman</surname><given-names>AF</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Heart fields and cardiac morphogenesis</article-title><source>Cold Spring Harbor Perspectives in Medicine</source><volume>4</volume><elocation-id>a015750</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a015750</pub-id><pub-id pub-id-type="pmid">25274757</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Cunningham</surname><given-names>TJ</given-names></name><name><surname>Duester</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Nuclear receptor corepressors Ncor1 and Ncor2 (Smrt) are required for retinoic acid-dependent repression of Fgf8 during somitogenesis</article-title><source>Developmental Biology</source><volume>418</volume><fpage>204</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2016.08.005</pub-id><pub-id pub-id-type="pmid">27506116</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langmead</surname><given-names>B</given-names></name><name><surname>Salzberg</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fast gapped-read alignment with Bowtie 2</article-title><source>Nature Methods</source><volume>9</volume><fpage>357</fpage><lpage>359</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1923</pub-id><pub-id pub-id-type="pmid">22388286</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>K</given-names></name><name><surname>Cho</surname><given-names>H</given-names></name><name><surname>Rickert</surname><given-names>RW</given-names></name><name><surname>Li</surname><given-names>QV</given-names></name><name><surname>Pulecio</surname><given-names>J</given-names></name><name><surname>Leslie</surname><given-names>CS</given-names></name><name><surname>Huangfu</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>FOXA2 Is Required for Enhancer Priming during Pancreatic Differentiation</article-title><source>Cell Reports</source><volume>28</volume><fpage>382</fpage><lpage>393</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.06.034</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>QY</given-names></name><name><surname>Newbury-Ecob</surname><given-names>RA</given-names></name><name><surname>Terrett</surname><given-names>JA</given-names></name><name><surname>Wilson</surname><given-names>DI</given-names></name><name><surname>Curtis</surname><given-names>AR</given-names></name><name><surname>Yi</surname><given-names>CH</given-names></name><name><surname>Gebuhr</surname><given-names>T</given-names></name><name><surname>Bullen</surname><given-names>PJ</given-names></name><name><surname>Robson</surname><given-names>SC</given-names></name><name><surname>Strachan</surname><given-names>T</given-names></name><name><surname>Bonnet</surname><given-names>D</given-names></name><name><surname>Lyonnet</surname><given-names>S</given-names></name><name><surname>Young</surname><given-names>ID</given-names></name><name><surname>Raeburn</surname><given-names>JA</given-names></name><name><surname>Buckler</surname><given-names>AJ</given-names></name><name><surname>Law</surname><given-names>DJ</given-names></name><name><surname>Brook</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family</article-title><source>Nature Genetics</source><volume>15</volume><fpage>21</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1038/ng0197-21</pub-id><pub-id pub-id-type="pmid">8988164</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Handsaker</surname><given-names>B</given-names></name><name><surname>Wysoker</surname><given-names>A</given-names></name><name><surname>Fennell</surname><given-names>T</given-names></name><name><surname>Ruan</surname><given-names>J</given-names></name><name><surname>Homer</surname><given-names>N</given-names></name><name><surname>Marth</surname><given-names>G</given-names></name><name><surname>Abecasis</surname><given-names>G</given-names></name><name><surname>Durbin</surname><given-names>R</given-names></name><collab>1000 Genome Project Data Processing Subgroup</collab></person-group><year iso-8601-date="2009">2009</year><article-title>The Sequence Alignment/Map format and SAMtools</article-title><source>Bioinformatics</source><volume>25</volume><fpage>2078</fpage><lpage>2079</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp352</pub-id><pub-id pub-id-type="pmid">19505943</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Pashmforoush</surname><given-names>M</given-names></name><name><surname>Sucov</surname><given-names>HM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Retinoic acid regulates differentiation of the secondary heart field and TGFbeta-mediated outflow tract septation</article-title><source>Developmental Cell</source><volume>18</volume><fpage>480</fpage><lpage>485</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2009.12.019</pub-id><pub-id pub-id-type="pmid">20230754</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>L</given-names></name><name><surname>Bu</surname><given-names>L</given-names></name><name><surname>Cai</surname><given-names>CL</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Evans</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Isl1 is upstream of sonic hedgehog in a pathway required for cardiac morphogenesis</article-title><source>Developmental Biology</source><volume>295</volume><fpage>756</fpage><lpage>763</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2006.03.053</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lohoff</surname><given-names>T</given-names></name><name><surname>Ghazanfar</surname><given-names>S</given-names></name><name><surname>Missarova</surname><given-names>A</given-names></name><name><surname>Koulena</surname><given-names>N</given-names></name><name><surname>Pierson</surname><given-names>N</given-names></name><name><surname>Griffiths</surname><given-names>JA</given-names></name><name><surname>Bardot</surname><given-names>ES</given-names></name><name><surname>Eng</surname><given-names>CHL</given-names></name><name><surname>Tyser</surname><given-names>RCV</given-names></name><name><surname>Argelaguet</surname><given-names>R</given-names></name><name><surname>Guibentif</surname><given-names>C</given-names></name><name><surname>Srinivas</surname><given-names>S</given-names></name><name><surname>Briscoe</surname><given-names>J</given-names></name><name><surname>Simons</surname><given-names>BD</given-names></name><name><surname>Hadjantonakis</surname><given-names>AK</given-names></name><name><surname>Göttgens</surname><given-names>B</given-names></name><name><surname>Reik</surname><given-names>W</given-names></name><name><surname>Nichols</surname><given-names>J</given-names></name><name><surname>Cai</surname><given-names>L</given-names></name><name><surname>Marioni</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>tegration of spatial and single-cell transcriptomic data elucidates mouse organogenesis</article-title><source>Nature Biotechnology</source><volume>10</volume><elocation-id>1006</elocation-id><pub-id pub-id-type="doi">10.1038/s41587-021-01006-2</pub-id><pub-id pub-id-type="pmid">34489600</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Shen</surname><given-names>H</given-names></name><name><surname>Estrada</surname><given-names>KD</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Kumar</surname><given-names>SR</given-names></name><name><surname>Sucov</surname><given-names>HM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Dysregulated endocardial TGFβ signaling and mesenchymal transformation result in heart outflow tract septation failure</article-title><source>Developmental Biology</source><volume>409</volume><fpage>272</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2015.09.021</pub-id><pub-id pub-id-type="pmid">26522286</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mesbah</surname><given-names>K</given-names></name><name><surname>Rana</surname><given-names>MS</given-names></name><name><surname>Francou</surname><given-names>A</given-names></name><name><surname>van Duijvenboden</surname><given-names>K</given-names></name><name><surname>Papaioannou</surname><given-names>VE</given-names></name><name><surname>Moorman</surname><given-names>AF</given-names></name><name><surname>Kelly</surname><given-names>RG</given-names></name><name><surname>Christoffels</surname><given-names>VM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Identification of a Tbx1/Tbx2/Tbx3 genetic pathway governing pharyngeal and arterial pole morphogenesis</article-title><source>Human Molecular Genetics</source><volume>21</volume><fpage>1217</fpage><lpage>1229</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddr553</pub-id><pub-id pub-id-type="pmid">22116936</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Metzler</surname><given-names>MA</given-names></name><name><surname>Sandell</surname><given-names>LL</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Enzymatic Metabolism of Vitamin A in Developing Vertebrate Embryos</article-title><source>Nutrients</source><volume>8</volume><elocation-id>E812</elocation-id><pub-id pub-id-type="doi">10.3390/nu8120812</pub-id><pub-id pub-id-type="pmid">27983671</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mic</surname><given-names>FA</given-names></name><name><surname>Molotkov</surname><given-names>A</given-names></name><name><surname>Benbrook</surname><given-names>DM</given-names></name><name><surname>Duester</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Retinoid activation of retinoic acid receptor but not retinoid X receptor is sufficient to rescue lethal defect in retinoic acid synthesis</article-title><source>PNAS</source><volume>100</volume><fpage>7135</fpage><lpage>7140</lpage><pub-id pub-id-type="doi">10.1073/pnas.1231422100</pub-id><pub-id pub-id-type="pmid">12782789</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minguillon</surname><given-names>C</given-names></name><name><surname>Nishimoto</surname><given-names>S</given-names></name><name><surname>Wood</surname><given-names>S</given-names></name><name><surname>Vendrell</surname><given-names>E</given-names></name><name><surname>Gibson-Brown</surname><given-names>JJ</given-names></name><name><surname>Logan</surname><given-names>MPO</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Hox genes regulate the onset of Tbx5 expression in the forelimb</article-title><source>Development</source><volume>139</volume><fpage>3180</fpage><lpage>3188</lpage><pub-id pub-id-type="doi">10.1242/dev.084814</pub-id><pub-id pub-id-type="pmid">22872086</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niederreither</surname><given-names>K</given-names></name><name><surname>Subbarayan</surname><given-names>V</given-names></name><name><surname>Dollé</surname><given-names>P</given-names></name><name><surname>Chambon</surname><given-names>P</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Embryonic retinoic acid synthesis is essential for early mouse post-implantation development</article-title><source>Nature Genetics</source><volume>21</volume><fpage>444</fpage><lpage>448</lpage><pub-id pub-id-type="doi">10.1038/7788</pub-id><pub-id pub-id-type="pmid">10192400</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niederreither</surname><given-names>K</given-names></name><name><surname>Vermot</surname><given-names>J</given-names></name><name><surname>Messaddeq</surname><given-names>N</given-names></name><name><surname>Schuhbaur</surname><given-names>B</given-names></name><name><surname>Chambon</surname><given-names>P</given-names></name><name><surname>Dollé</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Embryonic retinoic acid synthesis is essential for heart morphogenesis in the mouse</article-title><source>Development</source><volume>128</volume><fpage>1019</fpage><lpage>1031</lpage><pub-id pub-id-type="pmid">11245568</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishimoto</surname><given-names>S</given-names></name><name><surname>Wilde</surname><given-names>SM</given-names></name><name><surname>Wood</surname><given-names>S</given-names></name><name><surname>Logan</surname><given-names>MPO</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>RA Acts in a Coherent Feed-Forward Mechanism with Tbx5 to Control Limb Bud Induction and Initiation</article-title><source>Cell Reports</source><volume>12</volume><fpage>879</fpage><lpage>891</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2015.06.068</pub-id><pub-id pub-id-type="pmid">26212321</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogino</surname><given-names>H</given-names></name><name><surname>McConnell</surname><given-names>WB</given-names></name><name><surname>Grainger</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>High-throughput transgenesis in <italic>Xenopus</italic> using I-SceI meganuclease</article-title><source>Nature Protocols</source><volume>1</volume><fpage>1703</fpage><lpage>1710</lpage><pub-id pub-id-type="doi">10.1038/nprot.2006.208</pub-id><pub-id pub-id-type="pmid">17487153</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>FC</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Loeber</surname><given-names>J</given-names></name><name><surname>Henningfeld</surname><given-names>K</given-names></name><name><surname>Pieler</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>I-SceI meganuclease-mediated transgenesis in <italic>Xenopus</italic></article-title><source>Developmental Dynamics</source><volume>235</volume><fpage>247</fpage><lpage>252</lpage><pub-id pub-id-type="doi">10.1002/dvdy.20608</pub-id><pub-id pub-id-type="pmid">16258935</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>T</given-names></name><name><surname>Tian</surname><given-names>Y</given-names></name><name><surname>Boogerd</surname><given-names>CJ</given-names></name><name><surname>Lu</surname><given-names>MM</given-names></name><name><surname>Kadzik</surname><given-names>RS</given-names></name><name><surname>Stewart</surname><given-names>KM</given-names></name><name><surname>Evans</surname><given-names>SM</given-names></name><name><surname>Morrisey</surname><given-names>EE</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Coordination of heart and lung co-development by a multipotent cardiopulmonary progenitor</article-title><source>Nature</source><volume>500</volume><fpage>589</fpage><lpage>592</lpage><pub-id pub-id-type="doi">10.1038/nature12358</pub-id><pub-id pub-id-type="pmid">23873040</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Penvose</surname><given-names>A</given-names></name><name><surname>Keenan</surname><given-names>JL</given-names></name><name><surname>Bray</surname><given-names>D</given-names></name><name><surname>Ramlall</surname><given-names>V</given-names></name><name><surname>Siggers</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Comprehensive study of nuclear receptor DNA binding provides a revised framework for understanding receptor specificity</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>2514</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-10264-3</pub-id><pub-id pub-id-type="pmid">31175293</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perl</surname><given-names>E</given-names></name><name><surname>Waxman</surname><given-names>JS</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Reiterative Mechanisms of Retinoic Acid Signaling during Vertebrate Heart Development</article-title><source>Journal of Developmental Biology</source><volume>7</volume><elocation-id>11</elocation-id><pub-id pub-id-type="doi">10.3390/jdb7020011</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rankin</surname><given-names>SA</given-names></name><name><surname>Hasebe</surname><given-names>T</given-names></name><name><surname>Zorn</surname><given-names>AM</given-names></name><name><surname>Buchholz</surname><given-names>DR</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Improved cre reporter transgenic <italic>Xenopus</italic></article-title><source>Developmental Dynamics</source><volume>238</volume><fpage>2401</fpage><lpage>2408</lpage><pub-id pub-id-type="doi">10.1002/dvdy.22043</pub-id><pub-id pub-id-type="pmid">19653309</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rankin</surname><given-names>SA</given-names></name><name><surname>Zorn</surname><given-names>AM</given-names></name><name><surname>Buchholz</surname><given-names>DR</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>New doxycycline-inducible transgenic lines in <italic>Xenopus</italic></article-title><source>Developmental Dynamics</source><volume>240</volume><fpage>1467</fpage><lpage>1474</lpage><pub-id pub-id-type="doi">10.1002/dvdy.22642</pub-id><pub-id pub-id-type="pmid">21491543</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rankin</surname><given-names>SA</given-names></name><name><surname>Han</surname><given-names>L</given-names></name><name><surname>McCracken</surname><given-names>KW</given-names></name><name><surname>Kenny</surname><given-names>AP</given-names></name><name><surname>Anglin</surname><given-names>CT</given-names></name><name><surname>Grigg</surname><given-names>EA</given-names></name><name><surname>Crawford</surname><given-names>CM</given-names></name><name><surname>Wells</surname><given-names>JM</given-names></name><name><surname>Shannon</surname><given-names>JM</given-names></name><name><surname>Zorn</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>A Retinoic Acid-Hedgehog Cascade Coordinates Mesoderm-Inducing Signals and Endoderm Competence during Lung Specification</article-title><source>Cell Reports</source><volume>16</volume><fpage>66</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.05.060</pub-id><pub-id pub-id-type="pmid">27320915</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rankin</surname><given-names>SA</given-names></name><name><surname>McCracken</surname><given-names>KW</given-names></name><name><surname>Luedeke</surname><given-names>DM</given-names></name><name><surname>Han</surname><given-names>L</given-names></name><name><surname>Wells</surname><given-names>JM</given-names></name><name><surname>Shannon</surname><given-names>JM</given-names></name><name><surname>Zorn</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Timing is everything: Reiterative Wnt, BMP and RA signaling regulate developmental competence during endoderm organogenesis</article-title><source>Developmental Biology</source><volume>434</volume><fpage>121</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2017.11.018</pub-id><pub-id pub-id-type="pmid">29217200</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rochais</surname><given-names>F</given-names></name><name><surname>Mesbah</surname><given-names>K</given-names></name><name><surname>Kelly</surname><given-names>RG</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Signaling pathways controlling second heart field development</article-title><source>Circulation Research</source><volume>104</volume><fpage>933</fpage><lpage>942</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.109.194464</pub-id><pub-id pub-id-type="pmid">19390062</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryan</surname><given-names>K</given-names></name><name><surname>Chin</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>T-box genes and cardiac development</article-title><source>Birth Defects Research Part C</source><volume>69</volume><fpage>25</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1002/bdrc.10001</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryckebusch</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Bertrand</surname><given-names>N</given-names></name><name><surname>Lin</surname><given-names>SC</given-names></name><name><surname>Chi</surname><given-names>X</given-names></name><name><surname>Schwartz</surname><given-names>R</given-names></name><name><surname>Zaffran</surname><given-names>S</given-names></name><name><surname>Niederreither</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Retinoic acid deficiency alters second heart field formation</article-title><source>PNAS</source><volume>105</volume><fpage>2913</fpage><lpage>2918</lpage><pub-id pub-id-type="doi">10.1073/pnas.0712344105</pub-id><pub-id pub-id-type="pmid">18287057</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryckebüsch</surname><given-names>L</given-names></name><name><surname>Bertrand</surname><given-names>N</given-names></name><name><surname>Mesbah</surname><given-names>K</given-names></name><name><surname>Bajolle</surname><given-names>F</given-names></name><name><surname>Niederreither</surname><given-names>K</given-names></name><name><surname>Kelly</surname><given-names>RG</given-names></name><name><surname>Zaffran</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Decreased levels of embryonic retinoic acid synthesis accelerate recovery from arterial growth delay in a mouse model of DiGeorge syndrome</article-title><source>Circulation Research</source><volume>106</volume><fpage>686</fpage><lpage>694</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.109.205732</pub-id><pub-id pub-id-type="pmid">20110535</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rydeen</surname><given-names>AB</given-names></name><name><surname>Waxman</surname><given-names>JS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Cyp26 Enzymes Facilitate Second Heart Field Progenitor Addition and Maintenance of Ventricular Integrity</article-title><source>PLOS Biology</source><volume>14</volume><elocation-id>e2000504</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.2000504</pub-id><pub-id pub-id-type="pmid">27893754</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sagai</surname><given-names>T</given-names></name><name><surname>Amano</surname><given-names>T</given-names></name><name><surname>Tamura</surname><given-names>M</given-names></name><name><surname>Mizushina</surname><given-names>Y</given-names></name><name><surname>Sumiyama</surname><given-names>K</given-names></name><name><surname>Shiroishi</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>A cluster of three long-range enhancers directs regional Shh expression in the epithelial linings</article-title><source>Development</source><volume>136</volume><fpage>1665</fpage><lpage>1674</lpage><pub-id pub-id-type="doi">10.1242/dev.032714</pub-id><pub-id pub-id-type="pmid">19369396</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sagai</surname><given-names>T</given-names></name><name><surname>Amano</surname><given-names>T</given-names></name><name><surname>Maeno</surname><given-names>A</given-names></name><name><surname>Kimura</surname><given-names>T</given-names></name><name><surname>Nakamoto</surname><given-names>M</given-names></name><name><surname>Takehana</surname><given-names>Y</given-names></name><name><surname>Naruse</surname><given-names>K</given-names></name><name><surname>Okada</surname><given-names>N</given-names></name><name><surname>Kiyonari</surname><given-names>H</given-names></name><name><surname>Shiroishi</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Evolution of Shh endoderm enhancers during morphological transition from ventral lungs to dorsal gas bladder</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>14300</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms14300</pub-id><pub-id pub-id-type="pmid">28155855</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharpe</surname><given-names>CR</given-names></name><name><surname>Goldstone</surname><given-names>K</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Retinoid receptors promote primary neurogenesis in <italic>Xenopus</italic></article-title><source>Development</source><volume>124</volume><fpage>515</fpage><lpage>523</lpage><pub-id pub-id-type="pmid">9053327</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheikh</surname><given-names>BN</given-names></name><name><surname>Downer</surname><given-names>NL</given-names></name><name><surname>Kueh</surname><given-names>AJ</given-names></name><name><surname>Thomas</surname><given-names>T</given-names></name><name><surname>Voss</surname><given-names>AK</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Excessive versus physiologically relevant levels of retinoic acid in embryonic stem cell differentiation</article-title><source>Stem Cells</source><volume>32</volume><fpage>1451</fpage><lpage>1458</lpage><pub-id pub-id-type="doi">10.1002/stem.1604</pub-id><pub-id pub-id-type="pmid">25099890</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shiotsugu</surname><given-names>J</given-names></name><name><surname>Katsuyama</surname><given-names>Y</given-names></name><name><surname>Arima</surname><given-names>K</given-names></name><name><surname>Baxter</surname><given-names>A</given-names></name><name><surname>Koide</surname><given-names>T</given-names></name><name><surname>Song</surname><given-names>J</given-names></name><name><surname>Chandraratna</surname><given-names>RAS</given-names></name><name><surname>Blumberg</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Multiple points of interaction between retinoic acid and FGF signaling during embryonic axis formation</article-title><source>Development</source><volume>131</volume><fpage>2653</fpage><lpage>2667</lpage><pub-id pub-id-type="doi">10.1242/dev.01129</pub-id><pub-id pub-id-type="pmid">15128657</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sirbu</surname><given-names>IO</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Duester</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Retinoic acid controls heart anteroposterior patterning by down-regulating Isl1 through the Fgf8 pathway</article-title><source>Developmental Dynamics</source><volume>237</volume><fpage>1627</fpage><lpage>1635</lpage><pub-id pub-id-type="doi">10.1002/dvdy.21570</pub-id><pub-id pub-id-type="pmid">18498088</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sirbu</surname><given-names>IO</given-names></name><name><surname>Chiş</surname><given-names>AR</given-names></name><name><surname>Moise</surname><given-names>AR</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Role of carotenoids and retinoids during heart development</article-title><source>Biochimica et Biophysica Acta. Molecular and Cell Biology of Lipids</source><volume>1865</volume><elocation-id>158636</elocation-id><pub-id pub-id-type="doi">10.1016/j.bbalip.2020.158636</pub-id><pub-id pub-id-type="pmid">31978553</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Sive</surname><given-names>HL</given-names></name><name><surname>Grainger</surname><given-names>RM</given-names></name><name><surname>Harland</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="2000">2000</year><source>Early Development of Xenopus Laevis: A Laboratory Manual</source><publisher-name>Cold Spring Harbor Lab Press</publisher-name></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smemo</surname><given-names>S</given-names></name><name><surname>Campos</surname><given-names>LC</given-names></name><name><surname>Moskowitz</surname><given-names>IP</given-names></name><name><surname>Krieger</surname><given-names>JE</given-names></name><name><surname>Pereira</surname><given-names>AC</given-names></name><name><surname>Nobrega</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Regulatory variation in a TBX5 enhancer leads to isolated congenital heart disease</article-title><source>Human Molecular Genetics</source><volume>21</volume><fpage>3255</fpage><lpage>3263</lpage><pub-id pub-id-type="doi">10.1093/hmg/dds165</pub-id><pub-id pub-id-type="pmid">22543974</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stefanovic</surname><given-names>S</given-names></name><name><surname>Laforest</surname><given-names>B</given-names></name><name><surname>Desvignes</surname><given-names>JP</given-names></name><name><surname>Lescroart</surname><given-names>F</given-names></name><name><surname>Argiro</surname><given-names>L</given-names></name><name><surname>Maurel-Zaffran</surname><given-names>C</given-names></name><name><surname>Salgado</surname><given-names>D</given-names></name><name><surname>Plaindoux</surname><given-names>E</given-names></name><name><surname>De Bono</surname><given-names>C</given-names></name><name><surname>Pazur</surname><given-names>K</given-names></name><name><surname>Théveniau-Ruissy</surname><given-names>M</given-names></name><name><surname>Béroud</surname><given-names>C</given-names></name><name><surname>Puceat</surname><given-names>M</given-names></name><name><surname>Gavalas</surname><given-names>A</given-names></name><name><surname>Kelly</surname><given-names>RG</given-names></name><name><surname>Zaffran</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Hox-dependent coordination of mouse cardiac progenitor cell patterning and differentiation</article-title><source>eLife</source><volume>9</volume><elocation-id>e55124</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.55124</pub-id><pub-id pub-id-type="pmid">32804075</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steimle</surname><given-names>J. D</given-names></name><name><surname>Moskowitz</surname><given-names>IP</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>TBX5: A Key Regulator of Heart Development</article-title><source>Current Topics in Developmental Biology</source><volume>122</volume><fpage>195</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1016/bs.ctdb.2016.08.008</pub-id><pub-id pub-id-type="pmid">28057264</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steimle</surname><given-names>J</given-names></name><name><surname>Rankin</surname><given-names>SA</given-names></name><name><surname>Slagle</surname><given-names>CE</given-names></name><name><surname>Bekeny</surname><given-names>J</given-names></name><name><surname>Rydeen</surname><given-names>AB</given-names></name><name><surname>Chan</surname><given-names>SS-K</given-names></name><name><surname>Kweon</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>XH</given-names></name><name><surname>Ikegami</surname><given-names>K</given-names></name><name><surname>Nadadur</surname><given-names>RD</given-names></name><name><surname>Rowton</surname><given-names>M</given-names></name><name><surname>Hoffmann</surname><given-names>AD</given-names></name><name><surname>Lazarevic</surname><given-names>S</given-names></name><name><surname>Thomas</surname><given-names>W</given-names></name><name><surname>Boyle Anderson</surname><given-names>EAT</given-names></name><name><surname>Horb</surname><given-names>ME</given-names></name><name><surname>Luna-Zurita</surname><given-names>L</given-names></name><name><surname>Ho</surname><given-names>RK</given-names></name><name><surname>Kyba</surname><given-names>M</given-names></name><name><surname>Jensen</surname><given-names>B</given-names></name><name><surname>Zorn</surname><given-names>AM</given-names></name><name><surname>Conlon</surname><given-names>FL</given-names></name><name><surname>Moskowitz</surname><given-names>IP</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Evolutionarily conserved Tbx5-Wnt2/2b pathway orchestrates cardiopulmonary development</article-title><source>PNAS</source><volume>115</volume><fpage>E10615</fpage><lpage>E10624</lpage><pub-id pub-id-type="doi">10.1073/pnas.1811624115</pub-id><pub-id pub-id-type="pmid">30352852</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strate</surname><given-names>I</given-names></name><name><surname>Min</surname><given-names>TH</given-names></name><name><surname>Iliev</surname><given-names>D</given-names></name><name><surname>Pera</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Retinol dehydrogenase 10 is a feedback regulator of retinoic acid signalling during axis formation and patterning of the central nervous system</article-title><source>Development</source><volume>136</volume><fpage>461</fpage><lpage>472</lpage><pub-id pub-id-type="doi">10.1242/dev.024901</pub-id><pub-id pub-id-type="pmid">19141675</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subramanian</surname><given-names>A</given-names></name><name><surname>Tamayo</surname><given-names>P</given-names></name><name><surname>Mootha</surname><given-names>VK</given-names></name><name><surname>Mukherjee</surname><given-names>S</given-names></name><name><surname>Ebert</surname><given-names>BL</given-names></name><name><surname>Gillette</surname><given-names>MA</given-names></name><name><surname>Paulovich</surname><given-names>A</given-names></name><name><surname>Pomeroy</surname><given-names>SL</given-names></name><name><surname>Golub</surname><given-names>TR</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name><name><surname>Mesirov</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles</article-title><source>PNAS</source><volume>102</volume><fpage>15545</fpage><lpage>15550</lpage><pub-id pub-id-type="doi">10.1073/pnas.0506580102</pub-id><pub-id pub-id-type="pmid">16199517</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamplin</surname><given-names>OJ</given-names></name><name><surname>Kinzel</surname><given-names>D</given-names></name><name><surname>Cox</surname><given-names>BJ</given-names></name><name><surname>Bell</surname><given-names>CE</given-names></name><name><surname>Rossant</surname><given-names>J</given-names></name><name><surname>Lickert</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Microarray analysis of Foxa2 mutant mouse embryos reveals novel gene expression and inductive roles for the gastrula organizer and its derivatives</article-title><source>BMC Genomics</source><volume>9</volume><elocation-id>511</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2164-9-511</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thorvaldsdottir</surname><given-names>H</given-names></name><name><surname>Robinson</surname><given-names>JT</given-names></name><name><surname>Mesirov</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>tegrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration</article-title><source>Briefings in Bioinformatics</source><volume>14</volume><fpage>178</fpage><lpage>192</lpage><pub-id pub-id-type="doi">10.1093/bib/bbs017</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tosic</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>G-J</given-names></name><name><surname>Pavlovic</surname><given-names>M</given-names></name><name><surname>Schröder</surname><given-names>CM</given-names></name><name><surname>Mersiowsky</surname><given-names>S-L</given-names></name><name><surname>Barg</surname><given-names>M</given-names></name><name><surname>Hofherr</surname><given-names>A</given-names></name><name><surname>Probst</surname><given-names>S</given-names></name><name><surname>Köttgen</surname><given-names>M</given-names></name><name><surname>Hein</surname><given-names>L</given-names></name><name><surname>Arnold</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Eomes and Brachyury control pluripotency exit and germ-layer segregation by changing the chromatin state</article-title><source>Nature Cell Biology</source><volume>21</volume><fpage>1518</fpage><lpage>1531</lpage><pub-id pub-id-type="doi">10.1038/s41556-019-0423-1</pub-id><pub-id pub-id-type="pmid">31792383</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tran</surname><given-names>HT</given-names></name><name><surname>Sekkali</surname><given-names>B</given-names></name><name><surname>Van Imschoot</surname><given-names>G</given-names></name><name><surname>Janssens</surname><given-names>S</given-names></name><name><surname>Vleminckx</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Wnt/beta-catenin signaling is involved in the induction and maintenance of primitive hematopoiesis in the vertebrate embryo</article-title><source>PNAS</source><volume>107</volume><fpage>16160</fpage><lpage>16165</lpage><pub-id pub-id-type="doi">10.1073/pnas.1007725107</pub-id><pub-id pub-id-type="pmid">20805504</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsukiji</surname><given-names>N</given-names></name><name><surname>Amano</surname><given-names>T</given-names></name><name><surname>Shiroishi</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A novel regulatory element for Shh expression in the lung and gut of mouse embryos</article-title><source>Mechanisms of Development</source><volume>131</volume><fpage>127</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1016/j.mod.2013.09.003</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vermot</surname><given-names>J</given-names></name><name><surname>Niederreither</surname><given-names>K</given-names></name><name><surname>Garnier</surname><given-names>JM</given-names></name><name><surname>Chambon</surname><given-names>P</given-names></name><name><surname>Dollé</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Decreased embryonic retinoic acid synthesis results in a DiGeorge syndrome phenotype in newborn mice</article-title><source>PNAS</source><volume>100</volume><fpage>1763</fpage><lpage>1768</lpage><pub-id pub-id-type="doi">10.1073/pnas.0437920100</pub-id><pub-id pub-id-type="pmid">12563036</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vinckier</surname><given-names>NK</given-names></name><name><surname>Patel</surname><given-names>NA</given-names></name><name><surname>Geusz</surname><given-names>RJ</given-names></name><name><surname>Wang</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Matta</surname><given-names>I</given-names></name><name><surname>Harrington</surname><given-names>AR</given-names></name><name><surname>Wortham</surname><given-names>M</given-names></name><name><surname>Wetton</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Jhala</surname><given-names>US</given-names></name><name><surname>Rosenfeld</surname><given-names>MG</given-names></name><name><surname>Benner</surname><given-names>CW</given-names></name><name><surname>Shih</surname><given-names>HP</given-names></name><name><surname>Sander</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>LSD1-mediated enhancer silencing attenuates retinoic acid signalling during pancreatic endocrine cell development</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>2082</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-16017-x</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vitobello</surname><given-names>A</given-names></name><name><surname>Ferretti</surname><given-names>E</given-names></name><name><surname>Lampe</surname><given-names>X</given-names></name><name><surname>Vilain</surname><given-names>N</given-names></name><name><surname>Ducret</surname><given-names>S</given-names></name><name><surname>Ori</surname><given-names>M</given-names></name><name><surname>Spetz</surname><given-names>JF</given-names></name><name><surname>Selleri</surname><given-names>L</given-names></name><name><surname>Rijli</surname><given-names>FM</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Hox and Pbx factors control retinoic acid synthesis during hindbrain segmentation</article-title><source>Developmental Cell</source><volume>20</volume><fpage>469</fpage><lpage>482</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2011.03.011</pub-id><pub-id pub-id-type="pmid">21497760</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Dollé</surname><given-names>P</given-names></name><name><surname>Cardoso</surname><given-names>WV</given-names></name><name><surname>Niederreither</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Retinoic acid regulates morphogenesis and patterning of posterior foregut derivatives</article-title><source>Developmental Biology</source><volume>297</volume><fpage>433</fpage><lpage>445</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2006.05.019</pub-id><pub-id pub-id-type="pmid">16806149</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>A</given-names></name><name><surname>Yue</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Xie</surname><given-names>R</given-names></name><name><surname>Harper</surname><given-names>T</given-names></name><name><surname>Patel</surname><given-names>NA</given-names></name><name><surname>Muth</surname><given-names>K</given-names></name><name><surname>Palmer</surname><given-names>J</given-names></name><name><surname>Qiu</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Lam</surname><given-names>DK</given-names></name><name><surname>Raum</surname><given-names>JC</given-names></name><name><surname>Stoffers</surname><given-names>DA</given-names></name><name><surname>Ren</surname><given-names>B</given-names></name><name><surname>Sander</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Epigenetic priming of enhancers predicts developmental competence of hESC-derived endodermal lineage intermediates</article-title><source>Cell Stem Cell</source><volume>16</volume><fpage>386</fpage><lpage>399</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2015.02.013</pub-id><pub-id pub-id-type="pmid">25842977</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weirauch</surname><given-names>MT</given-names></name><name><surname>Yang</surname><given-names>A</given-names></name><name><surname>Albu</surname><given-names>M</given-names></name><name><surname>Cote</surname><given-names>AG</given-names></name><name><surname>Montenegro-Montero</surname><given-names>A</given-names></name><name><surname>Drewe</surname><given-names>P</given-names></name><name><surname>Najafabadi</surname><given-names>HS</given-names></name><name><surname>Lambert</surname><given-names>SA</given-names></name><name><surname>Mann</surname><given-names>I</given-names></name><name><surname>Cook</surname><given-names>K</given-names></name><name><surname>Zheng</surname><given-names>H</given-names></name><name><surname>Goity</surname><given-names>A</given-names></name><name><surname>van Bakel</surname><given-names>H</given-names></name><name><surname>Lozano</surname><given-names>JC</given-names></name><name><surname>Galli</surname><given-names>M</given-names></name><name><surname>Lewsey</surname><given-names>MG</given-names></name><name><surname>Huang</surname><given-names>E</given-names></name><name><surname>Mukherjee</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Reece-Hoyes</surname><given-names>JS</given-names></name><name><surname>Govindarajan</surname><given-names>S</given-names></name><name><surname>Shaulsky</surname><given-names>G</given-names></name><name><surname>Walhout</surname><given-names>AJM</given-names></name><name><surname>Bouget</surname><given-names>FY</given-names></name><name><surname>Ratsch</surname><given-names>G</given-names></name><name><surname>Larrondo</surname><given-names>LF</given-names></name><name><surname>Ecker</surname><given-names>JR</given-names></name><name><surname>Hughes</surname><given-names>TR</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Determination and inference of eukaryotic transcription factor sequence specificity</article-title><source>Cell</source><volume>158</volume><fpage>1431</fpage><lpage>1443</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.08.009</pub-id><pub-id pub-id-type="pmid">25215497</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xavier-Neto</surname><given-names>J</given-names></name><name><surname>Sousa Costa</surname><given-names>ÂM</given-names></name><name><surname>Figueira</surname><given-names>ACM</given-names></name><name><surname>Caiaffa</surname><given-names>CD</given-names></name><name><surname>Amaral</surname><given-names>FN</given-names></name><name><surname>Peres</surname><given-names>LMC</given-names></name><name><surname>da Silva</surname><given-names>BSP</given-names></name><name><surname>Santos</surname><given-names>LN</given-names></name><name><surname>Moise</surname><given-names>AR</given-names></name><name><surname>Castillo</surname><given-names>HA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Signaling through retinoic acid receptors in cardiac development: Doing the right things at the right times</article-title><source>Biochimica et Biophysica Acta</source><volume>1849</volume><fpage>94</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1016/j.bbagrm.2014.08.003</pub-id><pub-id pub-id-type="pmid">25134739</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>L</given-names></name><name><surname>Hoffmann</surname><given-names>AD</given-names></name><name><surname>Burnicka-Turek</surname><given-names>O</given-names></name><name><surname>Friedland-Little</surname><given-names>JM</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Moskowitz</surname><given-names>IP</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Tbx5-hedgehog molecular networks are essential in the second heart field for atrial septation</article-title><source>Developmental Cell</source><volume>23</volume><fpage>280</fpage><lpage>291</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2012.06.006</pub-id><pub-id pub-id-type="pmid">22898775</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>S-B</given-names></name><name><surname>Umair</surname><given-names>Z</given-names></name><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>U</given-names></name><name><surname>Lee</surname><given-names>S-H</given-names></name><name><surname>Kim</surname><given-names>J-I</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Park</surname><given-names>J-B</given-names></name><name><surname>Lee</surname><given-names>J-Y</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>xCyp26c Induced by Inhibition of BMP Signaling Is Involved in Anterior-Posterior Neural Patterning of <italic>Xenopus laevis</italic></article-title><source>Molecules and Cells</source><volume>39</volume><fpage>352</fpage><lpage>357</lpage><pub-id pub-id-type="doi">10.14348/molcells.2016.0006</pub-id><pub-id pub-id-type="pmid">26923193</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaffran</surname><given-names>S</given-names></name><name><surname>Robrini</surname><given-names>N</given-names></name><name><surname>Bertrand</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Retinoids and cardiac development</article-title><source>Journal of Developmental Biology</source><volume>2</volume><fpage>50</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.3390/jdb2010050</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Meyer</surname><given-names>CA</given-names></name><name><surname>Eeckhoute</surname><given-names>J</given-names></name><name><surname>Johnson</surname><given-names>DS</given-names></name><name><surname>Bernstein</surname><given-names>BE</given-names></name><name><surname>Nusbaum</surname><given-names>C</given-names></name><name><surname>Myers</surname><given-names>RM</given-names></name><name><surname>Brown</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>XS</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Model-based analysis of ChIP-Seq (MACS</article-title><source>Genome Biology</source><volume>9</volume><elocation-id>R137</elocation-id><pub-id pub-id-type="doi">10.1186/gb-2008-9-9-r137</pub-id><pub-id pub-id-type="pmid">18798982</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.69288.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Morrisey</surname><given-names>Edward E</given-names></name><role>Reviewing Editor</role><aff><institution>University of Pennsylvania</institution><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Peng</surname><given-names>Tien</given-names></name><role>Reviewer</role><aff><institution>University of California, San Francisco</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2021.04.09.439219">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2021.04.09.439219v1">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>Your study provides critical data on the early events regulated by mesoderm-endoderm signaling required for lung development. These studies are important for assessment of early foregut development and help to define causal cell types in genetic diseases of lung formation.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;TBX5 drives Aldh1a2 expression to regulate a RA-Hedgehog-Wnt gene regulatory network coordinating cardiopulmonary development&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Edward Morrisey as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Tien Peng (Reviewer #1).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1) Please address the issues raised by the reviewers on the specificity of the pharmacological inhibitors through the use of more specific techniques such as morpholinos. Also clearly state the limitations of such pharmacological inhibitors.</p><p>2) Address the requests of additional histological and gene expression analysis with new data where noted by the reviewers.</p><p>3) The manuscript needs to be revised to better link the current studies with previous work and to highlight to the uninitiated the importance of your study.</p><p>4) The manuscript also needs additional revision to temper some of the claims as mentioned by the reviewers.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>1. In Figure 1H,I, labeling of major anatomic landmarks would be helpful to delineate the domain of Aldh1a2 expression. Furthermore, it would be nice to highlight the relationship of the Shh expression domain alongside Aldh1a2 in Figure 1I as their complement anatomic relationship sets up the hypothesis studied in this manuscript.</p><p>2. In Figure 2a-c, it is clear that while there are some overlaps between Tbx5 and Aldh1a2, there are clearly domains of Aldh1a2 expression that are Tbx5-negative. It would be easier to visualize the overlap of the two domains in Figure 2b by coloring Tbx5 and Aldh1a2 green and red respectively with some quantification of the overlap. Furthermore, it is not clear how the reduction in Aldh1a2 is quantified. Finally, some discussion on what is driving Aldh1a2 expression in cells that are not Tbx5+.</p><p>3. In Figure 3A, a set of data shows that RA inhibition by DEAB can phenocopy RNA targeting of Tbx5, however, this is not really specific to the expression of Aldh1a2 per say. What is the phenotype of using MO to target Aldh1a2 in these set of experiments?</p><p>4. In Figure 4G, it would be nice to colocalize the expression of the GFP with in situ of Adh1a2 to see where the enhancer-driven GFP overlap with actual gene expression.</p><p>5. In Figure 5, I would raise a similar point as Comment 3, which is that the use of ketoconazole as a Cyp inhibitor is not as specific as MO targeting Cyp26a1. Would targeting of Cyp26a1 block the effect of FGF8 directly. This would provide stronger mechanistic proof for the model described.</p><p>6. In Figure 6E, can RA administration directly increase the reporter activity driven by the MACS1 enhancer? This would better link the Shh enhancer described to an RA response.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>Prior to publication, a few points need to be considered.</p><p>1. Figure 1H. It will be nice to zoom in the foregut region in addition to showing the whole embryo. Although it is not necessary, it will be informative if the authors can show the in situ hybridization of Fgf10, Shh in TBX5 mutants using the similar projection method.</p><p>2. Fgf10 is known (also shown in Fig1H) to be localized in the future lung budding sites. In between the budding sites Fgf10 is not expressed. Is Tbx5 expressed in this region? It will be informative if authors can also show the projection image of Tbx5 as other genes in H.</p><p>3. Figure 1I, Can the authors label the projection images, e.g. heart field, lung budding site.</p><p>4. Does TBX5 deletion/kd induce stronger foregut phenotypes in frog than mouse? It appears that trachea-esophageal separation is abnormal in frog models (Figure 2B-C). Can the authors provide more details?</p><p>5. Does addition of exogenous Tbx5 RNA or RA in the rescue experiments affect the development of other organs? The presence of any phenotypes can further confirm that the extra Tbx5 or RA works in addition to the qPCR data.</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>Phrasing throughout the manuscript should be cautious. For example, differentially expressed genes are not necessarily Tbx5-dependent as worded on page 8 second paragraph.</p><p>Listing Tbx5 regulation of shh signaling as a key finding is an overstatement.</p><p>Can the authors demonstrate loss of Aldh1a2 expression in Tbx5null embryos?</p><p>The authors should mention the role of Aldh2a2 in retinoic acid processing so that the reader can understand how it functions to regulate RA signaling. The only description present is RA-producing enzyme.</p><p>The Wnt GFP reporter data in figure 2 B and C could be moved to supplemental data as it is more distracting than informative.</p><p>A co-stain for lateral plate mesoderm would be beneficial in figure 2 B and C.</p><p>For comparison purposes and because the readout is qualitative Figure 3 should be organized in a manner such that DEAB is next to tbx5 MO and 25 nM RA is next to mismatch MO. TBX5 RNA could go to the far right.</p><p>Limitation of drug inhibition should be stated. There are likely many more developmental processes disrupted by addition of RA inhibitor at the NF20 stage.</p><p>Authors might consider highlighting what new data they have added to the illustration in figure 7.</p><p>Figure legend 3 should be revised to reflect the panels in the figure.</p><p>Several of the effects observed in Figure 3 A-J appear to span beyond the cardiopulmonary region of the embryo. The author should recognized this in the interpretation of their data.</p><p>The diagram in 3L is based primarily on one time point examination. It may be prudent to remove this figure.</p><p>Wording in figure 4A legend has mixed verb tenses.</p><p>The statement that Tbx5 activates and represses certain genes goes beyond the data demonstrated in Figure 4A.</p><p>The authors should try to separate the description of the results from their discussion of the results. For example, p 12 the entire first full paragraph is more discussion than results.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.69288.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) Please address the issues raised by the reviewers on the specificity of the pharmacological inhibitors through the use of more specific techniques such as morpholinos. Also clearly state the limitations of such pharmacological inhibitors.</p></disp-quote><p>We have repeated the Aldh1a2 and Cyp loss of function experiments with morpholinos that completely support the inhibitor studies. This data is presented in new Figure 3—figure supplement 1 and Figure 5—figure supplement 1. We have also clearly stated the limitations and advantages of pharmacological inhibitors.</p><disp-quote content-type="editor-comment"><p>2) Address the requests of additional histological and gene expression analysis with new data where noted by the reviewers.</p></disp-quote><p>We have added new analysis gene expression analysis in both sections and wholemount as requested and better annotated the anatomical structures in the images. These new data are presented in a revised Figure 1 D-F and in a revised Figure 1—figure supplement 1F-H.</p><disp-quote content-type="editor-comment"><p>2) The manuscript needs to be revised to better link the current studies with previous work and to highlight to the uninitiated the importance of your study.</p></disp-quote><p>We have revised the introduction and discussion to better link our results to previous work and to better highlight the importance of the work and the significance of the advance.</p><disp-quote content-type="editor-comment"><p>3) The manuscript also needs additional revision to temper some of the claims as mentioned by the reviewers.</p></disp-quote><p>We have revised the text to temper some of the claims as suggested by the reviewers.</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>1. In Figure 1H,I, labeling of major anatomic landmarks would be helpful to delineate the domain of Aldh1a2 expression. Furthermore, it would be nice to highlight the relationship of the Shh expression domain alongside Aldh1a2 in Figure 1I as their complement anatomic relationship sets up the hypothesis studied in this manuscript.</p></disp-quote><p>In retrospect, we agree that the relative expression domains were not as clear as they should have been. While the each of these gene expression patterns has been documented before in previous publications, their direct comparison is key for our hypothesis. Therefore, we performed additional 3D whole mount confocal imaging of the E9.5 mouse embryo simultaneously staining Tbx5, Aldh1a2, Shh-GFP and Nkx2-1 (new panels in Figure 1D-F), which clearly shows the co-expression of Tbx5 and Aldh1a2 in the pSHF adjacent to the Shh/Nk2-1 expressing pulmonary endoderm. In addition, we used anew online single cells expression resource from the Marioni lab (Lohoff 2020, BioRxiv), to generate a “digital” in situs hybridization of sagittal section through the cardiothoracic region of a E9.5 mouse showing the overlapping expression domains of <italic>Aldh1a2</italic> and <italic>Tbx5</italic> in the pSHF, <italic>Tbx1</italic> in the aSHF and endodermal <italic>Shh</italic> (Figure 1—figure supplement 1F). We also added better labels of anatomical structures on the 3D in situ reconstructions as requested. Finally, we also present 3D maximum projections of confocal images showing the co-expression domain Tbx5-Ald1ha2 in the <italic>Xenopus</italic> pSHF/foregut lpm (new panel Figure 2B).</p><disp-quote content-type="editor-comment"><p>2. In Figure 2a-c, it is clear that while there are some overlaps between Tbx5 and Aldh1a2, there are clearly domains of Aldh1a2 expression that are Tbx5-negative. It would be easier to visualize the overlap of the two domains in Figure 2b by coloring Tbx5 and Aldh1a2 green and red respectively with some quantification of the overlap. Furthermore, it is not clear how the reduction in Aldh1a2 is quantified. Finally, some discussion on what is driving Aldh1a2 expression in cells that are not Tbx5+.</p></disp-quote><p>As requested, we revised the immunostaining in Figure 2B with Tbx5 in green and Aldh1a2 in red. This better shows the overlapping expression domains in yellow, which we quantified by generating a 3D volume with Imaris imaging software (new panel Figure 2B). We also quantified the reduction in Aldh1a2 protein levels based on the average immunostaining pixel intensity in the lpm in both the Tbx5-MO and tbx5-CRISPR mutants (New Figure 2—figure supplement 1B).</p><p>Yes there are some Aldh1a2 expression domains that do not overlap with Tbx5 including the somite and kidney mesenchyme (figures ??), which must be regulated by different enhancers independent of Tbx5. While studying these other enhancers and expression domains is interesting, this are not really relevant to the present and so we only briefly mention this in the revised discussion.</p><disp-quote content-type="editor-comment"><p>3. In Figure 3A, an set of data shows that RA inhibition by DEAB can phenocopy RNA targeting of Tbx5, however, this is not really specific to the expression of Aldh1a2 per say. What is the phenotype of using MO to target Aldh1a2 in these set of experiments?</p></disp-quote><p>We agree that this is an important point given the potential off target effects of inhibitors. As requested, we performed Aldh1a2-MO knockdowns with targeted microinjection to the foregut lpm. Immunostaining confirmed loss of Aldh1a2 protein, and resulted in gene expression changes largely identical to the DEAB treatment. Moreover, addition of exogenous RA rescued the Aldh1a2-MO phenotype. Since Aldh1a2 has earlier functions in the paraxial mesoderm, if the targeting was not efficient the embryos can have other defects, which is why we initially used the DEAB where we can control the timing of RA inhibition. We address the limitations and advantages of inhibitors in the revised manuscript. This new data presented in Figure 3—figure supplement 1A-E further strengthens our conclusions.</p><disp-quote content-type="editor-comment"><p>4. In Figure 4G, it would be nice to colocalize the expression of the GFP with in situ of Adh1a2 to see where the enhancer-driven GFP overlap with actual gene expression.</p></disp-quote><p>As requested, we performed co-staining of the enh1-GFP transgenes with endogenous Aldh1a2, which shows a specific overlap in the Tbx5+ foregut lpm, but not in the somites (new panels in Figure 4—figure supplement 1D-E). Again this is consistent with other Tbx5-independent enhancers regulating Aldh1a2 in other tissues.</p><disp-quote content-type="editor-comment"><p>5. In Figure 5, I would raise a similar point as Comment 3, which is that the use of ketoconazole as a Cyp inhibitor is not as specific as MO targeting Cyp26a1. Would targeting of Cyp26a1 block the effect of FGF8 directly. This would provide stronger mechanistic proof for the model described.</p></disp-quote><p>To address this, we performed MO knockdown of redundant Cyp26a1 and Cyp26a1, both of which are direct FGF targets. RT-PCR analysis of dissected foregut tissue shows that the cyp261a/c-MO phenocopies the Cyp-inhibitors ketoconazole, rescuing FGF8’s inhibition of <italic>shh</italic>, <italic>tbx5</italic>, <italic>wnt2b</italic> and <italic>nkx2-1</italic> expression and elevating their expression levels in untreated foregut explants (new Figure5—figure supplement 1). This new data provides a stronger mechanistic proof that FGF8 restricts RA-dependent cardiopulmonary development in the anterior foregut domain by regulating expression of Cyp26 RA-degrading enzymes. We thank the reviewer for the suggestion.</p><disp-quote content-type="editor-comment"><p>6. In Figure 6E, can RA administration directly increase the reporter activity driven by the MACS1 enhancer? This would better link the Shh enhancer described to an RA response.</p></disp-quote><p>We have added new luciferase assay data that demonstrate that both the human and <italic>Xenopus</italic> MACS1 enhancers can be activate by RA in isolated foregut endoderm and that this activation is dependent on RXR/RAR DNA-binding sites (new Figure 6—figure supplement 2).</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>Prior to publication, a few points need to be considered.</p><p>1. Figure 1H. It will be nice to zoom in the foregut region in addition to showing the whole embryo. Although it is not necessary, it will be informative if the authors can show the in situ hybridization of Fgf10, Shh in TBX5 mutants using the similar projection method.</p></disp-quote><p>As suggested, we have improved the imaging of the cardiopulmonary region with additional high magnification 3D whole mount confocal imaging of the E9.5 mouse embryo simultaneously staining Tbx5, Aldh1a2, Shh-GFP and Nkx2-1 (new panels in Figure 1D-F), which clearly shows the co-expression of Tbx5 and Aldh1a2 in the pSHF adjacent to the Shh/Nk2-1 expressing pulmonary endoderm. In addition, we used a new online single cells expression resource from the Marioni lab (Lohoff 2020, BioRxiv), to generate a “digital” in situs hybridization in sagittal section of the E9.5 mouse cardiothoracic region showing the overlapping expression domains of <italic>Aldh1a2</italic> and <italic>Tbx5</italic> in the pSHF, <italic>Tbx1</italic> in the aSHF and endodermal <italic>Shh</italic> (Figure 1—figure supplement 1F). We focused on Tbx5, Aldh1a2 and Shh rather than Fgf10 since these are the main focus of the work. As the mouse RNA-seq and RT-PCR as well as the <italic>Xenopus</italic> data show reduced Fgf10 and Shh expression of in Tbx5 mutants we did not repeat this by in situ in mice, given our time constraints.</p><disp-quote content-type="editor-comment"><p>2. Fgf10 is known (also shown in Fig1H) to be localized in the future lung budding sites. In between the budding sites Fgf10 is not expressed. Is Tbx5 expressed in this region? It will be informative if authors can also show the projection image of Tbx5 as other genes in H.</p></disp-quote><p>Arora et al., PLOS Genetics, 2012, have already published a description of Tbx5 and Tbx4 expression in the fetal mouse lung, including the distal mesenchyme where they regulate expression of <italic>Fgf10</italic>, <italic>Wnt2</italic>, as well as branching morphogenesis. It is unclear whether RA is involved in this role, but we have mentioned the similarity in the discussion.</p><disp-quote content-type="editor-comment"><p>3. Figure 1I, Can the authors label the projection images, e.g. heart field, lung budding site.</p></disp-quote><p>In addition to providing better analysis of the gene expression, we have labeled the anatomy on the 3D in situ reconstruction.</p><disp-quote content-type="editor-comment"><p>4. Does TBX5 deletion/kd induce stronger foregut phenotypes in frog than mouse? It appears that trachea-esophageal separation is abnormal in frog models (Figure 2B-C). Can the authors provide more details?</p></disp-quote><p>The mouse and <italic>Xenopus</italic> Tbx5 null mutant phenotypes are very similar. As previously described, both have major defects in cardiac morphogenesis and fail to specify respiratory fate in the ventral foregut (Bruneau et al., 2001 Cell, Brown et al., 2005 Development and Steimle et al., 2018 PNAS). Tbx5-/- null mice die between E9.5 and E10.5 due to cardiac defects, before trachea-esophageal separation at E11.5. <italic>Xenopus</italic> tadpoles on the other hand are well known to survive for many days with severe heart defects as they can absorb oxygen from the water, which is one reason that we used <italic>Xenopus</italic> for this study. We now make this clearer in the manuscript and show data on the late tbx5-MO phenotype confirming the previously published hypoplastic atria and vertical lacking trabeculae as well as the failed trachea-esophageal separation (new Figure 2—figure supplement 1).</p><disp-quote content-type="editor-comment"><p>5. Does addition of exogenous Tbx5 RNA or RA in the rescue experiments affect the development of other organs? The presence of any phenotypes can further confirm that the extra Tbx5 or RA works in addition to the qPCR data.</p></disp-quote><p>We did not look at other organs, but focused our analysis on early heart and lung specification, which is the theme of the paper. We show that addition of Tbx5 or RA can rescue cardiopulmonary development as assessed by immunostaining, in situ hybridization and RT-qPCR. There are publications suggesting that Tbx5 and RA may also interact in other tissue such as the limb, but the logic of the regulatory networks appears to be somewhat different. We address this in the discussion. While beyond the scope of this work, in the future it would be interesting to compare the different developmental contexts.</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Recommendations for the authors):</p><p>Phrasing throughout the manuscript should be cautious. For example, differentially expressed genes are not necessarily Tbx5-dependent as worded on page 8 second paragraph.</p></disp-quote><p>We have revised the phasing to be more accurate and cautious as requested.</p><disp-quote content-type="editor-comment"><p>Listing Tbx5 regulation of shh signaling as a key finding is an overstatement.</p></disp-quote><p>We are not sure what the reviewer means here. In our view the finding that Tbx5 indirectly regulates <italic>shh</italic> expression via RA is a major finding and one of the key mechanisms linking mesoderm and endoderm development. We have revised how we describe this to be clear that Tbx5 regulates <italic>shh</italic> expression.</p><disp-quote content-type="editor-comment"><p>Can the authors demonstrate loss of Aldh1a2 expression in Tbx5null embryos?</p></disp-quote><p>The RNA-seq and RT-PCR of the Tbx5-null mouse foregut do clearly demonstrate the loss of Aldh1a2, as does the many experiments in <italic>Xenopus</italic>. Give the time constraints, and the other revisions requested did not repeat this experiment with immunostaining or in situ.</p><disp-quote content-type="editor-comment"><p>The authors should mention the role of Aldh2a2 in retinoic acid processing so that the reader can understand how it functions to regulate RA signaling. The only description present is RA-producing enzyme.</p></disp-quote><p>Yes, we agree that this would be helpful, and we have added this. Thank you for the suggestion.</p><disp-quote content-type="editor-comment"><p>The Wnt GFP reporter data in figure 2 B and C could be moved to supplemental data as it is more distracting than informative.</p><p>A co-stain for lateral plate mesoderm would be beneficial in figure 2 B and C.</p></disp-quote><p>We understand the reviewer perspective, but we have shown the figure to a number of colleagues take a different view and find the Wnt-GFP reporter helpful as this shows the respiratory progenitors. Having said that we take the reviewers point and simplified the description of these data. We also show the panels without the GFP for those readers who find it distracting. To better show the Tbx5-Aldh1a2 co-staining in lateral plate mesoderm we have new immunostaining (Figure 2B) showing the overlap in the ventral-lateral foregut lateral plate mesoderm.</p><disp-quote content-type="editor-comment"><p>For comparison purposes and because the readout is qualitative Figure 3 should be organized in a manner such that DEAB is next to tbx5 MO and 25 nM RA is next to mismatch MO. TBX5 RNA could go to the far right.</p></disp-quote><p>We respectfully prefer to keep the original organization of the columns.</p><disp-quote content-type="editor-comment"><p>Limitation of drug inhibition should be stated. There are likely many more developmental processes disrupted by addition of RA inhibitor at the NF20 stage.</p></disp-quote><p>We have now clearly stated the limitation of the inhibitor experiments. In addition, we have added new Aldh1a2-MO and Cyp261a/c-MO experiments to complement the DEAB and ketoconazole experiments, which support our model. We also acknowledge that these inhibitors can affect other organ system notably the kidney where RA is known to play a role as published by others. While these to not change the interpretation in the cardiopulmonary tissue we agree that it is important to state this.</p><disp-quote content-type="editor-comment"><p>Authors might consider highlighting what new data they have added to the illustration in figure 7.</p></disp-quote><p>Thank you for this suggestion we agree that is helpful.</p><disp-quote content-type="editor-comment"><p>Figure legend 3 should be revised to reflect the panels in the figure.</p></disp-quote><p>Done. Thank you for pointing out this error.</p><disp-quote content-type="editor-comment"><p>Several of the effects observed in Figure 3 A-J appear to span beyond the cardiopulmonary region of the embryo. The author should recognized this in the interpretation of their data.</p></disp-quote><p>We agree that the Tbx5 depleted embryos have non-cell autonomous defects in other tissues including the kidney primordia, pharynx, head and ectoderm. We interpret this to be due to the disrupted RA and FGF signaling that we have documented. We have modified the text to explain this.</p><disp-quote content-type="editor-comment"><p>The diagram in 3L is based primarily on one time point examination. It may be prudent to remove this figure.</p></disp-quote><p>We have revised the figure legend of the model to make it clear that we are refereeing to a specific time point. We agree that this is important since Tbx5-RA interactions may be different at different times.</p><disp-quote content-type="editor-comment"><p>Wording in figure 4A legend has mixed verb tenses.</p></disp-quote><p>Thank you we have corrected this.</p><disp-quote content-type="editor-comment"><p>The statement that Tbx5 activates and represses certain genes goes beyond the data demonstrated in Figure 4A.</p></disp-quote><p>We have revise language to state that expression levels increase and decreases in Tbx5 GOF.</p><disp-quote content-type="editor-comment"><p>The authors should try to separate the description of the results from their discussion of the results. For example, p 12 the entire first full paragraph is more discussion than results.</p></disp-quote><p>We have done this, although we kept some description of previous work where is provides a rational for the experiments.</p></body></sub-article></article>